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ABSTRACT 
 
KIMON DIVARIS: Exploring the genetic basis of chronic periodontitis: a genome-wide 
approach 
(Under the direction of Andrew F. Olshan) 
 
 
Chronic periodontitis (CP) is a common-complex oral disease that affects the 
majority of the adult population and is a major cause of tooth loss. The disease is 
characterized by an oral biofilm pathological shift that contributes to cascade of events 
leading to periodontal destruction. Factors modulating the establishment of a dysbiotic oral 
microbiome or affecting the host immunity and inflammatory response are promising 
preventive and therapeutic targets. Although a substantial genetic component of CP is 
theorized and numerous candidate-gene studies have been completed, to-date no whole-
genome association (GWA) studies have been performed.  
We performed a GWA analysis of CP in well-defined cohort of 4500 white subjects 
who were participants of the Atherosclerosis Risk In Communities study. Traits of interest 
were the three-level disease CDC/AAP classification (healthy/mild, moderate, severe CP) 
and a continuous extent of disease [proportion of sites exhibiting ≥3 mm attachment loss 
(EAL)] measure. Additionally, we examined three traits of high bacterial colonization 
defined as the highest quintile of the distribution of “red” and “orange” complex bacteria, 
and Aggregatibacter actinomycetemcomitans that were quantified using DNA-DNA 
iv 
 
checkerboard hybridization in a subset of 1020 white study subjects. Genotyping was 
performed using the Affymetrix 6.0 platform. Imputation to 2.5million markers was based on 
HapMap II-CEU and a multiple-test corrected significance threshold was applied (P<5x10-8).  
We detected no genome-wide significant signals. However, we found suggestive 
evidence of association (P<5x10-6) for CP with ten loci including NPY, NIN, WNT5A for 
severe, NCR2, EMR1 for moderate CP, and TBX18, ETS1, DYNC2H1, TTC26 and ZC3HAV1 
for EAL. Additionally, thirteen loci including KCNK1, FBXO38,  IL33, RUNX2,  CAMTA1 
and VAMP3 provided suggestive signals of association (P<5x10-6) with the examined “high” 
bacterial colonization traits. The NPY (7p15) locus was replicated in an independent cohort 
of whites of European descent. These genome-wide scan results from a large well-defined 
cohort provide information on multiple candidate regions for interrogation in genetic studies 
of CP. Future investigations providing further replication of these findings may lead to an 
improved understanding of the complex nature of host-biofilm and -bacteria interactions that 
characterizes states of health and disease. 
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CHAPTER 1 
BACKGROUND 
A. Introduction 
Periodontitis, along with dental caries, is one of the two most common diseases of the 
oral cavity. It constitutes an inflammatory response to predominantly commensal oral 
bacteria. This relatively common chronic inflammatory disease is found in about 20% of the 
adult US population, is characterized by gingival pocket formation and clinical attachment 
loss, results in gradual destruction of periodontal tissues and tooth-supporting alveolar bone, 
and is considered the main cause of tooth loss among adults (1,2).  
B. Definition and Pathophysiology of chronic periodontitis 
1. Dental ecology- the host  
The composition and complexity of the oral ecology has recently re-emerged as a focus 
of research, with the investigation of the oral microbiome’s composition and significance 
gaining increased attention (3). It is commonly assumed that an oral ecosystem in 
harmonious symbiosis with its host will likely be associated with health (4). Departures from 
this equilibrium due to pathogenic ecological shifts, up-regulated host inflammatory/immune 
responses, or both, are characteristics of disease (5). In periodontitis, highly organized oral 
microbial biofilms (dental plaque) interact with a plethora of host-specific factors 
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(periodontal anatomy, oral hygiene, inflammatory response, and more) to result in tissue 
damage. Because tissue destruction appears to be a result of host responses to bacterial 
challenges rather than of the lytic effects of periodontal pathogens (6), the nature and extent 
of the microbiome-induced host response is considered an important determinant of the 
periodontitis phenotype. In fact, recent evidence indicates that autoimmune reactions may 
play role in the pathogenesis of the aggressive form of periodontitis (7) 
 
2. Dental ecology- the oral microbiome  
The “specific plaque” theory was articulated more than three decades ago, and 
emphasized the role of oral ecological shifts, essentially the bacterial insult in periodontitis 
(8, 9). In fact, Socransky summarized that in order for a pathogen to cause a disease the 
following conditions must be satisfied: 1) it must be a virulent type; 2) it must possess the 
chromosomal and extra-chromosomal genetic factors to initiate disease; 3) the host must be 
susceptible to the pathogen; 4) the pathogen must be in numbers sufficient to exceed the 
threshold for the host; 5) it must be located at the right place; 6) other bacterial species must 
foster, or at least not inhibit, the process; and 7) the local environment must be one which is 
conducive to the expression of the species' virulence properties (10). 
  The current state of knowledge with regard to the microbiology in periodontitis has 
not shifted from these core principles, as they were described in the 1970s and 1980s (11). 
The importance of the proliferating oral Gram-negative bacteria of the “orange” and the “red 
complex” is firmly established. Socransky in 1998 (12) defined these complexes as follows: 
“orange complex”: Prevotella intermedia (Pi), Campylobacter rectus (Cr), Fusobacterium 
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nucleatum (Fn) and Prevotella nigriscens (Pn). The “red complex” includes Porphyromonas 
gingivalis (Pg), Tannerella forsythia (Tf) and Treponema denticola (Td) (Figure 1). 
It is commonly agreed that periodontitis manifests as a response to predominantly 
commensal microbes, but some authors have argued that Pg and Aggregatibacter 
actinomycetemcomitans (Aa) which are important periodontal pathogens (13) should be 
considered exogenous (14, 15) although this is not well established in the literature. Although 
it is known that the aforementioned bacteria are organized in colonies or biofilms on the 
tooth surfaces, the dental plaque, the question of whether innate factors may facilitate or 
prevent such an infection and colonization is intriguing.  
Recent findings have added to our understanding of how periodontal pathogens harbor 
the oral cavity from early age, symbiose and get organized, and interact among themselves 
and with the host (16, 17). For example, it has been shown that Fn possesses the capacity to 
adhere to and invade oral epithelial cells (18).  Tf, a “red complex” pathogen, has been 
shown to possess a glycosylated S-layer, which is responsible for evading the bacterium’s 
recognition by the host immune system (19). 
Several lines of research have used the presence and colonization level of periodontal 
pathogens as a “refined” exposure of periodontitis (20, 21). Many investigations have used 
serum antibody levels (IgG) to periodontal pathogens as a measure of exposure and/or 
systemic response (17, 22-25). Fewer studies have used direct quantification methods to 
assess the counts of specific pathogens in the subgingival biofilms (microbial plaque) (21, 
26, 27). Interestingly, in a study of the association of periodontal conditions with carotid 
intima-media thickness (IMT), Desvarieux et al (21) reported that total periodontal microbial 
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counts and specifically periodontal pathogens were associated with IMT, whereas 
periodontitis (as classified by CDC) was not. Beck et al (28) suggested that particularly “red 
complex” bacteria may pose a potential risk for the development of systemic disorders. For 
example, a recent report suggested that Pg and Aa may be associated with the risk for pro-
thrombotic state (29), while Pg possesses properties known to be related to the pathogenesis 
of atherosclerosis (30). These investigations support the consideration of these specific 
microbial factors as a distinct exposure in investigations of periodontal, oral and systemic 
health, consistent with the paradigm of “periodontal medicine” (31, 32). 
Interestingly, novel studies have provided insights on the induction by 
periodontopathogenic bacteria of epigenetic changes such as DNA hypermethylation (33). 
Epigenetics is one of the most rapidly expanding fields in biology, and the study of 
epigenetic mechanisms as well as the characterization of the human methylome alterations in 
health and disease, are priorities in biomedical research (34). Further research on the role of 
epigenetics in periodontal disease is needed.  
 
3. Modifying factors 
Despite important advances in our understanding of periodontal diseases the determinants of 
the inflammatory host response are not completely understood. While periodontal pathogens 
are necessary but not sufficient for disease activity to occur (10), several lines of research 
examine factors affecting or modulating the type and extent of inflammation evoked by the 
periodontal pathogens (35).  
The fact that Diabetes Mellitus (DM) and severe periodontitis co-exist has been 
documented, and although a two-way relationship has been suggested (36, 37) causality has 
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not been demonstrated (38-40). While diabetic status modifies the host response to bacterial 
challenges and constitutes a risk factor for periodontitis, adequate glycemic control may be 
facilitated by controlling of an existing periodontal infection and inflammation (41). This has 
been demonstrated by a recent randomized controlled trial (42). It has been shown that 
although the periodontitis-DM relationship holds for both insulin-dependent and non-insulin 
dependent DM, it is more pronounced among patients with poorly controlled DM (43). 
Similar modifying effects have been shown for obesity (44). 
Another example of host response-modification is thought to be the case of oral viral 
infections, which have been gaining attention with regard to CP (45-48). Noteworthy, 
Contreras et al. (49) showed that herpesviruses infections in combination with subgingival 
bacterial presence may exert periodontopathogenic potential by modifying the local host 
response.  
Vitamin D has been reported as an important biological parameter with regard to the risk 
for periodontitis. Recently, Boggess et al. showed that the presence of moderate or severe 
periodontitis among pregnant women was associated with vitamin D insufficiency (50). 
Other lines of research indicate that innate antimicrobial factors such as lactoferrin, a salivary 
defense protein which is also secreted in gingival crevicular fluid during inflammation (51, 
52), are important in the modulation of periodontitis (53).  
Further elucidation of these biological interactions and pathway dissections can create 
new preventive and therapeutic opportunities for periodontitis. Moreover, mechanistic 
insights into the model of periodontitis may be key in understanding pathogenetic pathways 
relevant to other biologic conditions or chronic diseases, such as diabetes mellitus (DM) (37, 
54), cardiovascular disease (CVD) (55, 56) and cancer (57-60). 
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C. Classification of periodontal diseases 
The broad term of “periodontal disease” incorporates conditions other than periodontitis, 
such as gingivitis (61). The latter constitutes of an entirely reversible gingival inflammation 
(62) without periodontal destruction, and is typically diagnosed by bleeding upon periodontal 
probing (BOP). Although gingivitis had long been considered the entry-level stage of 
periodontitis and integral part of the disease continuum, this is not the case according to the 
current state of knowledge.  
With regard to periodontitis, classification to two main types of chronic (CP) and 
aggressive periodontitis (AgP) was proposed in 1999 (61). The diagnosis between 
“aggressive” and “chronic” disease is only possible by knowledge of the rate of periodontal 
tissue destruction, or indirectly, by the assessment of tissue destruction level disproportional 
to a patient’s age. This type of sub-type classification may be problematic both in clinical 
practice (63) and surveillance or population-based studies. Although these two sub-types 
share several features and may appear close in pathogenetic features (64) distinct 
classification between AgP and CP is possible and feasible (65). For example, the 
consideration of an “aggressive” disease type, which likely corresponds to a more genetically 
penetrant or phenotypically expressed characteristic, may be worthwhile in genetic studies. 
On the other hand, it has been recognized that AgP cases may often represent manifestations 
of systemic conditions that interfere with resistance to bacterial infections (61). More recent 
evidence indicated the presence of auto-antibodies against come collagen types in patients 
with AgP but not CP (7). This phenomenon could pose a threat to validity due to disease 
misclassification in studies of periodontitis. At any rate, the classification of periodontitis by 
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sub-type has been a difficult exercise for clinicians and scientists over the last decades, and 
has been subject to numerous changes (65). Nonetheless, to aid in the design and 
interpretation of high-quality population-based studies of periodontitis, an accurate disease 
classification based on precise case definitions is warranted. 
Chronic periodontitis (CP), previously known as “adult periodontitis” (61) is associated 
with irreversible periodontal tissue damage manifested by gradual periodontal attachment 
loss (Figure B). In order to establish the presence and quantify the extent and severity of 
periodontitis a number of clinical signs or measurements have been used: increased 
periodontal pocket depth (measured as probing depth - PD), loss of clinical attachment 
(CAL), alveolar bone loss (ABL) evidenced in radiographic examination, and bleeding upon 
probing (BOP) (65-68). Of those measurements, combined use of both CAL and PD has been 
recommended as the preferred approach in ascertaining the prevalence or progression of 
periodontitis in epidemiologic studies (66). Other attempts to quantify the extent and severity 
of the disease using the maximum amount of clinical information possible resulted in the 
introduction of the extent and severity scores, included in the Extent and Severity Index (ESI) 
by Carlos et al. in 1986 (69). Essentially, the ESI is represents the proportion of sites that 
exhibit disease expressed as a percent of pre-defined probing sites. Because extent and 
severity scores quantify the periodontal destruction as evidenced by the intraoral distribution 
of clinical measurements they can be regarded as an improvement over a categorical 
nosological model. However, these quantitative measures are also particularly vulnerable to 
bias due to tooth loss, even more so compared to more “crude” categorical disease models. 
For this reason, analytical approaches that consider extent scores typically include 
adjustments for tooth loss (70). 
8 
 
Because various researchers had not been using a universally accepted case definition of 
periodontitis, collaborative efforts in Europe and in the US were initiated to work towards 
agreement and convergence in the periodontitis case definition and disease progression 
standards. A European consensus was reached in the 5th European Workshop in 
Periodontology. This consensus statement was published in 2005 and recommended the use 
of a three-level (including health) disease case definition (71). Subsequently, in the US a 
joint workgroup that was initially commissioned in 2003 by the Centers for Disease Control 
and Prevention (CDC) and the American Academy of Periodontology (AAP) reviewed 
existing definitions and suggested another standard (66). Based on that work, an analogous 
three-level classification of periodontitis was proposed for use in population-based studies 
(Table 1.2). At the same time, Offenbacher (72) used a combination of clinical, microbial, 
inflammatory and host-response parameters to propose a five-level disease classification 
labeled BGI (Biofilm-Gingival Interface) that is defined by a combination of PD and BOP 
measurements. The BGI classification is considered a major improvement, because it reflects 
recent advances in our knowledge of the disease characteristics on both biological and 
clinical level taking into consideration the “biological systems model” (35). 
For the purposes of the present investigation we will use the CDC definition and 
classification of CP. Based on the age structure of the studied population it is assumed that 
all periodontitis cases are representing chronic types and not AP. Continuous extent scores 
(e.g. percent of sites exhibiting ≥4mm CAL) will be considered for exploratory analyses. 
The “CDC definition” of periodontitis uses the following taxonomy (Table 1.2):  
1. Severe periodontitis: two or more interproximal sites not on the same tooth with 
≥6 mm CAL and one or more interproximal sites with ≥5 mm PD;  
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2. Initial (moderate) periodontitis: two or more sites with 4 or 5mm CAL not on the 
same tooth;  
3. Health/Gingivitis: individuals not meeting the above criteria.  
 
D. Epidemiology of periodontal diseases 
1.  Prevalence and methodological issues 
Most estimates of periodontitis indicate that advanced adult periodontitis does not exceed 
a 10-15% prevalence in most populations (1, 73). Estimates from the US are typically 
derived from the National Health and Nutrition Surveys. In the latest NHANES survey it was 
reported that 12.8% of the adult population had periodontitis, when the disease was defined 
as one or more sites with CAL≥ 5 mm. The prevalence was at a substantially higher 43.8% if 
the disease was defined as one or more sites with CAL≥ 3mm, and this reflects the dramatic 
impact that classification criteria can have on the disease prevalence estimates (66). 
Moreover, the NHANES employed a partial-mouth examination protocol, essentially 
selecting a subset of teeth, and then sites within teeth to examine. The partial-mouth 
examination protocol, while providing gains in efficiency (maximum examination sites were 
42 sites per individual in the 2001-2004 NHANES versus a maximum of 168 theoretically at 
risk sites per person) was found to substantially underestimate the disease prevalence by as 
much as 60% relative to the true prevalence, as determined by a full mouth examination (74). 
The impact of tooth loss on periodontitis estimates is also an important methodological 
consideration, and was outlined in a previous section. A more detailed investigation and 
quantification of the impact of tooth loss in population-based studies of periodontitis is 
warranted.  
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2. Disease burden 
Although the initially reported estimate of approximately 20% prevalence of CP in 
the adult population in the US is considerable, this figure is likely higher for the 
methodological reasons outlined above. Moreover, most countries in the world do not have 
adequate surveillance systems in place to monitor CP (1, 2). Another consideration is that 
while care-seeking individuals will be diagnosed and subsequently treated for the disease, 
others with sporadic pattern of or no dental attendance will not receive treatment and may 
progress to substantial tooth loss at early ages. This phenomenon will increase estimates of 
edentulism. Moreover, the increasing potential for dentition retention in older ages, combined 
with an ageing population is expected to contribute to a continuously increasing prevalence 
of CP in the next decades unless large scale awareness campaigns or interventions are 
effectively implemented in communities. This population approach is warranted because 
significant disparities in the prevalence of periodontitis exist between age and racial groups, 
with individuals of African American and Hispanic ethnicity being disproportionally affected 
(75).  
A rapidly increasing number of reports associate CP with systemic conditions 
(cardiovascular disease, pregnancy outcomes, diabetes control, oxidative stress, etc), with the 
microbial load and the resultant inflammation being the likely mediators of these 
relationships (76-78). Although definitive evidence that links the treatment of CP with 
improved systemic health outcomes is limited, there are several plausible hypotheses and 
numerous research reports pointing towards this direction (79).  
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3. Impact on the quality of life 
The impact of periodontitis on quality of life has been well-documented (80-83). 
Periodontitis is commonly associated with increased impacts on daily activities, even after 
adjustment for socio-demographic and other clinical conditions, such as caries, tooth loss and 
prostheses (81). Noteworthy, patients under treatment maintenance were found to report less 
daily impacts on their oral health-related quality of life (OHRQoL) compared to newly 
diagnosed patients with CP (83). Of course tooth loss and edentulism, representing the end-
stage of CP are disabling conditions that are associated with severe and multi-level impacts 
(84, 85). Specifically in the US, reports based on NHANES data indicate that oral disease 
disproportionally impacts disadvantaged groups (86). Another recent report based on 
NHANES data concluded that periodontitis, and particularly the level of serum antibodies 
against Pg, was associated with cognitive impairment among older US adults (22).  
 
E. Risk factors for chronic periodontitis 
Although a plethora of risk factors has been reported to be associated with periodontitis, 
the importance of each factor remains unknown. In fact person-level factors, such as age and 
race have been shown to be important determinants of periodontal inflammation (35, 87). 
Oral hygiene has been the longest considered “traditional” risk factor for periodontitis (1, 
88). In fact, while gingivitis parallels the level of oral hygiene on a population-level, this is 
not the case with CP (75).  
Smoking has been found to be the major risk factor for both periodontitis and tooth loss 
(89-91). This is consistent with the well-documented biological effects of smoking on 
periodontal health (92-94). Noteworthy, a substantial proportion of over 40% of periodontitis 
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cases in the US are attributable to smoking based on NHANES III estimates (89); a finding 
with great public health relevance. Prospective studies have also confirmed the causative role 
of smoking in the progression of periodontitis, as evidenced by CAL (95). Evidence also 
exists that smoking modifies the sub-gingival microbial colonization pattern (96) with a 
mechanism that is consistent with the observation that among smokers there is “higher 
infectious burden with periodontal pathogens but less inflammation” (97).  
With regard to DM, numerous studies have shown that diabetics have a greater 
prevalence and extent of periodontal pockets (37, 41, 98, 99). Interestingly, it has been 
reported that inflammatory markers that are evident in periodontitis, were associated with 
incident type 2 DM (100). These findings emphasize the links between oral and systemic 
conditions and the need for a comprehensive consideration of such co-morbidities in the 
diagnosis and treatment of both conditions.  
To date, there is no consensus in the literature regarding the role of alcohol consumption 
as a risk factor for CP (101). A report from the Health Professionals Follow-up Study (HPSF) 
suggested a weak association (in the range of RR=1.2-1.3) but relied upon self-reports of 
periodontitis (102). Another investigation suggested that increased periodontitis risk may be 
conferred by alcohol consumption among individuals with certain polymorphisms of the 
ALDH2 gene (103). Despite the documented multi-level detrimental effects of alcohol, it is 
well established that alcohol also exhibits antimicrobial effects that can confer protection 
from the microbial-plaque diseases. Evidence of such a protective effect has been found in 
both in vitro (104) and clinical (105) investigations.  
Although some evidence suggests that dietary factors such as whole-grain and fiber 
intake may be associated with decreased risk of periodontitis (106) and nutrients such as 
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calcium (107) with decreased prevalence of the disease, most evidence indicates that 
impaired dental condition may be the cause of sub-optimal diet diversity and quality (108, 
109).  
Stress and other psychosocial factors such as coping skills and personality type have also 
been reported as risk factors for development or progression of periodontitis (110, 111). For 
example, in a study by Moss et al. (112), stress and depression traits were important risk 
factors for being a periodontitis case and manifesting disease progression, respectively.  
 
F. The genetic basis of chronic periodontitis 
1.  Early reports of familial segregation 
The genetic component of periodontitis was supported by early reports in the dental 
literature. These reports observed a familial aggregation of severe forms of the disease (113-
117). Other reports, such as the one by Chung et al. (118) who carried out a path analysis 
using data from 241 nuclear families, did not detect any important evidence of heritability. 
These authors instead suggested that common family environment may be a major 
determinant of periodontal health. Michalowicz (119) later suggested that, although other 
periodontal diseases such as gingivitis have a substantial behavioral etiologic component, 
most of the observed heritability in periodontitis is attributable to genetics. The realization of 
the fact that “genes do not function in a vacuum” and that it is unlikely that a “master gene” 
for periodontitis will be discovered (120) underlines the necessity to investigate periodontitis 
risk loci within the full spectrum of common genetic variation. 
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2. Twin studies 
An early report of a periodontitis study among twins was published by Ciancio (121) in 
1969; two more reports were published by Michalowicz in the early 1990s (122, 123). In 
1993 Corey et al. (124), published their investigation of self-reported periodontitis among 
twins. For their study they used a mailed survey among the members of a Virginia-based 
twin registry, and they reported concordance rates of 0.38 and 0.16 between monozygotic 
(MZ) and dizygotic (DZ) twins, respectively. The authors’ conclusion was that, based on 
their findings, genetic factors make an important contribution to the risk of adult-onset 
periodontitis. Subsequently, Michalowicz et al. in 2000 (119) improved the current state of 
knowledge by employing clinical examinations to diagnose periodontitis among 117 MZ and 
DZ pairs of adult twins. In interpreting their findings the authors estimated that periodontitis 
has approximately 50% heritability and thus concluded “approximately half of the variance 
in disease in the population is attributed to genetic variance”. A more recent but small 
investigation that was carried out among 10 pairs of MZ and 8 pairs of DZ twins (125) found 
a substantial amount of discordance in disease severity among the twins, with that 
discordance being greater among DZ pairs. The authors suggested that previous estimates of 
heritability may be exaggerated (125, 126).  
 
3. Candidate-gene studies 
A large number of publications have reported on the association of several gene 
polymorphisms with periodontitis. In these approaches the studied risk variants are thought 
to be associated with altered immune response to the bacterial insult and include, among 
other genes, the interleukin-1 (IL-1) (127), tumor necrosis factors (TNF) (128), matrix 
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metalloproteinases (129), estrogen (130) and vitamin D receptor (50). A summary of these 
findings is illustrated in Table 1.2. There have been very few candidate-gene investigations 
of CP among African Americans (131).  
Previous candidate gene studies have found evidence for an association between 
periodontitis risk and interleukin (IL) gene polymorphisms (particularly IL-1), Fcγ, TNF, and 
matrix metalloproteinsases (128, 131, 132). A recent study reported an association between 
periodontitis and variants in FAM5C (133). Other candidate-gene studies did not detect any 
strong associations between AgP or CP and selected polymorphisms, and suggested the use 
of haplotype or genome-wide analyses as potentially more fruitful strategies (134). 
Moreover, the largest and best-powered candidate-gene study that was carried out in a 
Caucasian population (135) did not detect any important association between the IL-1 cluster 
and AgP risk. In spite of the high risk of bias from very small studies in the field, most 
reviews suggest that the balance of published evidence favors a causative role of IL gene 
cluster polymorphisms with periodontitis (127, 136). Two such meta-analyses summarized 
the evidence of increased risk for CP conferred by IL-1 (137) and Fcγ receptor 
polymorphisms (138). Nikolopoulos et al. summarized 53 published studies and concluded 
that there was a statistically significant association of IL-1A and IL-1B polymorphisms with 
CP risk. Dimou et al. suggested that there is accumulating evidence and supporting biological 
plausibility linking the FcγRIIIB NA1/NA2 polymorphism with increased risk for both AgP 
and CP (138). Finally, one recent investigation reported an association of IL-6 polymorphism 
with colonization with Aa but not Pg, among Caucasian CP patients (139). 
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4. Genome-wide association evidence 
The opportunity to use whole-genome scans for the exploration of the association with 
various phenotypes was early recognized, in the era of family-based studies (140).  Because 
current knowledge, technologies, and methods employed in GWAS allow a satisfactory 
coverage of the common genetic variation (at least among white populations), this approach 
has gained great popularity (141, 142) for the study of common complex diseases. Although 
the initial impact of GWAS has been less dramatic than initially postulated (141, 143), they 
have provided an unprecedented amount of new information regarding the susceptibility for 
and the pathogenesis of many diseases.  
 Schaefer et al. (144) were the first to report a genome-wide association hit with 
periodontal disease. Specifically, these investigators also reported the existence of a shared 
risk susceptibility locus on 9p21.3 (rs1333048), for both AgP and coronary heart disease 
(145). This region was mapped to the sequence of the large antisense noncoding RNA 
ANRIL, which partly overlaps regulatory and coding sequences of CDKN2A/CDKN2B. This 
association was recently replicated in an independent case-control sample with 130 cases of 
AgP and 339 controls (146), where the authors suggested that the most plausible genetic 
model underlying the association between the identified SNPs and AgP is the multiplicative 
one. Further, the same group of investigators in another publication reported that an intronic 
SNP rs1537415 located in the glycosyltransferase gene GLT6D1 was associated with AgP. 
In that study, the rare G allele showed 10% enrichment in cases (total ~280 cases). The 
authors suggested that the rare allele was associated with reduction of the binding affinity of 
the zinc-finder transcription factor GATA-3, which could be important in the pathogenesis of 
AgP. 
17 
 
While these GWA investigations provide the first insights into the genome-wide evidence 
of risk loci for periodontitis, their small sample sizes limited their statistical power. 
Moreover, both studies examined cases of AgP which represents the most aggressive form of 
periodontitis, and is found in about 3% or less among various populations (147, 148).  
A recent review of published articles up to April 2009 on genetic polymorphisms 
associated with CP was published by Laine in 2010 (131). The authors noted that for their 
search strategy they used the keywords: Periodontitis, Periodontal disease in combination 
with the words: Genes, Mutation, or Polymorphism to identify articles written in the English 
language, employing a case-control design to study CP or adult periodontitis and reporting 
genotype distribution. The authors however did not provide an exact search string that could 
be replicated, information about which databases were searched and with what limits, the 
exact number of abstract and full-text articles identified from their searches, additional 
information for seeking additional articles, exclusions including removing duplicates, etc.  
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G. Tables 
 
Table 1.1 Clinical case definitions of Periodontitis proposed by the CDC working group 
for use in population-based surveillance of Periodontitis1 (2) 
 Clinical Definition 
Disease Category 
Clinical Attachment 
Level 
(CAL)  
Probing Depth 
(PD)  
Severe periodontitis ≥2 interproximal sites
2
 
with CAL ≥ 6mm and 
≥1 interproximal site 
with PD ≥5mm 
 
Moderate 
periodontitis 
≥2 interproximal sites2 
with CAL ≥ 4mm or 
≥2 interproximal sites2 
with PD ≥5mm 
 
No or mild 
periodontitis 
Neither “moderate” nor 
“severe” periodontitis   
 
1: third molars are excluded 
2: not on the same tooth 
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Table 1.2. Overview of published genetic effects from candidate-gene case control 
studies of the risk of chronic periodontitis among Caucasians. 
   Number studies found: 
Gene Polymorphism Race Association 
with CP 
No association 
with CP 
IL1A IL1A -889 (+4845) C>T Caucasian 1 11 
IL1B IL1B +3954 (+3953) C>T Caucasian 4 12 
IL1RN IL1RN VNTR (+2018) C>T Caucasian 1 3 
TFNA TFNA (-367) G>A Caucasian 1 5 
IL6 IL6 (-572) C>G Caucasian 1 2 
 
IL6 (-1363) 
G>T Caucasian 1 1 
IL10 IL10 -819 (-824) C>T 
Mixed (~80% 
Caucasians) 2 4 
 
IL10 -592 (-
597) C>A 
Mixed & 
Caucasians 4 4 
FcγRIIα ΙΙα 131 Η>R Caucasian 1 (among 
smokers only) 4 
FcγRIIIb IIIb NA1> NA2 Japanese 1 4 
VDR VDR Taq1 T>C Caucasian 2 2 
CD14 CD14 -260 C>T Caucasian 2 6 
TLR4 TLR4 Thr399Ile Japanese 1 5 
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Figures 
Figure 1. Classification of microbial periodontal pathogens according to Socransky 1998 
(12) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aggregatibacter actinomycetemcomitans 
 
 
“Orange complex” 
Prevotella intermedia 
Campylobacter rectus 
Fusobacterium nucleatum 
Prevotella nigriscens 
 
“Red complex” 
Porphyromonas gingivalis 
Tannerella forsythia 
Treponema denticola 
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CHAPTER 2 
SPECIFIC RESEARCH AIMS 
 
A. Rationale - the case for a GWAS of chronic periodontitis 
Exploring and unraveling the genetic basis of complex diseases has promise in aiding 
therapy, prevention and care for such diseases, and can ultimately lead to improved health 
outcomes (1, 2). The opportunity to use whole-genome scans for the exploration of the 
association with various phenotypes was early recognized, in the era of family-based studies 
(3).  Because current knowledge, technologies, and methods employed in GWAS allow a 
satisfactory coverage of the common genetic variation among whites (4), this approach has 
gained great popularity for the study of common complex diseases (5, 6). Although the 
impact of GWAS has been less dramatic than initially postulated (5, 7), they have generated 
an unprecedented amount of new information regarding the susceptibility for and the 
pathogenesis of many common complex diseases. Notably, a large number of nucleotide 
polymorphisms (SNPs) were found to be associated with a total of 165 traits and were 
reported in 951 published GWA studies through June 2011 (8).  
In the field of dentistry, thus far there have been limited applications of GWAS. 
Three small GWA investigations have reported genome-wide associations of loci with 
aggressive periodontitis (9-11) and two have reported on suggestive risk loci for dental caries 
(12, 13). These investigations were hampered by small sample size and other methodological 
issues such as clinical examination procedures, disease definition, and more. We propose to 
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add on to the existing knowledge basis and improve on these previous investigations by 
carrying out a GWA analysis of chronic periodontitis in the context of a well-defined cohort, 
using a moderately-sized sample of approximately 4600 white individuals for whom detailed 
socio-demographic, anthropometric, periodontal, medical, and behavior data have been 
collected (Specific Aim 1). As a supplement to this aim, we will conduct exploratory 
analyses of genome-wide [gene] x [environment] interactions, by considering SNP 
interactions with sex, smoking, and diabetes mellitus. 
With regard to microbial factors, the pathogenetic role of specific bacterial strains in 
periodontitis is well-established and has been characterized in detail. While there is a great 
diversity in the periodontal microbiome, few microorganisms have been directly implicated 
in the pathogenesis of periodontitis (14). It is well established that colonization with high 
amounts of “red complex” bacteria (Pi, Pg, Tf), as well as Aa, is more common in severe or 
aggressive forms of periodontitis. Pi causes periodontal tissue destruction by triggering the 
host immune response, inducing Prostaglandin E2 and increasing the expression of matrix 
metalloproteinases (15). Pg and Tf have been shown to be more common among cases with 
“refractory” periodontitis versus “treatment-responsive” or periodontally-healthy individuals 
(16). Tf, in particular, was recently shown to possess an external S-layer that likely is 
responsible for the attenuated host response to this pathogen (17). Moreover, periodontal 
pathogens have been associated with systemic morbidities such as CHD, and they have been 
used as a “refined” exposure in studies of oral-systemic health links over clinical 
classifications of periodontitis (18, 19). Thus, preventing or controlling oral ecological shifts 
towards pathogenic biofilms (proliferation of the “orange” or “red” complex) is critical. 
Moreover, it is intriguing to determine why some individuals harbor more or more 
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pathogenic periodontal bacteria, and to this end detect whether innate host factors are 
important. In this domain, one report of a positive association between an IL-6 
polymorphism and harboring of Aa was based on a small sample of forty Caucasian patients 
(20).  We will address this question by exploring whether there are genome-wide loci that are 
associated with increased susceptibility for colonization with CP-risk associated bacteria of 
the “red” and the “orange” complex, as well as Aa (Specific Aim 2). As an additional 
exploratory aim, due to the major role of Pg in the pathogenesis of CP (21), we will 
investigate risk loci for Pg colonization.  
 
B. SPECIFIC AIMS 
By performing the proposed genome-wide association analysis among the white ARIC 
study participants we aim: 
Specific Aim 1: To identify susceptibility loci for chronic periodontitis among a moderate-
sized sample of community-dwelling white adults using the CDC disease classification and a 
continuous measure of disease severity. 
As an addition to Specific Aim 1, we will explore for effect measure modification or gene x 
environment interactions of SNPs with sex, smoking and diabetes mellitus.  
Specific Aim 2: To identify susceptibility loci for colonization with periodontal 
microorganisms of the “orange” and “red” complex, and Aggregatibacter 
actinomycetemcominats. 
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As an additional exploratory step for Specific Aim 2 we will examine for risk loci for another 
individual pathogen, Porphyromonas gingivalis which is member of the “red” complex.
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CHAPTER 3 
RESEARCH METHODS 
 
A. The Atherosclerosis Risk in Communities (ARIC) study 
1. The ARIC study 
The ARIC is a National Heart, Lung, and Blood Institute (NHLB)-funded prospective 
epidemiologic study conducted in four U.S. communities (Jackson, Mississippi; Washington 
County, Maryland; suburban Minneapolis, Minneapolis; Forsyth County, North Carolina). 
The study was IRB-approved for every participating site, and all participants had given 
informed consent. ARIC was designed to investigate the etiology and natural history of 
atherosclerosis, the etiology of clinical atherosclerotic diseases, and variation in 
cardiovascular risk factors, medical care and disease by race, gender, location, and date (1). 
Within the context of ARIC, an NIDCR-funded ancillary dental study was carried out, the 
Dental ARIC. The Dental ARIC aims were to determine the prevalence, extent, and severity 
of periodontal conditions in the dentate ARIC population, and to describe the associations 
between those conditions and prevalent coronary heart disease, coronary artery IMT, 
presence of carotid artery lesions, and atherosclerosis risk factors (2).  
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2. Study population 
The ARIC Cohort Component began in 1987 and recruited a total of 15,792 community-
dwelling participants aged 45-64 sampled from a defined population in their communities (1, 
3). These participants were reexamined every three years with the first screen (baseline) 
occurring in 1987-89, the second in 1990-92, the third in 1993-95, and the fourth and last 
exam was in 1996-98. The Dental ARIC ancillary study took place during the fourth visit, 
between 1996 and 1998 among dentate ARIC subjects.  
From the initial recruitment of 15,792 participants 11,656 were seen in visit 4. Of 
those, 6797 underwent the periodontal examination. After exclusions for various reasons a 
final sample of 6017 subjects formed the Dental ARIC sample (2). There participants had 
mean age of 62 years (range 52-75), 21% had severe periodontitis when using the study 
protocol criteria (≥30% of sites with AL ≥3mm), 13% were diabetics and 44% were males. 
 
3. Dental data 
The Dental ARIC included a clinical oral examination, collection of gingival crevicular 
fluid, oral microbial plaque, and serum, as well as in-person interviews. Clinical 
measurements of PD and CAL were made on six sites on all teeth, and the number of missing 
teeth was recorded. For these measurements, very good accuracy and reproducibility is to be 
expected with trained and calibrated examiners (4-6), as was the case in ARIC. Studies have 
estimates that agreement between examiners for PD and CAL are within 1mm in 90% of the 
measurements taken (4, 7). In the Dental ARIC weighted kappa statistics ranged between 
0.76-0.86 indicating excellent agreement with a standard examiner and intraclass correlation 
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coefficients (ICC) ranged between 0.76-0.90 indicating excellent to outstanding agreement 
(2).  
Using the PD and CAL measurements and based the CDC/AAP criteria (Table 1.1), 
subjects were classified as having no disease, moderate or severe CP. Additionally, a 
continuous measure of disease severity or “extent” based on Carlos et al. (8) was defined as 
the proportion of sites exhibiting CAL ≥3mm. The distribution characteristics of these 
variables in the analytical sample overall and across strata of covariates are presented in 
Tables 3-7. Additional dental (time of and reason for last dental visit, tooth brushing 
frequency, oral hygiene practices) and anthropometric data (body mass index) were used for 
exploratory descriptive and bivariate analyses, and are presented in the Appendix. Details 
about the analytical strategy followed to analyze the CDC and the “extent” traits are 
presented as part of the analytical approach for Specific Aim 1. 
 
4. Microbiological data 
Microbiological data are available for a subset of approximately 1200 white participants 
(9). Samples of subgingival microbial plaque were obtained during the clinical examination. 
Subsequently, the levels of eight periodontal pathogens were determined by DNA-DNA 
checkerboard hybridization analysis, a technique initially described by Gunaratnam et al. 
(10) and Socransky et al. (11). The selection of these eight microbes was based on their 
reported and plausible implication in the pathogenesis of periodontitis (10-12). The method 
has a lowest detection threshold of 103-104 microbial counts, and has been shown to have 
good detection properties (10). Therefore, subgingival microbial counts were obtained for 
organisms of the “red” complex: Pg, Tf, and Td, the “orange” complex: Pi, Pn, Cr, Fn, as 
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well as Aa. Additional information about the analytical strategy with regard to the 
microbiological data is presented as part of the approach for Specific Aim 2.  
 
5. Covariates 
The ARIC study investigators have collected a comprehensive list of socio-demographic, 
behavior, anthropometric and biological measurements (clinical, laboratory, and other 
specialized tests). An extensive list of variables collected can be found on the ARIC website 
(http://www.cscc.unc.edu/aric/) and in previous publications (1). For the purposes of the 
GWA analyses we used the following ARIC study variables: examination center (modeled 
with two indicator variables), age (measured in years and modeled as a continuous variable) 
and sex (male or female). For exploratory “sensitivity” analyses we also used smoking 
(modeled as a three-level ordinal categorical variable were 0: never, 1: former, and 2: current 
smoker), and diabetic status (modeled as a dichotomous variable where 0: healthy and 1: 
fasting glucose levels of ≥126 mg/dL, non-fasting of ≥200 mg/dL, or pharmacological 
treatment for diabetes). To correct for population stratification (admixture) we included in all 
analyses ten principal components derived by the EIGENSTRAT method (see section 3.B.2).  
 
B. Genotyping, quality control and exclusions 
1. Genotyping and imputation 
In the study population, DNA was extracted from blood samples drawn from an 
antecubital vein into tubes containing serum separator gel. Blood samples were analyzed at a 
central ARIC laboratory in Houston, TX. Genotyping was performed with the Affymetrix 
Genome-Wide Human SNP Array 6.0 chip. The platform offers 906,600 markers for SNPs. 
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The rigorous quality control procedures included initial blind duplicate genotyping and 
identification/flagging of SNPs with kappa<0.95 and reconciliation of unintentional duplicate 
samples (17 duplicates and one triplicate). Imputation to 2.5million markers was performed 
using 669,450 SNPs and MACH v1.0.16 (http://www.sph.umich.edu/csg/abecasis/MaCH/ 
index.html), based on HapMap Phase II CEU build 36. The SNPs used for imputation were 
selected from 839,048 autosomal SNPs restricted to those with minor allele frequency 
(MAF)>0.01 (129,543 excluded), Hardy-Weinberg equilibrium (HWE) P>10-5 (12,432 
excluded) and call rate >95% (1,693 excluded). We used the following SNP exclusion 
criteria for further analyses: quality score <0.8 and missing data rate >10% after imputation, 
and MAF of <5%. 
2. Population stratification 
To obtain estimates of relatedness and population stratification a subset of 85,947 
“high quality” linkage-disequilibrium (LD)-pruned SNPs was selected. These SNPs met the 
following criteria among self-reported whites: MAF ≥0.1, call rate >99.5%, HWE P≥10-3, 
autosomal, with annotation in the platform annotation file, not labeled “AFFX” or 
“chromosome 0”, and not monomorphic. Using these SNPs identity-by-state (IBS) allele 
sharing distance (DST values) were computed using PLINK, as such: DST = IBS distance 
(IBS2 + 0.5*IBS1) / (n SNP pairs). First degree relative status was assigned to pairs of 
individuals with DST≥0.8 and second degree relatives were considered those with 0.763 
≤DST< 0.8. Among the white ARIC participants there were 380 pairs of first degree and 207 
pairs of second degree relatives identified. To minimize exclusions, related pairs were broken 
by iterative selection of individuals with most relatives using a custom program. 
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Population stratification was further evaluated with principal component (PC) 
analysis using the EIGENSTRAT approach (13) and the EIGENSOFT program (14). The 
above chosen set of LD-pruned SNPs was used for the computation of ten principal 
components. Genetic outliers were considered those that were further than 8 standard 
deviations (SD) away from any of the ten PCs over ten runs of PC computation. Based on 
DST and PC criteria there were 716 subjects flagged from removal from the analysis (206 as 
genetic outliers based on PCs and 16 based on average DST values (“too little IBS sharing” 
with the rest of the sample), 351 first degree relatives and 143 second degree relatives. All 
but ten second degree relatives (whose relatives were excluded as genetic outliers) were re-
entered in the dataset and were assigned PCs. After exclusion of 364 individuals (4%) there 
were 9349 whites who were included in the GWA analysis and of those, 4610 had 
periodontal phenotype data available as Dental ARIC participants. 
 
C. Analytical strategy 
Goldstein (15), Manolio (16), McCarthy (17) and Hirschorn (18) have summarized 
the key challenges in the analysis and interpretation of genome-wide data. We acknowledge 
the inherent limitations of GWAS, such as the low power to detect very small effects, and the 
consideration of common genetic variance for the detection of “single-polymorphism 
effects”. The problem of the “little variance explained” by the discovered SNPs for most 
diseases has led investigators to look for the “dark matter” of genetic effects in the so-called 
rare (<5% or <1%) variants (19); the study of the latter however, may be methodologically 
challenging unless whole-genome typing becomes more accessible, or when multi-stage (20) 
or novel, more powerful statistical methods (21) are implemented. However, GWAS are a 
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powerful discovery tool that has the potential to unveil previously unknown genetic risk loci 
and provide insights on novel mechanisms and pathways. Acknowledging the strengths and 
limitations of the GWA approach which simultaneously interrogates millions of SNPs across 
the genome, we embarked on this investigation with a “risk locus discovery” rather than an 
“effect estimation” approach.  
 
1. Analytical sample 
Primary analyses were conducted among the Dental ARIC white subjects with imputed 
data (‘freeze 3’ version of genomic dataset). After exclusions specified above (364 whites) 
and merging of the genetic and clinical datasets, our final analytical sample included 4610 
white individuals for whom clinical and genomic data were successfully matched. The 
analytical sample description for Specific Aim 1 is presented in Tables 3-7, and for Aim 2 in 
Tables 4-11. The distribution of the phenotype classification (CP status: CDC definition and 
extent of attachment loss: percent of sites with attachment loss of 3mm or greater) by the 
study covariates is also presented in Table 3. Participants’ mean age is 62 years (range 52-
75), 13% are diabetics and 44% are males. When Beck et al. used the CDC classification of 
periodontitis in a subset of ~5000 Dental ARIC participants, 42% were periodontally healthy, 
41% had initial periodontitis and 17% had ‘severe’ periodontitis (22). In our analytical 
sample, these proportions are virtually identical, 43 and 17% respectively. 
   
2. Analytical strategy for Specific aim 1 
The primary phenotype of interest to address our Specific aim 1 was chronic periodontitis as 
defined by CDC, a three-level categorical classification. The secondary phenotype was the 
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“extent” of attachment loss, a continuous measure that is expressed as the proportion of site 
with attachment loss of 3mm or greater. The following traits were defined and considered for 
the GWA analyses: 
1. Binary outcome: severe periodontitis (coded as 1) versus initial periodontitis or 
health (coded as 0). Statistical analysis will be based on a logistic regression model assuming 
multiplicative (log-additive) allelic effects.  
2. Binary outcome: moderate periodontitis (coded as 1) versus initial periodontitis or 
health (coded as 0). As above, statistical analysis will be based on a logistic regression model 
assuming multiplicative (log-additive) allelic effects.  
 3. Continuous outcome: “extent” or “severity” of periodontitis (proportion of sites 
with CAL≥3mm). An appropriate transformation of this measure (z-score, normal curve 
equivalent transformation of the “crude” proportion of sites) was performed prior to 
conducting the GWAS. Statistical analysis was based on a linear regression model assuming 
multiplicative (log-additive) allelic effects.  
 
“Minimally” adjusted models 
As noted in the general methods section, all models were adjusted for age, sex and 
population substructure/stratification. Adjustment for population substructure in the ARIC 
study has been based on principal component analysis. Although authors have argued that 
population stratification may not be a serious threat to the validity of GWAS results (23), 
adjustment for population ancestry has become standard practice (13). Therefore, the 
“minimal” genetic models include 10 principal components obtained by the statistical 
package EIGENSOFT (13, 14), as well as for sex and age. Additional terms adjusting for 
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examination center (two indicator variables) were entered in all models. For implementation 
in the context of the GWAS we used the probABEL package, which is part of the geneABEL 
suite (24).  
Interpretation of analysis results relied on the evidence that the data offer against the 
null hypothesis of no SNP (allelic) association with the traits of interest, and therefore was 
based on the associated P-values. When multiple SNPs emerged below the P-value threshold 
for prioritization (see following section on hypothesis testing), we presented the “top SNP” 
per locus, which was the one with the lowest P-value. The additional prioritized SNPs in the 
same locus were also presented, along with linkage disequilibrium metrics (R2 with the “top 
SNP” in the locus) obtained with the SNAP application (25). Moreover, effect estimates 
(odds ratios for the disease classification and betas for the “extent” trait), as well as ‘model-
predicted’ phenotypic estimates by genotype were also obtained and presented for the “top 
SNPs” in each locus.  
 
Hypothesis testing 
To determine genome-wide “significance” of the tested SNPs’ association with the 
examined phenotypes we considered a multiple-test correction. The Bonferroni has been 
most frequently used in published GWAS, it is commonly agreed however, that this approach 
is overly conservative. This issue is further discussed in the limitations part of the discussion 
section. After applying the multiple-test correction, assuming approximately a million 
independent tests, a genome-wide significance threshold of P<5x10-8 was set. We set 
another, less stringent threshold of P<5x10-6 for prioritizing SNPs for further investigation 
and locus exploration. 
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The FDR, as described by Storey and Tibshirani (26), an alternative method proposed 
to evaluate results from GWAS. In the FDR approach, a q value (instead of a p) is calculated 
as a measure of significance in terms of false discovery rate, versus false positive (in the p 
value setting). The interpretation of a q value can be thought as the proportion of significant 
findings (genome-wide “hits”) that turn out to be false positives, after replication/verification 
(26). Along these lines, Shi et al recently reported a simulation study based on a two-stage 
FDR approach and use of a least absolute shrinkage and selection operator (LASSO) 
regression to reduce false positives (27).  
 
Sensitivity analysis - exploratory “fully” adjusted models 
Using the accepted definition of a confounder (28), no confounding of the association 
SNPphenotype is to be expected by “environmental” or “behavioral” variables. This is 
supported by the fact that, under standard assumptions, these covariates do not affect the 
distribution of SNPs in the source population. However, because factors such as smoking and 
diabetes are risk factors for CP, one may argue that GWAS-identified signals for CP could be 
in fact, signals marking risk loci for these “intermediate” characteristics. In that scenario, 
adjusting for smoking and diabetes would “sanitize” the GWAS results from these results. 
On the other hand, in cases of pleiotropy (implying a true common genetic cause or risk 
locus of two traits) this result would reflect a valid association. Investigators have proposed 
methods of adjustment for correlated phenotypes (29), but “non-adjusted” analyses remain 
the current standard of practice to-date. Another view in favor of “adjusted” genetic 
modeling supports that the variance reduction that results from such adjustments is favorable 
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in the GWA “discovery” attempt, because there remains “less variance to  be explained” by 
the genetic effects.  
Motivated by the above, we undertook a “sensitivity” analysis as an exploratory step 
that is presented in the Appendix of Chapter 4. In these supplemental analyses we employed 
smoking and diabetes-adjusted genetic models for the three traits examined in the first 
manuscript (severe and moderate CP, and “extent” of attachment loss). We compared ‘crude’ 
and ‘adjusted’ effect estimates for the prioritized SNPs, using an empirical 10% change-in-
estimate criterion for ‘notable’ effect estimate changes, similar to settings of confounding 
evaluation (30). Moreover, we inspected whether additional SNPs emerged below the 
threshold of genome-wide significance (P<5x10-8) or prioritization (P<5x10-6), due to the 
“available variance reduction” effect that was explained above.  
   
Exploratory assessment of effect measure modification- “gene x environment” 
interactions 
Genome-wide explorations of gene x environment interactions are not common. As 
noted in the general methods section, our study of approximately 4000 subjects was 
underpowered to detect interaction effects. However, we conducted exploratory evaluations 
of EMM by three variables: sex, smoking and diabetes. The rationale for the selection of 
these three factors is supported by the fact that they represent important and well-
documented risk factors for CP: the disease is substantially more common among males, 
smokers and diabetics. This is evident both in the literature, as well as our Dental ARIC 
study population. We used the “extent” of attachment loss trait for these exploratory 
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analyses, because it represents a cumulative and non-reversible measure of periodontal 
destruction among the teeth present in the oral cavity.  
EMM was evaluated on the multiplicative (log-additive) scale in the context of 
statistical interaction between SNPs and sex (binary variable), smoking (three-level variable) 
and diabetes (binary variable). Each interaction term was entered in one of three linear 
regression models that apart from age, sex, examination center and 10 PCs, included the risk 
factor main effect (i.e. smoking) and its interaction with the SNP (SNP*smoking). We 
conducted these analyses with the probABEL package, and considered evidence of EMM 
interaction term P-values of less than 10-5. This relatively high P-value threshold was chosen 
because interaction evaluations have traditionally low power. An alternative approach of 
EMM evaluation could have been stratified analyses (by sex, smoking and diabetes) followed 
by a between-strata homogeneity evaluation, which would also be subject to reduced power. 
We chose the statistical interaction approach over stratified analyses as a more efficient 
strategy. 
 
Annotation and visualization of GWA results 
Genome-wide significant and ‘prioritized’ SNPs (based on the P-value criteria that 
were set in the ‘hypothesis testing’ section) were annotated using the WGAViewer (31) and 
Snipper (http://csg.sph.umich.edu/boehnke/snipper/) programs. We explored and reported SNPs 
locations and their role (i.e. intronic or intergenic, representing a base pair change or a 
synonymous change, and more), as well as their physical distance (in Kb) from the two or 
three closest known genes. Additionally, in the Appendix we present associations of the 
prioritized SNPs with known expression quantitative loci (eQTL) (32), as well as their 
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interacting genes. This expression-association information was obtained from the Scan (33) 
database (http://www.scandb.org/newinterface/about.html) via the Snipper annotator. We 
report eQTL-gene associations found in lymphoblastoid cell lines (LCL) among central 
European (CEU) population samples and P≤10-4. 
Quantile-quantile (Q-Q) plots were generated to compare the calculated versus 
expected empirical distributions of the test statistics (-log10 P-values) and detect any 
substantial deviations that could indicate residual population stratification. For this purpose 
we evaluated the Lambda (λ) inflation coefficients’ proximity to 1. Manhattan plots were 
also used to display the summary of the genome-wide analysis results (-log10 P-values) by 
chromosomal location. The Matlab® program was used to display Q-Q plots, λ coefficients 
and Manhattan plots. To inspect genomic regions that appear associated with the examined 
phenotypes, we used LocusZoom® version 1.1 (34) and Haploview v.4.2 (35). With these 
applications we were able to plot selected SNPs on their physical chromosome locations, 
along with their corresponding –log10 P-values, nearby gene locations, linkage 
disequilibrium (LD) and recombination rate statistics based on HapMap II-CEU. For 
missense changes, prediction of the possible impact of amino acid substitutions on protein 
structure and function was assessed using the PolyPhen-2 application (36). We used the 
USCF/Encode genome browser (http://genome-preview.ucsc.edu/cgi-bin/hgTracks?db=hg19 
) to visualize these prioritized loci for genomic areas that may include functionally relevant 
features, such as open chromatin and DNase I hypersensitivity annotation. Additionally, 
crude visualizations of functional pathways or interaction networks that identified genes may 
be implicated were generated with the GeneMANIA application (37). The complete set of 
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software that we used for annotation, visualization and additional exploration of identified 
SNPs and loci is presented in Table 3.1. 
 
 Power calculations 
Several programs are available for power calculations in GWA studies (38). Because 
of its flexibility in enabling power calculations in the presence of G*E (gene by exposure) 
interactions, we used the QUANTO v. 1.2.4 program (http://hydra.usc.edu/GxE/). 
Typical effect sizes of new SNPs detected by GWAS have been reported to range 
between 1.1 and 1.3 (15). Using our sample size of ~4,000 individuals and an outcome 
prevalence of 17 or 60% (depending on the definition) for Specific Aim 1, we had 80% 
power to detect effects of odds ratio size ≥1.4 for minor allele frequencies (MAF) greater 
than 10%. As expected, we were less powered to detect interaction effects in the exploratory 
analyses, unless one assumes relative interaction effects of ≥1.8 magnitude. Illustrations of 
various iterations of effect sizes, outcome prevalence values, MAF and power are presented 
in the Appendix. 
 
3. Analytical strategy for Specific aim 2 
Counts of the eight periodontal pathogens were derived with a semi-quantitative method, 
“checkerboard” DNA-DNA hybridization (10, 11). This method was applied on plaque 
samples to measure the extent of sub-gingival colonization with: Prevotella intermedia 
[American Type Culture Collection (ATCC) 25611], Campylobacter rectus (ATCC 33238), 
Fusobacterium nucleatum (ATCC 10953), and Prevotella nigriscens (ATCC 33563) 
(belonging to the “orange” complex); Porphyromonas gingivalis (ATCC 33277), Tannerella 
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forsythia (ATCC 43037) and Treponema denticola (ATCC 35404) (“red” complex); and 
Aggregatibacter actinomycetemcomitans (ATCC 43718). In this method bacterial levels are 
expressed as counts relative to established microbial standards.  
Three dichotomous traits of “high” colonization with “red” and “orange” complex, and 
Aggregatibacter actinomycetemcomitans were considered for analytical purposes. The two 
composite phenotypes were derived by the summation of bacterial count for each species 
belonging to the “red” (n=3) and “orange” (n=4) group, as described above. Because 
Porphyromonas gingivalis is considered the major periodontal pathogen implicated in 
periodontitis in adult populations, we explored for additional risk loci using its “high” 
colonization phenotype defined as above, as a separate trait, in analyses that we present in the 
Appendix.  
Various approaches in defining the bacterial colonization profiles have been previously 
used, including summations of the absolute microbial counts (9), tertile-categorization (39), 
and five-level categorization of log10-transformed counts (40). To approach Specific Aim 2, 
we defined a “high” colonization trait as the top quintile (20%) of each trait’s distribution. 
The rationale for the selection of this phenotype is based on the fact that the “checkerboard” 
semi-quantitative method has a lower detection threshold of ~103-104 and reduced precision 
in the lower end of the distribution. For this reason, individuals with “high” bacterial 
colonization profile may be those with reduced or impaired host and at high risk for 
periodontal tissue destruction, thus the “high colonization cases” are a trait of interest. 
Additionally, selection of a smaller subset of individuals (i.e. top 5 or 10%) would reduce our 
already low power for the GWA analysis among the ~1000 subjects.  
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 Genetic models, annotation and visualization of results, power calculations 
Three logistic regression models assuming multiplicative (log-additive) genetic effects 
were employed to address Specific aim 2, one for each trait of interest: “high red” complex, 
“high orange” complex, and “high” Aa colonization. We used identical model specifications 
as in Aim 1, and included age, sex, examination center and 10 PCs as covariates. We 
followed identical post-analysis annotation and visualization procedures. The power analyses 
are presented in the Appendix. As noted in the Specific Aims section, we developed an 
additional fourth model to examine for risk loci for Pg as an exploratory step. Results of this 
analysis are presented in the Supplemental material of Chapter 5.  
 
C. Replication plan for GWA findings 
Replication of identified SNPs from any GWA study to other samples is a warranted 
validation step (17, 41). Some investigators have suggested that because replication efforts 
may fail to confirm even true associations when power considerations exist there is no reason 
for investigators to place unreasonably high expectations on replication studies (42). In spite 
of this, the field appears settled into routinely requesting replication of GWA findings. 
  Candidate replication datasets for the present GWA analysis will ideally include 
detailed ascertainment of chronic periodontitis based on the CDC taxonomy (or alternatively 
extent of attachment loss) using full-mouth six-sites per tooth periodontal examinations of an 
adequately sized sample of white subjects. The investigators’ team is actively seeking 
opportunities for collaboration and eventually replication of our findings. Replication of the 
microbiological findings (Specific Aim 2) appears less likely, but opportunities may arise in 
the future, as more investigators explore the host-oral microbiome interactions. Candidate 
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studies where a replication of our main findings could be performed if genotype data become 
available include the National Health And Nutrition Examination Survey (NHANES), the 
Health ABC study, and the Health Professionals Follow-up Study (HPFS). Meta-analysis of 
replicated results will be performed using the METAL program (43). 
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D. TABLE 
 
Table 3.1. Software applications used for the genome-wide association analysis, annotation and 
visualization of results. 
Program 
name 
(version) Functions Website 
Developer, 
year and 
citation 
GeneMANIA Gene network discovery and 
visualization 
http://www.genemania.org/ Mostafavi, 
2008 
Haploview 
(ver.4.2) 
Linkage disequilibrium (LD) 
and haplotype visualization and 
analysis 
http://www.broadinstitute.org/scientific
-
community/science/programs/medical-
and-population-
genetics/haploview/haploview 
Barrett, 
2005 
LocusZoom 
(ver.1.1) 
Regional association results 
plotting 
http://csg.sph.umich.edu/locuszoom/ Pruim, 2010 
METAL Meta-analysis of GWAS results http://genome.sph.umich.edu/wiki/ME
TAL_Program 
Willer, 
2010 
Polyphen 
(ver.2.1.0) 
Prediction of damaging 
missense mutations 
http://genetics.bwh.harvard.edu/pph2/i
ndex.shtml 
Adzhubei, 
2010 
PLINK Genome-wide association 
analysis package 
http://pngu.mgh.harvard.edu/~purcell/p
link/ 
Purcel, 
2007 
ProbABEL 
(ver.1.0.3) 
Genome-wide association 
analysis package for imputed 
data 
http://www.genabel.org/packages/Prob
ABEL 
Aulchenko, 
2010 
QUANTO 
(ver.1.2.4) 
Power and sample size 
calculation in the presence of 
gene x environment interactions 
http://hydra.usc.edu/GxE/ Gauderman, 
2006 
SNAP 
(ver.2.2) 
Identification of proxy SNPs 
and generation of LD plots 
http://www.broadinstitute.org/mpg/sna
p/index.php 
Johnson, 
2008 
Snipper 
(ver.1.2) 
SNPs annotation including 
nearby genes and expression 
quantitative loci 
http://csg.sph.umich.edu/boehnke/snip
per/ 
Welch, 
2010 
WGAViewer 
(ver.1.26l) 
GWAS result annotation 
package 
http://people.chgv.lsrc.duke.edu/~dg48
/WGAViewer/std.php 
Ge, 2008 
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B. MANUSCRIPT #1 SUMMARY 
Chronic periodontitis (CP) is a common-complex oral disease that affects the majority of 
the adult population and is a major cause of tooth loss. Although a substantial genetic 
component of CP is theorized, to-date, no whole-genome association (GWA) analyses have 
been performed. We conducted a GWA analysis among 4610 white participants of the 
Atherosclerosis in Communities Study (mean age of 62 years). Traits of interest were the 
three-level CDC/AAP periodontitis classification (severe—17%, moderate—43%, healthy—
40%), and the continuous trait of “extent” of attachment loss (EAL; proportion of sites 
exhibiting ≥3mm attachment loss). Genotyping was performed with the Affymetrix 6.0 
platform and imputation to 2.5million markers was based on HapMap II-CEU. We used 
logistic genetic models for the examination of the “severe” and “moderate” CP, and a linear 
model for the EAL trait using a genome-wide significance threshold of P<5x10-8. No 
genome-wide significant association signals were noted. However, we found suggestive 
evidence of association (P<5x10-6) for seven loci including NIN, NPY, WNT5A for severe, 
NCR2, EMR1 for moderate, and TBX18, ETS1, DYNC2H1, TTC26 and ZC3HAV1 for EAL. 
These genome-wide association results from a large well-defined cohort provide information 
on multiple candidate regions for interrogation in future genetic studies of CP.  
 
Keywords: periodontitis, genome-wide association studies; oral health; dentistry; genetics;  
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C. INTRODUCTION 
Chronic periodontitis (CP) is a common-complex disease of the oral cavity that is 
characterized by an inflammatory response to commensal and pathogenic oral bacteria (1). 
This relatively common chronic inflammatory disease is found in about 20% of the adult US 
population, manifests with gingival pocket formation and clinical attachment loss (CAL), and 
results in gradual destruction of periodontal tissues and tooth-supporting alveolar bone. CP is 
considered the main cause of tooth loss among most adult populations worldwide (2). 
Moreover, a growing body of evidence has linked the disease with increased risk for 
systemic conditions including coronary heart disease (CHD) (3), pregnancy outcomes (4), 
poor diabetes control (5), and other conditions.  
 There are more than 450 species identified in the human microbiome (6), and 
although harboring of periodontal pathogens is virtually universal, only a small proportion of 
individuals develop the severe form of the disease. Risk factors for CP have been well-
studied and include smoking and diabetes mellitus (DM). In addition, age, race and obesity 
have also been shown to be important risk indicators (7). A genetic component of CP risk 
was supported by early reports of familial aggregation of severe forms of the disease (8), as 
well as twin studies (9), but the magnitude of risk conferred by genetics and the role of 
specific genes has been under debate.  
Recent candidate-gene studies for CP have focused on genes related to host immunity 
and inflammatory response, such as cytokines, cell-surface receptors, chemokines, enzymes 
and antigen recognition. Most of these studies have examined polymorphisms in the 
interleukin (IL)-1, IL-6, Fc gamma receptor (FcγR), tumor necrosis factor alpha (TNFα), 
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human vitamin D receptor (VDR), cluster of differentiation (CD)-14, matrix 
metalloproteinase (MMP)-1, toll-like receptor (TLR), cyclo-oxygenase-2 (COX-2), and C-
reactive protein (CRP) gene coding regions (10).  
 A recent genome-wide association (GWA) study of generalized aggressive 
periodontitis (gAgP) among a sample of whites of European descent identified associations 
with a susceptibility locus on 9p34.3 intronic to the glycosyltransferase 6 domain containing 
1 (GLT6D1) gene, as well as a shared susceptibility locus on 9p21.3 for both gAgP and CHD 
(11, 12). However, gAgP is a rare form of periodontitis, found in less than 1% of adults, and 
is a distinct entity from CP. To-date no GWA exploration has been performed for CP. To add 
to the knowledge base of the genetic etiology of CP, this study aims to investigate genetic 
risk loci for CP using a GWA approach in the context of a well-defined cohort. 
D. MATERIALS AND METHODS 
We conducted a GWA study among 4610 white participants of the Atherosclerosis Risk 
In Communities (ARIC) longitudinal cohort investigation (13). The ARIC is a longitudinal 
investigation of atherosclerosis, CVD risk factors and outcomes, which included a complete 
oral-dental examination between 1996 and 1998. As part of the Dental ARIC ancillary study, 
participants underwent complete periodontal examinations that recorded the number of 
missing teeth, probing depth, attachment loss and bleeding upon probing measurements at six 
sites per tooth, including third molars. Clinical examiners were trained and calibrated against 
a standard examiner, with corresponding kappas indicating excellent to outstanding level of 
agreement (14).  
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For the GWA analyses we used two traits, the Centers of Disease Control (CDC) and 
American Academy of Periodontology (AAP) consensus three-level classification and 
second, a continuous “extent” score of disease severity. The CDC/AAP classification uses 
CAL and PD criteria to define three CP categories as, healthy-mild, moderate and severe (15) 
(Supplemental Table 1). The “extent” of disease score was defined as the proportion of 
measured sites that exhibited CAL equal or greater than 3mm (16). The rationale for 
examining the continuous trait is supported by the fact that attachment loss is a non-
reversible marker of periodontal destruction, whereas the CDC/AAP taxonomy includes a PD 
criterion, which is potentially reversible. Additional covariates that we used for descriptive 
and exploratory ‘adjusted’ genetic models were smoking (measured as a three-level ordinal 
categorical variable: never, former and current), and diabetic status (fasting glucose levels of 
≥126 mg/dL, non-fasting of ≥200 mg/dL, or pharmacological treatment for diabetes). 
Genotyping was based on the Affymetrix Genome-Wide Human SNP Array 6.0 chip 
which offers 906,600 SNP markers. The platform offers 906,600 markers for SNPs. 
Following rigorous quality control procedures, imputation to 2.5million markers was 
performed using 669,450 SNPs and MACH v1.0.16 
(http://www.sph.umich.edu/csg/abecasis/MaCH/index.html), based on HapMap Phase II 
CEU build 36. Comprehensive descriptions of genotyping and imputation, quality control 
and population stratification procedures, are presented in the Appendix. 
Two analytical endpoints were considered for the main effects analysis of the present 
project: CDC/AAP CP disease classification and “extent” of disease (attachment loss). Two 
contrasts were considered for the first trait: moderate vs. mild/healthy and severe vs. 
mild/healthy. The rationale for considering these contrasts is that severe and moderate CP are 
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considered distinct forms rather than variable expressions or “natural progression” stages of 
the disease. These analyses relied upon logistic regression models where allele effects were 
considered multiplicative (log-additive). To investigate the continuous trait of attachment 
loss, the proportion of sites exhibiting ≥3mm CAL was Z-score transformed into a normal 
curve equivalent variable, and a linear genetic model was used. All models included age, sex, 
examination center and ten principal components from the EIGENSTRAT analysis as 
covariates. A correction for multiple comparisons was employed assuming 1 million 
independent tests resulting in a threshold of genome-wide statistical significance of P<5x10-8. 
Although variables such as smoking and DM are not likely confounders of the association 
between genetic polymorphisms and risk of CP, we developed a series of models adjusting 
for these variables, as a sensitivity analysis. For this step, the results of which are presented 
in the supplemental material, we used an arbitrary criterion of >10% change-in-estimate 
which is often used in confounding evaluation in epidemiologic studies (17). We used this 
criterion to inspect for “important” changes in estimate for the prioritized SNPs, and explored 
whether additional ones emerged below the P<5x10-6 threshold upon the resulting variance 
reduction.  
All genetic analyses were performed with the ProbABEL software (18). Post-analysis 
procedures included the generation of quantile-quantile (Q-Q) and Manhattan plots. A 
threshold of P<5x10-6 was set for prioritizing SNPs for further investigation. SNPs were 
annotated using WGAViewer ver.1.26l (19) and Snipper ver. 1.2 
(http://csg.sph.umich.edu/boehnke/snipper/), and regions were viewed using LocusZoom 
ver.1.1 (20) and Haploview ver.4.2 (21). We used additional online resources of the National 
Center for Biotechnology Information (NCBI- http://www.ncbi.nlm.nih.gov/). Reporting of 
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genes was based on the “HUGO Gene Nomenclature” naming convention 
(www.genenames.org). 
E. RESULTS 
The descriptive characteristics of the Dental ARIC cohort participants that were included 
in this analysis are presented in Table4.1. Participants had a mean age of 62 years, with a 
balanced sex distribution. Twelve percent were current smokers, and eleven percent had DM. 
In terms of CDC/AAP periodontal diagnoses, these were severe—17%, moderate—43%, and 
healthy—40%. In the main analyses we found no genome-wide significant association 
signals. Of the total 2178777 examined SNPs, 26 had a P<5x10-6 and thus were prioritized 
for further investigation (Figures 4.1-3). Lambda variance inflation factors for the three traits 
were low, and ranged between 1.003 for attachment loss to 1.024 for severe CP (Figures 
4.10-12). The prioritized SNPs marked three loci as associated with moderate (6p21.1, 
19p13.3 and 10p15), three with severe CP (14.21, 7p15, and 3p21), and four loci with the 
continuous trait of attachment loss (6q15, 11q24, 11q22, and 7q34). 
A comprehensive annotation of the prioritized SNPs, as well as corresponding allele 
frequencies by trait is presented in Table 4.2. Visualizations of the corresponding loci, along 
with nearby genes and recombination rates are presented in Figure 4.4-9 and Supplemental 
Figures 4.13-18. For severe CP, the strongest (with respect to P-value) association in the 
14q21 locus was produced by rs12883458, intronic to NIN. The minor C allele showed a 4% 
enrichment among severe CP patients, and was associated with an OR=1.89, P=3.5x10-7.  In 
the 7p15 locus, the common allele of rs2521634 (47Kb from NPY) produced an OR=1.47, 
P=1.6x10-6. Similarly, the common G allele of rs11925054 in the 3p21 locus, adjacent to 
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WNT5A and ERC2 produced the strongest signal in the region, showing 4% enrichment 
among severe CP patients. With regard to moderate CP, the SNP with the lowest P-value in 
6p21.1 was rs7762544 (OR=1.41; P=1.1x10-7). This variant is 61Kb from NCR2, and its 
minor (risk) allele showed 5% enrichment among moderate CP patients compared to healthy 
participants. Rs3826782 which is intronic to EMR1 and 30Kb from VAV1 provided the 
strongest signal in that locus with OR=2.00 and P=4.0x10-6.  
With regard to attachment loss, several SNPs in LD with the top SNP rs17792917 
(177Kb from TBX18; P=1.8x10-6) were found in the 6q15 locus. Individuals with 2 copies of 
the rare (risk) T allele had more than 10% higher mean extent of attachment loss (22.7% vs. 
20.2%) compared to those with CC genotype. The 11q24 locus where rs10790919 
(P=1.9x10-6) provided the strongest signal was in an intergenic region (671Kb from ETS1 
and 787Kb from KIRREL3). Rs7120142 provided the lowest P-value in the 11q22 locus 
(P=3.9x10-6), and was located 67Kb from DYNC2H1 and 360Kb from PDGFD. Carriers of 2 
risk allele copies (rare allele T) had a substantially higher mean extent of attachment loss 
(25.0) compared to those with no risk allele copy (20.4). The 7q34 locus is a gene-rich area, 
where rs10500130 emerged as the top SNP (P=4.6x10-6), with the common C allele being the 
one associated with higher extent of attachment loss score. Rs10500130 was 3Kb from 
TTC26 and 21Kb from ZC3HAV1. Rs1537415 which was the “top hit” in a GWA of AgP 
(11) did not show an important association (P=0.5) with the any of our examined traits. 
F. DISCUSSION 
This manuscript presents results of the first genome-wide exploration for loci associated 
with the risk of CP. The study is limited by the sample size for a GWA, of about 4,000 
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subjects and the absence of a replication sample. The study strengths include a well-defined 
cohort with a detailed phenotypical characterization of CP, using full mouth periodontal 
examinations and the latest commonly accepted taxonomy of CP. The CDC/AAP 
classification has been used in epidemiologic studies and surveillance. Offenbacher and 
colleagues (22) introduced a refined CP classification characterizing the disease’s biological 
(versus clinical-only) phenotype that may be more useful when exploring genetic effects of a 
trait with underlying heterogeneity. Nonetheless, the results of the present investigation 
provide a wealth of new information on potential candidate genes and mechanistic pathway 
analyses that will require further exploration, replication and validation in future studies. In 
general, it can be anticipated that interrogations of the genetic etiology of CP will identify 
markers associated with defense molecules and pathways, as is the case with numerous 
candidate-gene approaches (10).  
Several promising loci and candidate genes were identified in the present analysis. 
NIN is a gene known to encode a protein that plays a role in centrosomal microtubule 
organization and anchoring, which have recently been recognized as elements of the T cell 
cytolytic response (23). Interestingly, a recent candidate-gene study by Olson and colleagues 
reported two of the “top hits” for severe CP in 14q21 of the present study (rs12893300 and 
rs1004832) as associated with breast cancer risk (24). NPY is a gene encoding a neuropeptide 
that is widely expressed in the central nervous system and has been suggested to function as 
an anxiolytic peptide that helps explain inter-individual variation in trait anxiety and 
resiliency to stress (25); a common risk factor for many diseases, including CP. Moreover, 
experimental evidence supports a role of WNT5A in the activation of MMP-2 and the 
regulation of inflammatory cytokine genes of macrophages (26). NCR2 is the gene in the 
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region with strongest signal for moderate CP. It appears to have an important role in both 
normal and pathological innate immune responses, and is selectively expressed by 
Interleukin 2-activated natural killer cells (27). EMR1, VAV1 and CELF2 have also been 
implicated in immune functions such as eosinophilic inflammation, T-cell and B-cell 
development and activation (28).  
With regard to the “extent” of disease trait, apart from two genes are adjacent to the 
locus 6q15 (TBX18 at 177kb and KIAA1009 at 300Kb), the top SNP is 1Kb upstream of the 
novel processed transcript RP1-90L14.1-001. Other promising loci and potential candidate 
genes include PDGFD in 11q22, TTC26 and ZC3HAV1 at 7q34. Wagsater and colleagues 
(29) reported that PDGFs play important roles in atherosclerosis by stimulating matrix 
metalloproteinase (MMP) activity and influencing monocyte migration. ZC3HAV1 encodes a 
zinc finger protein that is thought to prevent infection by retroviruses, possibly by directly 
interacting with viral RNA (30) 
The lack of an overlap of identified loci for the three examined traits is not surprising, 
and in fact verifies the rationale of examining these three phenotypes separately. Moderate 
and severe CP are considered largely distinct entities and include in their case definitions a 
reversible clinical marker (probing depth), while “extent” attachment loss is a cumulative and 
non-reversible marker of periodontal destruction. From a statistical standpoint, the lack of 
overlap is not surprising because small stochastic variations can have a big impact on the 
tails of the test statistic distribution. However, because these traits share a common 
pathogenetic underpinning, and in our analyses we used the same controls for both contrasts, 
some overlap in GWA signals should be anticipated. Explorations at lower P-value 
thresholds may reveal more “good signals” and common risk loci. As an example, in our 
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exploratory smoking and diabetes-adjusted analyses 4q21.3 emerged as a common risk locus 
for severe CP and attachment loss and may be a reflection of this overlap (Figure 4.19). 
It must be acknowledged that although GWAS have provided invaluable new 
information on the genetic basis for many disease and health outcomes, a large component of 
the disease variation remains to-date unexplained (31). The inability of GWAS to detect very 
small effect sizes and interrogate rare polymorphisms, gene x gene interactions and 
epigenetics are additional layers of unaddressed complexity. In our study, although no SNP 
reached the level of genome-wide statistical significance, several loci were nominally 
associated with substantial effect sizes and, if replicated, may offer promising avenues for 
further investigation and mechanistic studies.  
Further investigations providing replication of these findings and additional 
examination of specific associations may lead to an improved understanding of the 
pathogenesis of the disease, as well as novel preventive and therapeutic approaches.  
MANUSCRIPT #1- REPORTING OF FUNDING SOURCES 
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study 
supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, 
HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, 
HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and 
HSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human 
Genome Research Institute contract U01HG004402; and National Institutes of Health 
contract HHSN268200625226C; and by a grant from the National Institute of Environmental 
Health Sciences (P30ES010126). The authors thank the staff and participants of the ARIC 
70 
 
study for their important contributions. Infrastructure was partly supported by Grant Number 
UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for 
Medical Research. The authors declare no potential conflicts of interest with regard to the 
authorship and publication of this article. 
71 
 
G. TABLES 
Table 4.1 Distribution in the total sample and bivariate associations of periodontal diagnosis 
(CDC/AAP disease classification) and periodontal attachment loss (extent score: percent of 
sites with ≥3mm attachment loss) with sex, smoking and diabetic status among the white 
participants of the Dental ARIC study (n=4610). 
  
 
CDC/AAP Periodontitis classification  
Attachment loss 
(≥3mm) 
 
Total 
(n, column %) 
 Health-mild 
(n, row %) 
Moderate 
(n, row %) 
Severe 
(n, row %)  
Extent score1 
mean(SD); 
median2 
Total sample 4610 (100)  1864 (40) 1961 (43) 785 (17)  21.1 (21.2); 14  
Sex3,4  
 
     
Females 2415 (52)  1197 (50) 939 (39) 279 (12)  16.6 (18.2); 10  
Males 2195 (48)  667 (30) 1022 (47) 506 (23)  26.1 (23.2); 19  
Smoking status3,5  
 
     
Never smoker 2104 (47)  1055 (50) 817 (39) 232 (11)  15.0 (15.3); 10  
Former smoker 1876 (42)  633 (34) 870 (46) 373 (20)  24.1 (22.5); 17  
Current smoker 526 (12)  147 (28) 221 (42) 158 (30)  33.7 (27.7); 25  
Diabetic status3,4  
 
     
Healthy 4077 (89)  1704 (42) 1704 (42) 669 (16)  20.6 (20.9); 14  
Diabetes mellitus 527 (11)  158 (30) 254 (48) 115 (22)  25.4 (23.9); 18  
1: Third molars were included in the calculation of the extent of attachment loss trait 
2: Rounded to the closest integer 
3: Chi-square test of equivalence between strata of periodontitis P<0.05 
4: Median test of stratum-specific attachment loss estimates P<0.05 
5: Kruskal-Wallis test of stratum-specific attachment loss or covariate estimates P<0.05 
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Table 4.2. Genome-wide association analysis results of the CDC/AAP chronic periodontitis (CP) classification 
traits (severe CP vs. healthy and moderate CP vs. healthy) and extent of attachment loss trait (EAL-proportion 
of sites exhibiting attachment loss ≥3mm), among the white participants of the Dental ARIC study (n=4610). 
Single nucleotide polymorphisms (SNPs) with minor allele frequency (MAF-HapMap II CEU) of ≥5% and 
associated P<5x10-6. The SNP with the lowest P-value per locus is presented; additional prioritized SNPs in 
each locus are presented in the footnote, along with corresponding R2 (based on 1000 genomes pilot 1 release) 
with the top SNPs. 
Chr. SNP 
Position  
Build36 ca1 nca2 
Risk allele 
frequency 
(HapMap 
II-CEU) 
Closest gene(s) and 
position or distance 
P value 
(beta) 
Risk allele 
frequency 
disease/ 
healthy 
Odds ratio 
(95% CI3) 
Severe CP        
14q214 rs12883458 50349129 C T [C] 0.104 NIN (Intronic) 3.5x10
-7 
(0.64) 0.13/0.09 1.89 (1.48, 2.41) 
7p155 rs2521634 24344565 A G [G] 0.754 NPY (47Kb) 1.6x10
-6 
(0.39) 0.80/0.74 1.47 (1.25, 1.73) 
3p216 rs11925054 55365926 G T [G] 0.865 WNT5A (109Kb); ERC2 (151Kb) 
6.5x10-7 
(0.53) 0.90/0.86 1.69 (1.37, 2.10) 
Moderate CP         
6p21.17 rs7762544 41487293 A G [G] 0.184 NCR2 (61Kb) 1.1x10
-7 
(0.34) 0.21/0.16 1.41 (1.24, 1.60) 
19p13.38 rs3826782 6838736 A G [A] 0.070 EMR1 (Intronic); VAV1 (30Kb) 
4.0x10-6 
(0.69) 0.05/0.04 2.00 (1.48, 2.70) 
10p15 rs12260727 10378335 A G [G] 0.846 CELF2 (709Kb) 6.0x10
-7 
(0.43) 0.89/0.85 1.54 (1.30, 1.82) 
 
  
Mean EAL9 (95% CI10) by genotype 
(number of risk allele copies) 
Extent of attachment loss (≥3mm)   0 copy 1 copy 2 copies 
6q1511 rs17792917 85323684 C T [T] 0.242 TBX18 (177Kb); KIAA1009 (330Kb) 
1.8x10-6 
(1.92) 
20.2 
(19.4, 21.0) 
22.4 
(21.3, 23.4) 
22.7 
(20.0, 25.4) 
11q2412 rs10790919 127162281 A G [A] 0.788 ETS1 (671Kb); KIRREL3 (787Kb) 
1.9x10-6 
(2.04) 
17.1 
(14.5, 19.5) 
19.9 
(18.9, 20.9) 
22.0 
(21.2, 22.8) 
11q2213 rs7120142 102922991 C T [T] 0.197 DYNC2H1 (67Kb); PDGFD (360Kb) 
3.9x10-6 
(1.98) 
20.4 
(19.7, 21.2) 
22.0 
(20.9, 23.1) 
25.0 
(21.3, 28.7) 
7q34 rs10500130 138466453 A C [C] 0.889 TTC26 (3Kb); ZC3HAV1 (21Kb) 
4.6x10-6 
(2.56) 
18.8 
(12.6, 25.0) 
19.0 
(17.7, 20.4) 
21.6 
(20.9, 22.3) 
1:coded allele 
2: non-coded allele 
3: confidence limits 
4: Additional SNPs in locus with P<5x10-6: rs1004832 (R2=1.00), rs8009874 (R2=0.84), rs12893300 (R2=0.49) 
5: Additional SNP in locus with P<5x10-6: rs11771124 (R2=1.00) 
6: Additional SNP in locus with P<5x10-6: rs503022 (R2=0.52) 
7: Additional SNPs in locus with P<5x10-6: rs9357360 (R2=0.89), rs1853406 (R2=0.89), rs1535582 (R2=0.33) 
8: Additional SNP in locus with P<5x10-6: rs12610529 (R2=0.79) 
9: Assuming a log-additive linear genetic model 
10: CL, confidence limits 
11: Additional SNPs in locus with P<5x10-6: rs9791329 (R2=0.58), rs11756650 (R2=0.96), rs7741380 (R2=0.60), rs4510639 (R2=0.67) 
12: Additional SNPs in locus with P<5x10-6: rs6590279 (R2=0.87), rs10893747 (R2=0.87) 
13: Additional SNP in locus with P<5x10-6: rs4440990 (R2=1.00) 
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H. FIGURES 
Figure 4.1 Manhattan plot of the genome-wide association analysis results for severe chronic 
periodontitis among the 4610 white dental ARIC participants.  
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Figure 4.2 Manhattan plot of the genome-wide association analysis results for moderate 
chronic periodontitis among the 4610 white dental ARIC participants. 
 
 
 
 
 
 
 
 
75 
 
Figure 4.3 Manhattan plot of the genome-wide association analysis results for extent of 
attachment loss (proportion of sites exhibiting ≥3mm attachment loss) among the 4610 white 
dental ARIC participants. 
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Figure 4.4 Visualization of the 14q21 locus that was marked by rs12883458 (P=3.5x10-7) for 
severe chronic periodontitis among the 4610 white participants of the Dental Atherosclerosis 
in Communities Study cohort. The vertical axis corresponds to each marker’s associated –
log10 P-value. The overlaid recombination rate plot and the color-coded pairwise linkage 
disequilibrium values with index SNPs were calculated based on HapMap II – CEU (human 
genome 18, build 36). 
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Figure 4.5 Visualization of the 19p13.3 locus that was marked by rs3826782 (P=4.0x10-6) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort. The vertical axis corresponds to each marker’s 
associated –log10 P-value. The overlaid recombination rate plot and the color-coded pairwise 
linkage disequilibrium values with index SNPs were calculated based on HapMap II – CEU 
(human genome 18, build 36). 
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Figure 4.6 Visualization of the 6p21.1 locus that was marked by rs7762544 (P=1.1x10-7) for 
severe chronic periodontitis among the 4610 white participants of the Dental Atherosclerosis 
in Communities Study cohort. The vertical axis corresponds to each marker’s associated –
log10 P-value. The overlaid recombination rate plot and the color-coded pairwise linkage 
disequilibrium values with index SNPs were calculated based on HapMap II – CEU (human 
genome 18, build 36). 
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Figure 4.7 Visualization of the 7p15 locus that was marked by rs2521634 (P=1.6x10-6) for 
severe chronic periodontitis among the 4610 white participants of the Dental Atherosclerosis 
in Communities Study cohort. The vertical axis corresponds to each marker’s associated –
log10 P-value. The overlaid recombination rate plot and the color-coded pairwise linkage 
disequilibrium values with index SNPs were calculated based on HapMap II – CEU (human 
genome 18, build 36). 
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Figure 4.8 Visualization of the 6q15 locus that was marked by rs17792917 (P=1.8x10-6) for 
extent of attachment loss (CAL; sites exhibiting CAL ≥3 mm) among the 4610 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure 4.9 Visualization of the 7q34 locus that was marked by rs10500130 (P=4.6x10-6) for 
extent of attachment loss (CAL; sites exhibiting CAL ≥3 mm) among the 4610 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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J. MANUSCRIPT #1 - SUPPLEMENTAL MATERIAL 
SUPPLEMENTAL MATERIALS AND METHODS 
Genotyping and imputation 
In the study population, DNA was extracted from blood samples drawn from an 
antecubital vein into tubes containing serum separator gel. Blood samples were analyzed at a 
central ARIC laboratory in Houston, TX. Genotyping was performed with the Affymetrix 
Genome-Wide Human SNP Array 6.0 chip. The platform offers 906,600 markers for SNPs. 
The rigorous quality control procedures included initial blind duplicate genotyping and 
identification/flagging of SNPs with kappa<0.95 and reconciliation of unintentional duplicate 
samples (17 duplicates and one triplicate). Imputation to 2.5million markers was performed 
using 669,450 SNPs and MACH v1.0.16 (http://www.sph.umich.edu/csg/abecasis/MaCH/ 
index.html), based on HapMap Phase II CEU build 36. The SNPs used for imputation were 
selected from 839,048 autosomal SNPs restricted to those with minor allele frequency 
(MAF)>0.01 (129,543 excluded), Hardy-Weinberg equilibrium (HWE) P>10-5 (12,432 
excluded) and call rate >95% (1,693 excluded). We used the following SNP exclusion 
criteria for further analyses: quality score <0.8 and missing data rate >10% after imputation, 
and MAF of <5%. 
Population stratification 
To obtain estimates of relatedness and population stratification a subset of 85,947 
“high quality” SNPs was selected. These SNPs met the following criteria among self-
reported whites: MAF ≥0.1, call rate >99.5%, HWE P≥10-3, autosomal, with annotation in 
the platform annotation file, not labeled “AFFX” or “chromosome 0”, and not monomorphic. 
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Using these SNPs identity-by-state (IBS) allele sharing distance (DST values) were 
computed using PLINK, as such: DST = IBS distance (IBS2 + 0.5*IBS1) / (n SNP pairs). 
First degree relative status was assigned to pairs of individuals with DST≥0.8 and second 
degree relatives were considered those with 0.763 ≤DST< 0.8. Among the white ARIC 
participants there were 380 pairs of first degree and 207 pairs of second degree relatives 
identified. To minimize exclusions, related pairs were broken by iterative selection of 
individuals with most relatives using a custom program. 
Population stratification was further evaluated with principal component (PC) 
analysis using the EIGENSTRAT method (1). The above chosen set of SNPs was used for 
the computation of ten principal components. Genetic outliers were considered those that 
were further than 8 standard deviations (SD) away from any of ten PCs over ten runs of PC 
computation. Based on DST and PC criteria there were 716 subjects flagged from removal 
from the analysis (206 as genetic outliers based on PCs and 16 based on average DST values 
(“too little IBS sharing” with the rest of the sample), 351 first degree relatives and 143 
second degree relatives. All but ten second degree relatives (whose relatives were excluded 
as genetic outliers) were re-entered in the dataset and were assigned PCs. After exclusion of 
364 individuals (4%) there were 9349 whites who were included in the GWA analysis and of 
those, 4610 had periodontal phenotype data available as Dental ARIC participants. 
 
SUPPLEMENTAL RESUTS 
Adjusted genetic models 
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Adjustment for smoking and diabetic status resulted in small (<10%) and predominantly 
upwards changes in odds ratios of the prioritized SNPs for the two disease classification traits 
(Supplemental Table S2). Noteworthy, the effect estimate of rs7762544 associated with 
moderate CP increased by 6% for a genome-wide significant adjusted OR=1.44 (P=3.8x10-8). 
Larger and exclusively downwards changes in effect size estimates were noted for the 
prioritized SNPs in the domain of attachment loss. These estimate attenuations ranged from 
11% for rs10500130 to 23% for rs7120142. Four additional loci emerged below the P<5x10-6 
threshold in the adjusted analyses, one of those common for severe CP and extent of 
attachment loss: moderate CP—[rs11615037, OR=1.33; Padj=4.4x10-6, in a region between 
CPM (98Kb) and CPSF6 (178Kb)]; severe CP—(rs10493998, OR=1.68; Padj=2.2x10-6, 90Kb 
from COL11A); extent of CP—(rs8006336, Padj=1.4x10-6 adjacent to RPS29 and PPIL5). 
Rs17006135, was intronic to SCD5, approximately 3Kb from the exon boundary, marking 
the 4q21.3 locus, and was associated with both severe CP (OR=1.82; Padj=4.4x10-6) and 
increased extent of attachment loss (Padj=8.2x10-7). 
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K. SUPPLEMENTAL TABLES 
Table 4.3 Clinical case definitions of Periodontitis proposed by the CDC working group 
for use in population-based surveillance of Periodontitis1 (2) 
 Clinical Definition 
Disease Category 
Clinical Attachment 
Level 
(CAL)  
Probing Depth 
(PD)  
Severe periodontitis ≥2 interproximal sites
2
 
with CAL ≥ 6mm and 
≥1 interproximal site 
with PD ≥5mm 
 
Moderate 
periodontitis 
≥2 interproximal sites2 
with CAL ≥ 4mm or 
≥2 interproximal sites2 
with PD ≥5mm 
 
No or mild 
periodontitis 
Neither “moderate” nor 
“severe” periodontitis   
 
1: third molars are excluded 
2: not on the same tooth 
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Table 4.4 Changes in estimate of top SNPs for the three chronic periodontitis traits after adjustment for smoking (never, former, 
current) and diabetic status (binary) among the white participants of the Dental ARIC study.  
Trait Chr. SNP 
RAF1 
Disease/ 
Healthy Crude estimates  Adjusted2 estimates  
Change in 
estimate3 
(percent) 
    OR/beta4 (95% CL) P value  OR/beta4 (95% CL5) P value   
Moderate vs. 
Healthy 6p21.1 rs7762544 0.21/0.16 1.41 (1.24, 1.60) 1.1x10
-7
  1.44 (1.26, 1.63) 3.8x10-8  +6% 
 19p13.3 rs3826782 0.05/0.04 2.00 (1.48, 2.70) 4.0x10-6  2.09 (1.54, 2.84) 1.4x10-6  +7% 
 10p15 rs12260727 0.15/0.11 1.54 (1.30, 1.82) 6.0x10-7  1.51 (1.27, 1.79) 3.0x10-6  -4% 
Severe vs. 
Healthy 14q21 rs12883458 0.13/0.09 1.89 (1.48, 2.41) 3.5x10
-7
  1.88 (1.46, 2.43) 1.1x10-6  -0.3% 
 7p15 rs2521634 0.80/0.74 1.47 (1.25, 1.73) 1.6x10-6  1.43 (1.21, 1.69) 2.6x10-5  -7% 
 3p21 rs11925054 0.90/0.86 1.69 (1.37, 2.10) 6.5x10-7  1.78 (1.42, 2.23) 2.6x10-7  +10% 
Extent of 
attachment loss 6q15 rs17792917  1.92 (1.13, 2.71) 1.8x10
-6
  1.61 (0.84, 2.38) 4.1x10-5  -16% 
 11q24 rs10790919  2.04 (1.20, 2.88) 1.9x10-6  1.78 (0.96, 2.59) 1.9x10-5  -13% 
 11q22 rs7120142  1.98 (1.14, 2.83) 3.9x10-6  1.54 (0.71, 2.36) 2.5x10-4  -23% 
 7q34 rs10500130  2.56 (1.47, 3.66) 4.6x10-6  2.28 (1.21, 3.34) 2.8x10-5  -11% 
1: Risk allele frequency 
2: Adjusted for smoking (three-level categorical where 0: never, 1: former, 2: current smoker) and diabetic status (dichotomous variable where 0: healthy and 1: 
diabetic) 
3: Calculated as follows: change-in-estimate= [(|betaadjusted| - |betacrude|)  / |betacrude|] *100 
4: OR (odds ratios) are presented for the two binary periodontitis classification traits and beta coefficients for the continuous trait of attachment loss 
5: Confidence limits 
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Table 4.5 Distribution of genotype (based on number of minor allele copies of SNPs with P<5x10-6) by phenotypic classification (three disease traits 
and mean “extent” of disease) among the Dental ARIC participants.  
   Healthy (%)  
Moderate chronic 
periodontitis (%)  
Severe chronic 
periodontitis (%)  
Mean extent of attachment loss 
(≥3mm) and (95% confidence limits) 
Minor allele copies (n)  0 (%) 1 (%) 2 (%)  0 (%) 1 (%) 2 (%)  0 (%) 1 (%) 2 (%)  0 (%) 1 (%) 2 (%) 
Chr. SNP                 
6p21.1 rs77625441,4  69.6 27.9 2.5  62.3 33.9 3.9  68.1 29.3 2.6  20.9 (20.1, 21.6) 
21.5 (20.4, 
22.7) 
22.4 (18.6, 
26.2) 
19p13.3 rs38267821,4  93.0 6.9 0.1  90.2 9.6 0.3  91.7 8.3 0.0  21.1 (20.4, 21.7) 
22.5 (20.3, 
24.7) 
16.1 (9.1, 
23.1) 
10p15 rs122607271  72.4 25.5 2.1  78.3 20.6 1.1  76.3 22.0 1.7  21.5 (20.8, 22.3) 
20.0 (18.7, 
21.3) 
17.1 (12.6, 
21.6) 
14q21 rs128834582,4  82.6 17.1 0.3  80.2 18.9 0.9  74.8 23.6 1.7  20.7 (20.0, 21.4) 
22.6 (21.2, 
24.1) 
25.6 (19.1, 
32.1) 
7p15 rs25216342,4  54.1 39.2 6.8  55.4 38.8 5.8  63.8 32.4 3.8  21.6 (20.8, 22.4) 
20.8 (19.8, 
21.8) 
18.6 (16.2, 
21.1) 
3p21 rs119250542  74.0 24.0 2.0  74.5 23.8 1.7  81.0 18.0 1.0  21.7 (21.0, 22.4) 
19.6 (18.4, 
20.8) 
16.8 (13.2, 
20.5) 
6q15 rs177929173,4  61.9 33.0 5.1  56.9 37.6 5.5  53.6 39.1 7.3  20.2 (19.4, 21.0) 
22.4 (21.3, 
23.4) 
22.7 (20.0, 
25.4) 
11q24 rs107909193  60.2 35.4 4.4  63.0 33.0 3.9  68.7 28.8 2.5  22.0 (21.2, 22.8) 
19.9 (18.9, 
20.9) 
17.1 (14.8, 
19.5) 
11q22 rs71201423,4  66.7 30.5 2.8  61.6 34.3 4.1  62.9 33.3 3.8  20.4 (19.7, 21.2) 
22.0 (20.9, 
23.1) 
25.0 (21.3, 
28.7) 
7q34 rs105001303  79.0 19.7 1.3  81.6 17.5 0.9  82.9 15.9 1.2  18.8 (12.6, 25.0) 
19.0 (17.7, 
20.4) 
21.6 (20.9, 
22.3) 
1: Associated P<5x10-6 for moderate CP 
2: Associated P<5x10-6 for severe CP 
3: Associated P<5x10-6 for extent of attachment loss 
4: The minor allele is the ‘risk allele’ for the corresponding trait 
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Table 4.6 Reported genes’ symbols [HUGO Gene Nomenclature Committee (HGNC) approved 
symbols], names and chromosomic locations.  
Gene symbol Gene name Location 
NCR2 Natural cytotoxicity triggering receptor 2 6p21.1 
EMR1 Egf-like module containing, mucin-like, hormone receptor-like 1 19p13.3 
VAV1 Vav 1 guanine nucleotide exchange factor 19p13.2 
CELF2 CUGBP, Elav-like family member 2 10p13 
NIN Ninein (GSK3B interacting protein) 14q21-q22 
NPY Neuropeptide Y 7p15.3 
WNT5A Wingless-type MMTV integration site family, member 5A 3p21-p14 
ERC2 ELKS/RAB6-interacting/CAST family member 2 3p14.3 
TBX18 T-box 18 6q14.1-q15 
KIAA1009 KIAA1009 14.3 
ETS1 V-ets erythroblastosis virus E26 oncogene homolog 1 (avian) 11q23.3 
KIRREL3 Kin of IRRE like 3 (Drosophila) 11q24 
DYNC2H1 Dynein, cytoplasmic 2, heavy chain 1 11q21-q22.1 
PDGFD Platelet derived growth factor D 11q22.3 
TTC26 Tetratricopeptide repeat domain 26 7q34 
ZC3HAV1 Zinc finger CCCH-type, antiviral 1 7q34 
CPM* Carboxypeptidase M 12q15 
CPSF6* Cleavage and polyadenylation specific factor 6, 68kDa 12q15 
COL11A1* Collagen, type XI, alpha 1 1p21 
RNPC3* RNA-binding region (RNP1, RRM) containing 3 1p21.1 
SCD5* Stearoyl-CoA desaturase 5 4q21.3 
SEC31A* SEC31 homolog A (S. cerevisiae) 4q21 
RPS29* Ribosomal protein S29 14q21.3 
LRR1* Leucine rich repeat protein 1 (PPIL5) 14q21.3 
*Genes adjacent to loci that emerged in adjusted analyses. 
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Table 4.7 Reported SNPs address according to the 1000 genomes (1000G) 
convention and proxy SNPs (R2>0.8 where available) based on 1000G pilot 1 
release. All SNPs were imputed based on HapMap II CEU with the exception of 
rs2521634 with was directly genotyped on the Affymetrix 6.0 platform. 
dbSNP 1000G Proxy SNPs (R2>0.8) 
rs7762544 6:41379315 rs1853406, rs9357360 
rs3826782 19:6887736 rs12610529 
rs12260727 10:10338329 rs12258450, rs7919833 
rs12883458 14:51279379 rs1004832 
rs2521634 7:24378040 rs11771124, rs10487606, 
rs10487605 
rs11925054 3:55390886 rs5030221 
rs17792917 6:85266965 rs16874800 
rs10790919 11:127657071 rs6590279 
rs7120142 11:103417781 rs4440990 
rs10500130 7:138815913 rs126739052, rs120561433 
1: R2=0.40; 2: R2=0.46; 3: R2=0.43 
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Table 4.8 Reported SNPs as expression quantitative loci (eQTLs) and their association 
with gene expression (lymphoblastoid cell line-based expression) in populations of 
European descent with P<10-4 in the Scan database (http://www.scandb.org). 
dbSNP Gene symbol Gene name Locus P-value 
rs3826782 GPR113 G protein-coupled 
receptor 113 2p23.3 2x10
-5
 
rs11925054 TMEM5 transmembrane protein 5 12q14.2 3x10
-5
 
 SLC20A2  
solute carrier family 20 
(phosphate transporter), 
member 2 
8p12-p11 8x10-5 
 RABEPK Rab9 effector protein 
with kelch motifs 9q33.3 9x10
-5
 
rs17792917 ULK4 unc-51-like kinase 4 3p22.1 1x10-4 
 DUSP4 dual specificity phosphatase 4 8p12-p11 1x10
-4
 
 CLCF1 cardiotrophin-like 
cytokine factor 1 11q13.3 3x10
-5
 
 CLYBL citrate lyase beta like 13q32 2x10-5 
 TSC22D1 TSC22 domain family, 
member 1 13q14 9x10
-6
 
 TRAK1 trafficking protein, kinesin binding 1 3p22.1 1x10
-4
 
 DNMBP dynamin binding protein 10q24.2 3x10
-5
 
 TNFRSF19 
tumor necrosis factor 
receptor superfamily, 
member 19 
13q12.11-q12.3 1x10-4 
 TBC1D8 TBC1 domain family, 
member 8 2q11.2 5x10
-5
 
 MNX1 motor neuron and pancreas homeobox 1 7q36 3x10
-5
 
 SLC43A2 solute carrier family 43, 
member 2 17p13.3 8x10
-5
 
 GOLGA8A golgin A8 family, 
member A 15q11.2 7x10
-5
 
 GOLGA8B golgin A8 family, 
member B 15q14 7x10
-5
 
 PLCL2 phospholipase C-like 2 3p24.3 5x10-5 
rs11615037 CENTA1/ ADAP1 ArfGAP with dual PH domains 1 7p22.3 1x10
-4
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L. SUPPLEMENTAL FIGURES 
Figure 4.10 Quantile-quantile plot of genome-wide association analysis results of severe 
chronic periodontitis among the 4610 white Dental ARIC participants. 
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Figure 4.11 Quantile-quantile plot of genome-wide association analysis results of moderate 
chronic periodontitis among the 4610 white Dental ARIC participants. 
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Figure 4.12 Quantile-quantile plot of genome-wide association analysis results of the extent 
of attachment loss trait (proportion of sites exhibiting ≥3 mm attachment loss) among the 
4610 white Dental ARIC participants. 
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Figure 4.13 Visualization of the 3p21 locus that was marked by rs11925054 (P=6.5x10-7) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort. The vertical axis corresponds to each 
marker’s associated –log10 P-value. The overlaid recombination rate plot and the color-
coded pairwise linkage disequilibrium values with index SNPs were calculated based on 
HapMap II – CEU (human genome 18, build 36). 
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Figure 4.14 Visualization of the 4q21.3 locus that was marked by rs17006135 
(P=1.8x10-5 and P=4.4x10-6 after adjustment for smoking and diabetic status) for severe 
chronic periodontitis among the 4610 white participants of the Dental Atherosclerosis in 
Communities Study cohort. The vertical axis corresponds to each marker’s associated –
log10 P-value. The overlaid recombination rate plot and the color-coded pairwise linkage 
disequilibrium values with index SNPs were calculated based on HapMap II – CEU 
(human genome 18, build 36). 
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Figure 4.15 Visualization of the 1p21.1 locus that was marked by rs10493998 
(P=9.2x10-6 and P=2.2x10-6 after adjustment for smoking and diabetic status) for severe 
chronic periodontitis among the 4610 white participants of the Dental Atherosclerosis in 
Communities Study cohort. The vertical axis corresponds to each marker’s associated –
log10 P-value. The overlaid recombination rate plot and the color-coded pairwise linkage 
disequilibrium values with index SNPs were calculated based on HapMap II – CEU 
(human genome 18, build 36). 
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Figure 4.16 Visualization of the 10p15 locus that was marked by rs12260727  
(P=6.0x10-7) for moderate chronic periodontitis among the 4610 white participants of the 
Dental Atherosclerosis in Communities Study cohort. The vertical axis corresponds to 
each marker’s associated –log10 P-value. The overlaid recombination rate plot and the 
color-coded pairwise linkage disequilibrium values with index SNPs were calculated 
based on HapMap II – CEU (human genome 18, build 36). 
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Figure 4.17 Visualization of the 12q15 locus that was marked by rs11615037  
(P=2.6x10-5 and P=4.4x10-6 after adjustment for smoking and diabetic status) for 
moderate chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort. The vertical axis corresponds to each 
marker’s associated –log10 P-value. The overlaid recombination rate plot and the color-
coded pairwise linkage disequilibrium values with index SNPs were calculated based on 
HapMap II – CEU (human genome 18, build 36). 
 
 
 
 
 
 
 
 
 
 
 
 
102 
 
Figure 4.18 Visualization of the 11q22 locus that was marked by rs7120142 (P=3.9x10-6) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort. The vertical axis corresponds to each 
marker’s associated –log10 P-value. The overlaid recombination rate plot and the color-
coded pairwise linkage disequilibrium values with index SNPs were calculated based on 
HapMap II – CEU (human genome 18, build 36). 
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Figure 4.19 Venn diagram representing genes adjacent to identified SNPs for the three 
chronic periodontitis traits. Genes with asterisk are associated with SNPs that emerged 
below the P<5x10-6 threshold in genetic models adjusted for smoking and diabetic status. 
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B. MANUSCRIPT #2 SUMMARY 
Periodontitis is characterized by an oral biofilm pathological shift that contributes to 
cascade of events leading to periodontal destruction. Host factors modulate the establishment 
of a dysbiotic oral microbiome, but to-date limited evidence exists with regard to associated 
genetic risk loci. We conducted a genome-wide association analysis (GWA) among 1020 
white participants enrolled in the Atherosclerosis in Communities Study cohort, for whom 
quantification of eight periodontal pathogens was performed using a “checkerboard” DNA 
hybridization technique. We examined three traits: “high red” and “high orange” bacterial 
complex, and “high” Aggregatibacter actinomycetemcomitans (Aa) colonization, with “high” 
being defined as the top quintile of each trait distribution. Genotyping was performed using 
the Affymetrix 6.0 platform. Imputation to 2.5million markers was based on HapMap II-
CEU and a multiple-test correction was applied (threshold of P<5x10-8). We detected no 
genome-wide significant signals. However, thirteen loci including KCNK1, FBXO38, 
UHRF2, IL33, RUNX2, TRPS1, CAMTA1 and VAMP3 provided suggestive evidence 
(P<5x10-6) of association with the measured traits. Further investigations providing 
replication of these findings and examination of specific associations may lead to an 
improved understanding of the complex nature of host-biofilm and -bacteria interactions that 
characterizes states of health and disease.  
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C. INTRODUCTION 
Despite advances in the science and practice of dentistry, periodontal diseases continue to 
affect adult populations worldwide. The understanding of the pathogenesis of CP has evolved 
through advances in biology, biochemistry, microbiology, immunology and genetics. Study 
of the composition and complexity of the oral ecology has recently re-emerged as a focus of 
research, with investigations of the oral microbiome gaining increased attention (1). To date, 
over 450 species have been identified in the human microbiome, and its diversity is greater 
than initially theorized (2, 3). In fact, while harboring of periodontal pathogens is virtually 
universal, only a small only proportion of individuals develop severe forms of CP. 
It is a common ground that an oral ecosystem in harmonious symbiosis with its host 
will likely be associated with health, whereas departure from this balance is characteristic of 
disease (4). Specific bacterial species that are implicated in CP have been identified, and in 
general are commensal and include gram-negative anaerobes. The degree or severity of the 
host response, which is a determinant of periodontal tissue destruction, has been found to be 
modulated by several local, systemic, and genetic factors. In this respect, the role of smoking 
and diabetes, as well as several single nucleotide polymorphisms (SNPs) in immune 
response-related genes such as interleukin (IL)-1, have been shown to alter the host response 
and impact the phenotype and clinical course of periodontitis (4,5).  
There is a large body of literature in candidate-gene studies investigating the genetics 
of host inflammatory response, inflammatory mediators and cytokines (5). One recent study 
found a positive association between an IL-6 polymorphism and harboring of 
Aggregatibacter actinomycetemcomitans (Aa), but that report was based on a small sample of 
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forty patients (6). No study to our knowledge has carried out a whole-genome investigation 
for genetic markers of host colonization with periodontal bacteria. To this end, and to add to 
the knowledge base of the genetic component of periodontitis, the aim of this study was to 
investigate susceptibility loci for colonization with sub-gingival pathogenic periodontal 
bacteria using a GWA analysis approach.  
D. MATERIALS AND METHODS 
Detailed descriptions of the study population, genotyping and imputation, quality 
control and population stratification procedures are included in the online Appendix. In brief, 
we conducted a GWA study among 1020 white participants of the Atherosclerosis Risk In 
Communities (ARIC) longitudinal cohort investigation (7). While ARIC is a study of 
atherosclerosis, CVD risk factors and outcomes, a complete oral-dental examination took 
place between 1996 and 1998 during the fourth ARIC visit. As part of the Dental ARIC, 
apart from a complete clinical examination, sub-gingival microbial plaque samples were 
collected for a subset of participants (8).  
The “checkerboard” DNA-DNA hybridization method (9) was used on plaque 
samples to measure the extent of sub-gingival colonization with eight periodontal pathogens: 
Prevotella intermedia [American Type Culture Collection (ATCC) 25611], Campylobacter 
rectus (ATCC 33238), Fusobacterium nucleatum (ATCC 10953), and Prevotella nigriscens 
(ATCC 33563) (belonging to the “orange” complex); Porphyromonas gingivalis (ATCC 
33277), Tannerella forsythia (ATCC 43037) and Treponema denticola (ATCC 35404) (“red” 
complex); and Aggregatibacter actinomycetemcomitans (ATCC 43718). In that method, 
bacterial levels are expressed as counts relative to established microbial standards. Three 
dichotomous traits of “high” colonization with “red” complex, “orange” complex, and 
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Aggregatibacter actinomycetemcomitans were considered for analytical purposes. The two 
composite phenotypes were derived by the summation of bacterial count for each species 
belonging to the “red” (n=3) and “orange” (n=4) group, as described above. Because 
Porphyromonas gingivalis is considered the major periodontal pathogen implicated in 
periodontitis in adult populations, we explored for additional risk loci using its “high” 
colonization phenotype defined as above, as a separate trait, in exploratory analyses that we 
present in the Appendix. Various approaches in defining the bacterial colonization profiles 
have been previously used, including summations of the absolute microbial counts (10), 
tertile-categorization (11), and five-level categorization of log10-transformed counts (12). 
For the present investigation, we defined a “high” colonization trait as the top quintile (20%) 
of each trait’s distribution. The rationale for the selection of this phenotype is based on the 
fact that the “checkerboard” semi-quantitative method has a lower detection threshold of 
~104 and reduced precision in the lower end of the distribution, whereas a individuals with 
“high” bacterial colonization profile may be those with reduced or impaired host and at high 
risk for periodontal tissue destruction.  
Participants’ DNA was extracted from blood samples drawn from an antecubital vein, 
and genotyping was performed with the Affymetrix Genome-Wide Human SNP Array 6.0 
chip. The platform offers 906,600 markers for SNPs. Following rigorous quality control 
procedures, imputation to 2.5million markers was performed using 669,450 SNPs and 
MACH v1.0.16 (http://www.sph.umich.edu/csg/abecasis/MaCH/index.html), based on 
HapMap Phase II CEU build 36. For analytical purposes, the dichotomous traits of “high 
colonization” phenotypes were entered in three logistic regression models assuming 
multiplicative (log-additive) allelic effects. The models included age, sex, examination center 
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and ten principal components from the population stratification analysis as covariates. A 
correction for multiple comparisons assuming 1 million independent tests was applied and a 
threshold of genome-wide statistical significance was set at P<5x10-8. An additional arbitrary 
threshold of P<5x10-6 was set to prioritize and investigate loci with suggestive evidence of 
association. All GWA analyses were performed with the ProbABEL software (13). SNP 
annotations were performed with WGAViewer ver.1.26l (14), Snipper ver.1.2 
(http://csg.sph.umich.edu/boehnke/snipper/), and loci visualizations with LocusZoom ver.1.1 
(15) and Haploview ver.4.2 (16). Reporting of genes was based on the “HUGO Gene 
Nomenclature” naming convention (www.genenames.org). 
E. RESULTS 
The sample’s descriptive information is presented in Table 1. The participants had 
mean age of 63 years and approximately even gender distribution. “High” bacterial 
colonization profiles were found in all groups of periodontal diagnosis according to the CDC 
classification; however, the prevalence of “high red” colonization cases was more than 
double among participants with severe periodontitis compared to those with mild or no 
disease. Similar, but less pronounced associations were noted for “orange” complex and Aa. 
The bacterial counts of “high colonization cases” were [median (interquartile range); range)] 
“red” complex bacteria—[64725 (108516); 21943-3894605), “orange” complex bacteria—
[304155 (483373); 111926-1.5x107), and Aggregatibacter actinomycetemcomitans—[17309 
(20034); 7520-410713]. 
Of the 2178777 examined SNPs, none had P<5x10-8. However, 53 had a P<5x10-6 
and thus were prioritized for further investigation. Lambda inflation factors for three traits 
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were: “red”—1.040, “orange”—1.045 and Aa—1.032. The corresponding Q-Q plots are 
presented in Figure S1 in the Supplemental Material. Upon inspection of the prioritized 
SNPs, there were five loci that emerged for “red”, three loci for “orange” and five loci for Aa 
colonization (Figure 1). Of those, one locus on 1q42 was shared for the “red” complex and 
Aa. Graphical representations of the genomic areas adjacent to six of these loci are presented 
in Figure 2.  
The strongest signal with regard to “red” complex colonization (Table 1) was 
produced by rs11800854 in the 1q42 locus [P=2.8x10-7; OR=12.3 (95% CL=3.7, 41.3); MAF 
in HapMap-CEU (MAF-CEU): 0.067] in the promoter region (30Kb upstream) of KCNK1 
and adjacent to KIAA1804. The common [G] allele showed 3% enrichment among “high 
colonization cases” for both “red” complex and Aa. Another locus in chromosome 1p22 was 
marked by rs12032672 (P=9.6x10-7), ~500Kb upstream of PKN2.  Rs10043775, in LD with 
multiple markers in the 5q33 locus, represents a missense change in the FBXO38 gene 
(resulting in [Pro][Arg] substitution, predicted as ‘benign’ by PolyPhen-2) and provided 
the strongest signal in that locus (P=2.4x10-6), also adjacent to HTR4. A high LD area in 
9p24 including the UHRF2, GLDC, TPD52L3 and IL33 genes is marked by rs16924631 
[intronic to UHRF2; P=3.2x10-6; OR=2.29 (95% CL=1.61, 3.24); MAF-CEU: 0.275], of 
which the [C] risk allele showed almost 10% enrichment among “cases”. An intronic variant 
(rs10010758) of the TBC1D1 gene, adjacent (24Kb) to PTTG2 provided the strongest signal 
in the 4p14 locus [P=3.7x10-6; OR=1.91 (95% CL=1.25, 2.21)]. In the Appendix we present 
results of the exploratory analysis for Pg “high” colonization, which revealed three loci with 
P<5x10-6 including OTOF, C2Orf70, CIB4, DAB2IP, TTLL11 and AKNRD3.  
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The common allele of rs1932040 showed 9% enrichment and provided the strongest 
association signal with “high orange” bacterial colonization [P=1.3x10-6, OR=2.47 (95% 
CL=1.67, 3.65)], marking an intergenic area between RUNX2 and CLIC5 on the 6p21.1 
locus. A low recombination area on 8q23, adjacent to TSPS1 (1.3Mb) and CSMD3 (672Kb) 
is marked by multiple alleles, of which rs9942773 provided the strongest signal (P=1.9x10-6) 
and 10% enrichment among “cases”. A variant intronic to CAMTA1 [rs1616122; P=4.9x10-6; 
OR=1.85 (95% CL=1.41, 2.42)] marks the 1p36.2 locus.  
The 1q42 locus that was identified for “red” bacteria also provided the third strongest 
association signal for Aa [rs11800854; P=4.0x10-6; OR=8.12 (95% CL=2.73, 24.11)]. The 
common [T] allele of rs11621969 was also nominally associated with high Aa colonization 
(P=9.4x10-7) and was adjacent to FOS and JPD2 in 14q24. The rare [G] allele of rs1970525 
was more than twice as prevalent among “cases” (0.118 versus 0.054 among “non-cases”), 
provided the strongest signal in the 10q23 locus [P=3.8x10-6; OR=2.89 (95% CL=1.85, 4.52); 
MAF-CEU: 0.045)] , and represents a nonsense-mediated decay transcript variant in the 
GRID1 gene. Rs9287989 is adjacent to KIAA1715 (30Kb) and EVX2 (227Kb) and marks the 
2q31 locus (P=4.4x10-6). An intronic variant of ODZ2 (rs6885116) provided the strongest 
signal in the locus 5q35 [P=1.4x10-6; OR=2.57 (95% CL=1.76, 3.74); MAF-CEU: 0.084], 
showing 9% enrichment among “cases”. Rs1800795, that was found to be significantly 
associated with Aa colonization in the recent study of Nibali and colleagues (6) did not show 
any important association in this GWA scan [P=0.34, OR=1.12 (95% CL=0.88, 1.43)]. 
 
 
113 
 
F. DISCUSSION 
This study is the first report of a genome-wide association analysis investigating risk loci for 
colonization with pathogenic periodontal bacteria. Although limited by the sample size, this 
investigation explores a novel phenotype and benefits from a comprehensive quantitative 
phenotypical characterization. Upon replication or validation, these findings have the 
potential to unveil pathways and mechanisms that direct the host’s symbiosis with healthy 
microflora that if altered may predispose for states of disease. In fact, several of the risk loci 
identified in this study may offer promising leads for further exploration and mechanistic 
studies. 
The 1q42 locus and rs11800854, which emerged as a common risk marker for both “red” 
complex and Aa colonization is in the promoter region of KCNK1, a gene that encodes a 
potassium channel protein and has been linked to cardiac outcomes (17). The prioritized 
SNPs at the 9p24 locus marked an area with low recombination rate that includes the 
UHRF2, TPD52L3 and IL33 genes. IL33, as other members of the interleukin family, has 
important roles in immunity and inflammation and has been suggested to function as an 
“alarmin”, alerting the immune system to endogenous trauma such as physical stress or 
infection (18).  
RUNX2, a gene in the 6p21.1 locus that emerged due to the association of rs1932040 with 
“orange” complex colonization encodes a transcription factor that is essential for osteoblastic 
differentiation and skeletal morphogenesis. Mutations in this gene have been associated with 
the cleidocranial disorder syndrome, which has multiple and severe oral manifestations (19). 
Experimental evidence shows that RUNX2 is involved in the inhibition of MMP-13 
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expression, which appears to be involved in periodontitis, as well as osteoblastic and 
osteoclastic activity (20). Another locus that was identified as associated with “orange” 
colonization was 1p36.2 with the “top” SNP rs1616122 being intronic to the CAMTA1 gene. 
CAMTA1 has been reported as a candidate gene for type II diabetes risk (21). VAMP3 is 
adjacent (310Kb upstream) to the marked locus and may also be plausible gene candidate, as 
it has been shown to regulate podosome organization in macrophages, and thus mediate their 
adhesion, spreading and migration (22). 
With regard to association results with Aa “high” colonization, the strongest signal was 
produced by the 14q24 locus, where the FOS and JDP2 genes are located. FOS was recently 
reported as part of a novel mechanism of RANKL expression in T cells (23), which may 
constitute an important link with immune responses, as FOS levels have been shown to 
increase by lippopolysaccharide infusion in vivo (24). JDP2 (85Kb downstream of the top 
SNP of the 14q24 locus) is a transcription factor that has been associated with the 
maintenance of Epstein-Barr virus latency (25), which has been implicated in the 
pathogenesis of chronic periodontitis via inhibition of oral bacteria-induced macrophage 
activation and phagocytosis (26).  
Socransky (27) and other investigators have described how organisms such as Pg, 
Tannerella forsythia, Treponema denticola, Aa and other species found in dental plaque, 
organize themselves in complex communities collectively called “biofilm”, and interact with 
each other and with the host to result in different states of health and disease. While the 
presence of a highly organized biofilm appears a unique feature of dental plaque-induced 
diseases including caries and periodontitis, several other chronic conditions such as 
tuberculosis, rheumatic fever, syphilis, gastrointestinal ulcers and Lyme disease share a 
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bacterial colonization etiologic component (28). Consequently, an increased understanding of 
the genetic underpinning of interactions between the host and exogenous or symbiosing 
bacterial communities has the potential to advance the state of knowledge in periodontitis, 
but also other chronic inflammatory diseases (29).  
The findings of the present investigation, if replicated, have the potential to add to the 
knowledge base of oral microbiome, host-biofilm, host-bacteria interactions, and more. We 
acknowledge that the study of periodontal pathogen colonization phenotypes is rare and this 
limits the replication options of our findings. However, the consideration of specific 
microbial factors as a distinct exposure in investigations of periodontal, oral and systemic 
health is consistent with the paradigm of “periodontal medicine” and may provide novel 
insight in the oral-systemic diseases connection. Although the prevention and treatment of 
periodontitis is an obvious goal, the links of CP with of other systemic conditions and the 
“common theme” of pathogenic ecological shift in other diseases, provide opportunities for 
even greater impact.  
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G. TABLES 
Table 5.1 Distribution of subjects’ demographic characteristics and bacterial “high 
colonization” (defined as the top quintile of the distribution) profile (with “Red”, “Orange” 
complex, and Aggregatibacter actinomycetemcomitans) overall, and stratified by periodontal 
diagnosis (CDC/AAP classification) among the Dental ARIC study participants (n=1020) 
 Total  Healthy/mild  Moderate  Severe 
 
n (column %)  n (column %)  n (column %)  n (column %) 
n (row %) 1020 (100)  416 (41)  415 (41)  189 (19) 
Sex 
       
Females 478 (47)  246 (59)  178 (43)  54 (29) 
Males 542 (53)  170 (41)  237 (57)  135 (71) 
Age (years; mean, standard 
deviation) 63.2 (5.7)  62.3 (5.5)  63.6 (5.7)  64.0 (5.9) 
“High” bacterial 
colonization (n, % of 
column) 
     
  
“Red” complex 203 (20)  58 (14)  84 (20)  61 (32) 
“Orange” complex 201 (20)  73 (18)  72 (17)  56 (30) 
A. actinomycetemcomitans 204 (20)  75 (18)  81 (20)  48 (25) 
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Table 5.2 Genome-wide association analysis results of the high colonization traits (highest quintile of the distribution versus 
the other four; quantified with DNA-DNA “checkerboard” hybridization) for “Red”, “Orange” complex and Aggregatibacter 
actinomycetemcomitans, among the white participants of the Dental ARIC study (n=1020). Single nucleotide 
polymorphisms (SNPs) with minor allele frequency (MAF-HapMap II CEU) of ≥5% and associated P<5x10-6. The SNP with 
the lowest P-value per locus is presented; additional prioritized SNPs in each locus are presented in the footnote, along with 
corresponding R2 (based on 1000 genomes pilot 1 release) with the top SNPs. 
Chr. SNP 
Position  
Build36 ca1 nca2 
MAF 
(HapMap 
II-CEU) 
Closest gene(s) and 
position or distance 
Risk allele 
frequency low/ 
high colonization P value 
Odds ratio 
(95% CL) 
“Red” complex        
1q42 rs118008543 231786607 A G [A] 0.068 KCNK1 (30Kb) [G] 0.947/0.978 2.8x10-7 12.3 (3.7, 41.3) 
1p22 rs12032672 88398224 A C [C] 0.350 PKN2 (524Kb) [C] 0.332/0.446 9.6x10-7 1.99 (1.50, 2.62) 
5q33 rs100437754 147785313 C T [C] 0.274 
FBXO38 (missense 
change)6 
/HTR4 (19Kb) 
[T] 0.703/0.791 2.4x10-6 2.06 (1.51, 2.83) 
9p24 rs169246315 6476308 C G [C] 0.142 
UHRF2 (non-coding 
transcript variant) 
/GLDC (46kb) 
[C] 0.122/0.219 3.2x10-6 2.29 (1.61, 3.24) 
4p14 rs10010758 37614913 C T [C] 0.275 
TBC1D1(intron 
variant)/ PTTG2 
(24Kb)7 
[C] 0.291/0.384 3.7x10-6 1.91 (1.45, 2.51) 
“Orange” complex        
6p21.1 rs19320408 45804766 A G [A] 0.142 CLIC5 (169Kb)/ RUNX2 (178Kb) [G] 0.808/0.896 1.3x10
-6
 2.47 (1.67, 3.65) 
8q23 rs99427739 115190203 A C [C] 0.283 CSMD3 (672Kb)/ TRPS1 (1.3Mb) [A] 0.703/0.803 1.9x10
-6
 2.07 (1.51, 2.82) 
1p36.2 rs1616122 7444172 C T [C] 0.482 
CAMTA1 (intron 
variant)/VAMP3 
(310Kb) 
[T] 0.506/0.624 4.9x10-6 1.85 (1.41, 2.42) 
“Aggregatibacter actinomycetemcomitans”     
14q24 rs11621969 74883781 C T [C] 0.167 FOS (65Kb)/ JDP2 (85Kb) [T] 0.789/0.885 9.4x10
-7
 2.46 (1.68, 3.62) 
10q23 rs197052510 87624904 C G [G] 0.045 
GRID1 (NMD12 
transcript variant) 
/MI346/ WAPAL 
(560Kb) 
[G] 0.054/0.118 3.8x10-6 2.89 (1.85, 4.52) 
1q42 rs1180085411 231786607 A G [A] 0.067 KCNK1 (30Kb)/ KIAA1804 (199Kb) [G] 0.947/0.978 4.0x10
-6
 8.12 (2.73, 24.11) 
2q31 rs9287989 176425987 C T [T] 0.433 
KIAA1715 (73Kb)/ 
EVX2 (227Kb)/ 
EXTLP213 (10Kb) 
[C] 0.484/0.605 4.4x10-6 1.80 (1.39, 2.33) 
5q35 rs6885116 167576123 A G [G] 0.084 
ODZ2 (intron 
variant)/ WWC1 
(76Kb) 
[G] 0.078/0.169 1.4x10-6 2.57 (1.76, 3.74) 
1: coded allele 
2: non-coded allele 
3: Additional SNPs in locus with P<5x10-6: rs6682365 (R2=1.00) 
4: Additional SNP in locus with P<5x10-6: rs10068216 (R2=1.00), rs10072051 (R2=1.00), rs17108251 (R2=1.00), rs10044061 (R2=1.00), rs4349707 
(R2=1.00), rs10477376 (R2=1.00), rs9325095 (R2=1.00), rs10041283 (R2=1.00), rs9325097 (R2=0.87),  rs3734120 (R2=1.00), rs4574533 (R2=0.87),  
rs4274967 (R2=1.00), rs4274968 (R2=1.00), rs6884076 (R2=1.00), rs9325098 (R2=1.00) 
5: Additional SNP in locus with P<5x10-6: rs11795355 (R2=1.00), rs7876000 (R2=1.00), rs10975603 (R2=0.93), rs16924626 (R2=0.93), rs16924624 
(R2=1.00), rs10975605 (R2=0.93), rs10115883 (R2=0.93), rs10122116 (R2=0.93) 
6: T>C – Ser>Pro, 35b from the exon boundary 
7: R2=0.29 with rs6811863 which is a missense change in PTTG2: G>C – [Arg][Pro] 
8: Additional SNPs in locus with P<5x10-6: rs12525547(R2=0.93), rs9349326(R2=0.93), rs16873698(R2=0.93) 
9: Additional SNP in locus with P<5x10-6: rs10089040 (R2=1.00), rs9942776 (R2=1.00), rs10086149 (R2=1.00), rs7845243 (R2=0.87), rs10105817 
(R2=1.00), rs7006291 (R2=1.00), rs11779159 (R2=1.00), rs11783996 (R2=1.00), rs10098056 (R2=1.00), rs7018200 (R2=0.92) 
10: Additional SNPs in locus with P<5x10-6: rs4325261 (R2=1.00) 
11: Additional SNP in locus with P<5x10-6: rs6682365 (R2=1.00) 
12: nonsense-mediated decay 
13: EXTLP2 is a pseudogene 
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H. FIGURES 
Figure 5.1 Manhattan plot of the GWAS results (-log10 P-values of the ~2.5 million 
examined SNPs arranged by chromosome) for “high red” complex bacterial colonization 
among the 1020 white participants of the Dental ARIC Study cohort. 
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Figure 5.2 Manhattan plot of the GWAS results (-log10 P-values of the ~2.5 million 
examined SNPs arranged by chromosome) for “high orange” complex bacterial colonization 
among the 1020 white participants of the Dental ARIC Study cohort. 
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Figure 5.3 Manhattan plot of the GWAS results (-log10 P-values of the ~2.5 million 
examined SNPs arranged by chromosome) for “high” Aggregatibacter 
actinomycetemcomitans bacterial colonization among the 1020 white participants of the 
Dental ARIC Study cohort. 
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Figure 5.4 Visualization of the 1p22 locus that was marked by rs12032672 (P=9.6x10-7) 
for “high red” complex bacterial colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure 5.5 Visualization of the 5q33 locus that was marked by rs10043775 (P=2.4x10-6) 
for “high red” complex bacterial colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure 5.6 Visualization of the 9p24 locus that was marked by rs16924631 (P=3.2x10-6) 
for “high red” complex bacterial colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure 5.7 Visualization of the 4p14 locus that was marked by rs10010758 (P=3.7x10-6) 
for “high red” complex bacterial colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure 5.8 Visualization of the 1p36.2 locus that was marked by rs1616122 (P=4.9x10-6) 
for “high orange” complex bacterial colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure 5.9 Visualization of the 1q42 locus that was marked by rs11800854 (P=4.0x10-6) 
for “high” Aggregatibacter actinomycetemcomitans colonization among the subset of 
1020 white participants of the Dental Atherosclerosis in Communities Study cohort. The 
vertical axis corresponds to each marker’s associated –log10 P-value. The overlaid 
recombination rate plot and the color-coded pairwise linkage disequilibrium values with 
index SNPs were calculated based on HapMap II – CEU (human genome 18, build 36). 
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J. MANUSCRIPT #2- SUPPLEMENTAL MATERIAL 
SUPPLEMENTAL MATERIALS AND METHODS 
Study population 
The study sample consisted of participants of the Dental ARIC, an ancillary study of 
the Atherosclerosis Risk In Communities (ARIC) longitudinal cohort investigation (1). ARIC 
is a study of atherosclerosis, CVD risk factors and outcomes. The Dental ARIC, an ancillary 
study was undertaken between 1996 and 1998 during the ARIC visit 4. For the purposes of 
Dental ARIC a complete oral-dental examination was performed among 6979 subjects, 
whereas collection of gingival crevicular fluid and sub-gingival microbial plaque samples 
was undertaken for a subset of participants (2). Specifically, of the 6979 Dental ARIC 
participants, 1450 had microbial plaque samples collected (2-4). For the purposes of the 
present GWA study, we considered white subjects who had provided microbial plaque 
samples (n=1236) and were successfully matched with genotype data (n=1020). Additional 
information that was collected as part of ARIC visit 4 and was used for data presentation and 
analysis included the following variables: sex, age, CP diagnosis [Centers for Disease 
Control (CDC) and American Academy of Periodontology (AAP) three-level classification: 
health/mild, moderate, and severe disease] (5), smoking status (never, former, current), and 
DM (healthy or DM).  
Genotyping and imputation 
In the study population, DNA was extracted from blood samples drawn from an 
antecubital vein into tubes containing serum separator gel. Blood samples were analyzed at a 
central ARIC laboratory in Houston, TX. Genotyping was performed with the Affymetrix 
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Genome-Wide Human SNP Array 6.0 chip. The platform offers 906600 markers for SNPs. 
The rigorous quality control procedures included initial blind duplicate genotyping and 
identification/flagging of SNPs with kappa<0.95 and reconciliation of unintentional duplicate 
samples (17 duplicates and one triplicate). Imputation to 2.5 million markers was performed 
using 669450 SNPs and MACH v1.0.16 (http://www.sph.umich.edu/csg/abecasis/MaCH/ 
index.html), based on HapMap Phase II CEU build 36. The selected SNPs were selected 
from 839048 autosomal SNPs restricted to those with minor allele frequency (MAF)>0.01 
(129543 excluded), Hardy-Weinberg equilibrium (HWE) P>10-5 (12432 excluded) and call 
rate >95% (1693 excluded). After imputation, SNPs with a quality score <0.8 and missing 
data rate >10% were identified and flagged for removal, while only those with MAF of ≥5% 
were considered for analytical purposes. 
Population stratification 
To obtain estimates of relatedness and population stratification a subset of 85,947 
“high quality” SNPs was selected. These SNPs met the following criteria among self-
reported whites: MAF ≥0.1, call rate >99.5%, HWE P≥10-3, autosomal, with annotation in 
the platform annotation file, not labeled “AFFX” or “chromosome 0”, and not monomorphic. 
Using these SNPs identity-by-state (IBS) allele sharing distance (DST values) were 
computed using PLINK, as such: DST = IBS distance (IBS2 + 0.5*IBS1) / (n SNP pairs). 
First degree relative status was assigned to pairs of individuals with DST≥0.8 and second 
degree relatives were considered those with 0.763 ≤DST< 0.8. Among the Caucasian ARIC 
participants there were 380 pairs of first degree and 207 pairs of second degree relatives 
identified. To minimize exclusions, related pairs were broken by iterative selection of 
individuals with most relatives using a custom program. 
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Population stratification was further evaluated with principal component (PC) 
analysis using the EIGENSTRAT program (6). The above chosen set of SNPs was used for 
the computation of ten principal components. Genetic outliers were considered those that 
were further than 8 standard deviations (SD) away from any of ten PCs over ten runs of PC 
computation. Based on DST and PC criteria there were 716 subjects flagged from removal 
from the analysis (206 as genetic outliers based on PCs and 16 based on average DST values 
(“too little IBS sharing” with the rest of the sample), 351 first degree relatives and 143 
second degree relatives. All but ten second degree relatives (whose relatives were excluded 
as genetic outliers) were re-entered in the dataset and were assigned PCs. After exclusion of 
364 individuals (4%) there were 9349 Caucasians who were included in the GWA analysis 
and of those, 1020 had periodontal microbiological data available as Dental ARIC 
participants. 
SUPPLEMENTAL RESULTS REGARDING PORPHYROMONAS GINGIVALIS 
 We detected no genome-wide significant association signals with regard to Pg “high” 
colonization. However, six SNPs marking three loci emerged below the P<5x10-6 threshold 
and were prioritized for further investigation. Of those, rs10760187 in 9q33.2 provided the 
lowest P-value [P=4.5x10-7; OR=2.07 (95% CL=1.55, 2.76)], with the ‘risk’ [C] allele 
(HapMap II CEU MAF [T]: 0.514) showing 12% enrichment among subjects with “high” 
colonization. This SNP is in an intergenic area between DAB2IP (18Kb) and TTLL11 (18Kb) 
and in LD with several variants intronic to both genes. Rs1011108 [P=2.0x10-6; OR=1.79 
(95% CL=1.40, 2.27); MAF-CEU: [T] 0.374] is in a gene-dense locus at 2p23.3, 1Kb from 
OTOF, 3Kb from C2Orf70 and 18Kb from CIB4. In fact, the second prioritized SNP in this 
locus (rs1275992) is intronic to CIB4 and in linkage disequilibrium (R2=0.58, D’0.94) with 
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rs13002673 which represents a missense change in C2Orf70 resulting to a [Gln][His] 
substitution, predicted as ‘benign’ by PolyPhen-2. The third locus that was associated with 
Pg “high” colonization was marked by rs1360573 at 10p11.21 [P=1.5x10-6; OR=2.75 (95% 
CL=1.78, 4.26)]. The common “risk” allele [A] showed a 10% enrichment, and the closest 
gene is ANKRD30A (529Kb).  
SUPPLEMENTAL DISCUSSION REGARDING PORPHYROMONAS GINGIVALIS 
The examination of Pg colonization as a distinct trait is supported by the major role that this 
pathogen has in chronic periodontitis (7, 8). These exploratory analysis results, above and 
beyond those reported for “red” complex bacteria, can be considered as additional candidate 
regions that may be implicated in increased colonization with Pg and thus, higher risk for 
chronic periodontitis.  
With regard to genes in the 2p23.3 locus, CIB4 (KIP4) is known as calcium and 
integrin binding family member 4. Mutations in the OTOF (otoferlin) gene have been 
associated with non-syndromic types of deafness (9). No information is available on the role 
of C2Orf70.  Interestingly, the 9q33.3 locus that was marked by rs10760187 in our GWAS 
was also identified as associated with abdominal aortic aneurysm in a Northern European 
GWAS (10). This genomic area has also been reported to harbor important susceptibility 
variants associated with cleft lip/palate (11). One candidate gene in the 9q33.3 locus, 
DAB2IP, is also known as DAB2-interacting protein or AIP1. This gene is member of a 
family of regulators of extracellular stimuli that serve to maintain the homeostasis of cellular 
functions (12) and has been shown to be inactivated by methylation in prostate and breast 
cancer (13). TTLL11, another candidate gene in this locus, encodes a member of a large 
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family of proteins involved in the catalytic ligation of amino acids to tubulins or other 
substrates (14). Finally, the closest gene to the top SNP in the 21q22.3 locus was 
ANKRD30A, or ankyrin repeat domain-containing protein 30A. Reports have linked this gene 
and its protein (NY-BR-1) as a differentiation marker of the mammary gland, and thus as a 
potential diagnostic and immunotherapeutic aid for breast carcinomas (15, 16) with cancer. 
Moreover, a recent study found an association of a 3’UTR SNP of ANKRD30A with the 
human serum metabolic profile (17). 
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K. SUPPLEMENTAL TABLE 
Table 5.3 Porphyromonas gingivalis “high” colonization (quantified with DNA “checkerboard” hybridization) 
GWA results among the white participants of the Dental ARIC study (n=1020). Single nucleotide polymorphisms 
(SNPs) with minor allele frequency (MAF-HapMap II CEU) of ≥5% and P<5x10-6. The SNP with the lowest P-
value per locus is presented; additional prioritized SNPs in each locus are presented in the footnote, along 
with corresponding R2 (based on 1000 genomes pilot 1 release) with the top SNPs. 
Chr. SNP 
Position  
Build36 ca1 nca2 
Risk allele 
frequency 
(HapMap 
II- CEU) 
Closest gene(s) 
and position or 
distance 
Risk allele 
frequency 
low/ 
high 
colonization P value 
Odds ratio 
 (95% CL3) 
2p23.3 rs10111084 26636125 C T [T] 0.374 
OTOF (1Kb); 
C2Orf70 (3Kb); 
CIB4 (21Kb) 
0.341/0.485 2.0x10-6 1.79 (1.40, 2.27) 
9q33.2 rs107601875 123605641 C T [C] 0.514 DAB2IP (18Kb); TTLL11 (18Kb) 0.498/0.618 4.5x10
-7
 2.07 (1.55, 2.76) 
10p11.21 rs1360573 36925927 A G [A] 0.759 
ANKRD30A (529 
Kb); FZD8 (956 
Kb) 
0.752/0.853 1.5x10-6 2.75 (1.78, 4.26) 
1: coded allele 
2: non-coded allele 
3: Confidence limits 
4: Additional SNP in locus with P<5x10-6: rs1275992  (R2=0.33), intronic to CIB4 and in linkage disequilibrium (R2=0.58, D’0.94) with 
rs13002673 which represents a missense change in C2Orf70 resulting to a [Gln][His] substitution 
5: Additional SNPs in locus with P<5x10-6: rs7849478 (R2=0.63), rs10985387 (R2=0.67) 
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Table 5.4 Reported SNPs as expression quantitative loci (eQTLs) and their association 
with gene expression (lymphoblastoid cell line-based expression) in populations of 
European descent with P<10-4 in the Scan database (http://www.scandb.org). 
dbSNP 
Gene 
symbol Gene name Locus 
P-
value 
rs10043775 KIAA0515 (PRRC2B) proline-rich coiled-coil 2B 9q34.13 6x10
-5
 
 CCDC57 coiled-coil domain containing 57 17q25.3 5x10-5 
rs1932040 MRPL15 mitochondrial ribosomal protein L15 8q11.2-q13 9x10
-5
 
 EAF1 ELL associated factor 1 3p25.1 3x10-5 
 TAF5L 
TAF5-like RNA polymerase II, p300/CBP-
associated factor (PCAF)-associated factor, 
65kDa 
1q42.11
-q42.3 8x10
-5
 
rs16924631 MED15 mediator complex subunit 15 22q11.2 10-4 
 PSMB7 proteasome (prosome, macropain) subunit, beta type, 7 
9q34.11
-q34.12 2x10
-5
 
 MVD mevalonate (diphospho) decarboxylase 16q24.3 10-4 
 MAN2A2 mannosidase, alpha, class 2A, member 2 15q25 9x10-6 
 DNMBP dynamin binding protein 10q24.31 6x10
-5
 
 PQLC1 PQ loop repeat containing 1 18q23 4x10-5 
 PRKCE protein kinase C, epsilon 2p21 3x10-6 
 NEK6 NIMA (never in mitosis gene a)-related kinase 6 
9q33.3-
q34.11 2x10
-5
 
 PREX1 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 
20q13.1
3 10
-4
 
rs1011108 TMEM2 transmembrane protein 2 9q21.13 3x10-5 
 LRRK1 leucine-rich repeat kinase 1 15q26.3 10-5 
 A4GALT alpha 1,4-galactosyltransferase 22q13.2 10-4 
 MTTP microsomal triglyceride transfer protein 4q24 5x10-5 
 MYO6 myosin VI 6q14.1 2x10-5 
 ASPH aspartate beta-hydroxylase 8q12.1 6x10-6 
 CNKSR3 CNKSR family member 3 6q25.2 9x10-5 
 F13A1 coagulation factor XIII, A1 polypeptide 6p24.2-p23 4x10
-5
 
 RASSF6 Ras association (RalGDS/AF-6) domain family member 6 4q21.1 5x10
-6
 
 
LOC100129
069 hypothetical protein LOC100129069 11q24.2 10
-4
 
 HNF4G hepatocyte nuclear factor 4, gamma 8q21-q22 10
-4
 
 MLSTD1 fatty acyl CoA reductase 2 2p11.23 10-4 
 CHL1 cell adhesion molecule with homology to L1CAM (close homolog of L1) 3p26 6x10
-5
 
 PIP3-E interaction protein for cytohesin exchange 6q25.2 10-5 
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factors 1 
 HNF1B HNF1 homeobox B 17q12 3x10-5 
 SERPINB1 serpin peptidase inhibitor, clade B (ovalbumin), member 1 6p25 7x10
-5
 
 ESAM ribosomal protein L6 pseudogene 25 12q21.31 10
-4
 
 IL17RB interleukin 17 receptor B 3p21.1 10-4 
 CCDC64 coiled-coil domain containing 64 12q24.23 10
-4
 
 C14orf105 chromosome 14 open reading frame 105 14q22.2 2x10-5 
 C1orf161 mab-21-like 3 1p13.1 2x10-5 
 MMAA methylmalonic aciduria (cobalamin deficiency) cblA type 4q31.1 5x10
-5
 
 C10orf137 mosome 10 open reading frame 137 10q26.2 6x10-5 
 ZNF503 zinc finger protein 503 10q22.3 5x10-5 
 ZNF44 zinc finger protein 44 19p13.2 10-4 
 CXorf21 chromosome X open reading frame 21 Xp21.3 6x10-5 
 PIR pirin (iron-binding nuclear protein) Xp22.31 2x10-5 
 MGC13057 chromosome 2 open reading frame 88 2q32.2 4x10-5 
 SERPINB9 serpin peptidase inhibitor, clade B (ovalbumin), member 9 6p25 2x10
-5
 
 
CCDC4 
(BEND4) BEN domain containing 4 4p13 3x10
-5
 
 SYNE2 spectrin repeat containing, nuclear envelope 2 14q22.1
-q22.3 8x10
-5
 
 BHLHB5 basic helix-loop-helix family, member e22 8q12.1 10-4 
 LRRK1 leucine-rich repeat kinase 1 15q26.3 4x10-6 
 GTF3C6 general transcription factor IIIC, polypeptide 6, alpha 35kDa 6q21 7x10
-5
 
 PLA1A phospholipase A1 member A 3q13.13
-q13.2 2x10
-5
 
 WDR91 WD repeat domain 91 7q33 6x10-5 
 LIN7A lin-7 homolog A 12q21 9x10-6 
 MAGEF1 melanoma antigen family F, 1 3q13 10-4 
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SUPPLEMENTAL FIGURES 
Figure 5.10 Quantile-quantile plot of genome-wide association analysis results of “high red” 
complex bacterial colonization, among the 1020 Dental ARIC participants. 
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Figure 5.11 Quantile-quantile plot of genome-wide association analysis results of “high 
orange” complex bacterial colonization, among the 1020 Dental ARIC participants. 
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Figure 5.12 Quantile-quantile plot of genome-wide association analysis results of “high” 
Aggregatibacter actinomycetemcomitans colonization, among the 1020 Dental ARIC 
participants. 
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Figure 5.13 Visualization of the 2p23.3 locus that was marked by rs1011108 (P=2.0x10-6) 
for “high” Porphyromonas gingivalis colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure 5.14 Visualization of the 9q33.2 locus that was marked by rs10760187 (P=4.5x10-7) 
for “high” Porphyromonas gingivalis colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure 5.15 Visualization of the 10p11.21 locus that was marked by rs1360573 (P=1.5x10-6) 
for “high” Porphyromonas gingivalis colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort. The vertical axis 
corresponds to each marker’s associated –log10 P-value. The overlaid recombination rate 
plot and the color-coded pairwise linkage disequilibrium values with index SNPs were 
calculated based on HapMap II – CEU (human genome 18, build 36). 
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CHAPTER 6 
DISCUSSION AND CONCLUSIONS 
A. Summary of findings 
In our genome-wide analysis of chronic periodontitis (CP) in a well-defined 
cohort of approximately 4600 white subjects we detected no genome-wide significant 
signals. However, we found suggestive evidence of association (P<5x10-6) for CP 
with markers at ten loci including NPY, NIN, and WNT5A for severe CP, NCR2 and 
EMR1 for moderate CP, and TBX18, ETS1, DYNC2H1, TTC26 and ZC3HAV1 for the 
“extent” of attachment loss (EAL) trait. Several of these loci include candidate genes 
that are related to immune function and regulation, as well as neurological function. 
Noteworthy, four loci marked by rs3826782, rs11925054, rs17792917, rs11615037 
have been identified as expression quantitative trait loci (eQTL) on lymphoblastoid 
cell lines (LCL). Sensitivity analyses including smoking and diabetes-adjusted 
genetic models did not show any material impact on these results. However, in these 
adjusted analyses five additional loci including SCD5, RPS29, PPIL5, COL11A1, 
CPM and CPSF6 emerged below the P<5x10-6 threshold. The 4q21.3 (SCD5) locus 
was shared for severe CP and EAL, and the 6p21.1 (NCR2) locus reached genome-
wide significance for moderate CP (rs7762544; Padjusted= 3.8x10-8). The NPY (7p15) 
locus was replicated for severe CP in an independent sample of whites of European 
descent. We performed inverse-variance weighted meta-analysis for three loci that 
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revealed no evidence of effect heterogeneity between the two studies. Pooled odds 
ratios for these three loci were: 7p15 (NPY, rs2521634)—OR=1.49 (95% CI=1.28-
1.73), P=3.5x10-7; 19p13.3 (EMR1, rs3826782)—OR=2.01 (95% CI=1.52-2.65), 
P=8.2x10-7; 6p21.1 (NCR2, rs7762544)—OR=1.40 (95% CI=1.24-1.59), P=7.5x10-8. 
Our exploratory analyses of SNP interactions with sex, smoking and diabetes detected 
several interaction effects below an empirical P<10-5 threshold: 20 SNPs with sex, 17 
with diabetic status, and 12 with the three-level smoking categorization (never, 
former, current). 
In the GWA scan in a subset of approximately 1000 subjects for which 
periodontal microbiological data were available we detected associations with 
markers at thirteen loci including KCNK1, FBXO38, UHRF2, IL33, RUNX2, TRPS1, 
CAMTA1 and VAMP3 providing suggestive signals of association (P<5x10-6) with 
“high” bacterial colonization with “red” complex, “orange” complex, and 
Aggregatibacter actinomycetemcomitans (Aa). Exploratory analyses revealed three 
additional loci including OTOF, C2Orf70, CIB4, DAB2IP, TTLL11 and AKNRD3 
associated with Porphyromonas gingivalis (Pg) “high” colonization. Four of these 
loci marked by rs10043775, rs1932040, rs16924631 and rs1011108 were identified to 
be eQTLs on LCL. Two missense changes that were identified for “high” bacterial 
colonization traits (rs10043775, 5q33, FBXO38 gene [Pro][Arg] and rs13002673 
(in LD with the prioritized rs1011108), 2p23.3, C2Orf70 gene [Gln][His]) were 
predicted to be ‘benign’.  
These genome-wide scan results provide new information on multiple 
candidate regions for interrogation in genetic studies of CP. Further investigations 
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providing replication of these findings and examination of specific associations may 
lead to an improved understanding of the pathogenesis of CP as well as the complex 
nature of host-biofilm and -bacteria interactions that characterizes states of health and 
disease. 
 
B. Strengths 
1. Genome-wide association analysis approach 
The opportunity that GWAS provide for investigators to examine the association 
of currently more than a million DNA markers with a given phenotype without being 
limited by prior knowledge, known pathways or mechanistic hypotheses in their marker 
selection, is unique. It has been argued that most associations detected by GWAS 
represent new discoveries. This “unbiased” or “agnostic” (1) approach in examining the 
genetic component of various phenotypes facilitates identification of novel loci and thus, 
potential insights into new pathways or mechanisms of biological processes. The present 
study is the first report of a GWA analysis of CP to-date, and provides suggestive 
evidence of association for several genomic loci that may be promising leads for further 
genetic investigations.  
 
2. Phenotype characterization 
The value and quality of the Dental ARIC clinical examinations protocol is 
truly unique. It is known that clinical-periodontal examination data are accurate and 
reproducible when they are performed by trained and calibrated dental examiners, as 
was the case with Dental ARIC study. Recent reports (2) stress that national estimates 
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of CP prevalence may severely underestimate the true prevalence due to disease 
misclassification in the NHANES III and IV. The next NHANES oral-dental 
examinations will be performed for the first time following the “full-mouth six site 
per tooth” protocol used in the Dental ARIC study. As outlined in the introduction, 
numerous definitions and quantitative measures exist to capture the extent and 
severity of periodontitis (3), with each been subject to varying degrees of bias 
(measurement error, bias due to loss of severely affected teeth, and more). The use of 
the most widely accepted and consensus CDC/AAP classification of CP, in 
combination with a clinical examinations protocol of highest standard is a major 
strength of the proposed investigation. We considered a continuous and non-
reversible measure of periodontal destruction as an additional strength. 
The investigation of microbiological colonization phenotypes in addition to 
CP is offering additional insights into the factors facilitating or antagonizing the 
cascade of pathological oral ecological shifts that are characteristic of the disease. 
The oral microbial load of Gram-negative and anaerobic periodontal pathogens may 
be an independent risk factor for, or modifier of several systemic conditions (4-7), 
and its exploration adds value to this study. While periodontitis is a clinical 
manifestation of exaggerated immune response to predominantly commensal oral 
bacteria, investigating genetic factors associated with colonization and proliferation 
of these causative bacterial agents is a fundamental question.  
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3. Covariates and sensitivity analysis 
Because population stratification (“systematic” differences in ancestry 
between trait categories) can result in spurious GWA results, appropriate adjustment 
for population substructure was undertaken in all analyses, using 10 EIGENSTRAT-
derived principal components. Inspection of the quantile-quantile plots did not reveal 
any “early departure” of the observed versus expected P-values. Additionally, 
genomic inflation (lambda) factors for most analyses were generally low, below 
1.030. Our analyses also benefitted from the detailed measurement and consideration 
in sensitivity analyses of the well-documented risk factors or disease modifiers, 
smoking and diabetic status. Although no confounding is expected in the association 
between SNPs and the examined traits, the consideration of smoking history in the 
sensitivity analysis provides the opportunity to rule out the identification of risk loci 
for this risk factor, which has been shown to confer epigenetic changes (8, 9). 
Moreover, the inclusion of the diabetic status as a covariate in the sensitivity analysis 
is based on the fact that diabetes is associated with altered host response (10, 11) and 
increased susceptibility to bacterial infections (12). A sensitive definition of diabetes 
was used in the ARIC study, including fasting and non-fasting serum glucose levels, 
and pharmacological treatment for the disease.  
 
C. Limitations 
1. Phenotype characterization 
As noted previously, the use of the CDC/AAP definition of CP represents the 
most widely accepted standard for classifying the disease. While our clinical data and 
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case-definition used for CP are of the highest standards possible, the disease itself 
entails some unique methodological challenges. Although periodontitis is a defined as 
a disease at the “person- or oral cavity-level”, it is actually characterized by multiple-
attacks on the periodontal attachment of individual teeth (13). As it progresses, 
periodontitis leads to gradual periodontal tissue destruction, alveolar bone loss, and 
eventually tooth loss. For example, in a cross-sectional study of periodontal status in 
relation to age and tooth type it was found that incisor teeth were the most frequently 
affected by advanced disease, whereas molar teeth were most frequently missing (14). 
In “periodontal maintenance” studies, it has similarly been found that molar teeth are 
the most frequently extracted due to periodontal reasons (15). This constitutes a form 
of “censoring” of the most affected “diseased units”, the teeth. In this respect, CP can 
be a self-limiting disease on a tooth-level. This is also the case on a patient-level, as 
(considering the extreme scenario) an edentulous individual is not at risk to develop 
periodontitis. A consequence of this phenomenon is the observation that the 
prevalence, as well as extent and severity of CP in epidemiologic studies are likely 
biased downwards from tooth loss attributable to the disease. It has been recognized 
that variation in the criteria and case definitions used for the classification of CP has 
been a source of inconsistencies in the dental literature (16). Also, as outlined in the 
introduction, more quantitative measures exist to capture the extent and severity of 
periodontitis compared to “crude” classifications, such as the “extent” of attachment 
loss, which was employed in this study. It will be worthwhile for future studies to 
consider juxtaposing the present investigation’s findings to additional sensitivity 
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analyses using extent scores (e.g. ≥3mm CAL) as continuous variables for the GWA 
analyses, while adjusting for tooth loss. 
Another consideration is that periodontitis, when measured by clinical 
measures of PD and (mainly) CAL, essentially represents the cumulative history of 
periodontal tissue destruction and not necessarily active disease or infection. 
Capturing this cumulative impact on periodontal tissues may be beneficial when 
considering longitudinal effects or progression patterns of periodontitis that may be 
biologically admixed. While more biologically-relevant disease classifications have 
been developed, our independent consideration of the association of host genetic 
variants with the microbial biofilm composition represents an improvement over the 
study of CP diagnoses alone. Despite being limited by small sample size for a GWAS 
(approximately 1000 individuals with microbial level counts), we consider this 
approach as the first exploration of loci associated with the composition of the oral 
microbiome. However, we acknowledge that this discovery step is limited by the very 
low power to detect modest effects. Similarly, our GWAS was underpowered to 
detect interaction effects in this additional exploratory step.  
 
2. Genome-wide analysis approach 
Whole-genome sequencing for population-based studies is financially and 
resource-prohibitive with today’s state of technology. For this purpose, imputation 
methods for non-typed markers have been developed, and imputation has become a 
standard step in GWA studies (17). Imputing does introduce some uncertainty in the non-
typed allele frequencies, but publicly available programs for GWA analyses such as 
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probABEL (18) allow the use of “dosage files” including imputed SNPs. As denser 
mapping of the human genome is realized, opportunities to use a 1000 genomes-based 
(19) imputation of the ARIC genotyped data (up to 10 million markers) will be an 
important improvement to the current approach. 
A frequent criticism of the GWAS concerns the current state of very conservative 
criteria of (genome-wide) statistical significance that are necessary to reduce the false-
positive rate (1). The traditional Bonferroni correction is believed to be ultra-conservative 
due to the fact that SNPs are to some degree correlated, as the ~2.5 million association 
tests performed in imputed datasets are not truly independent from each other. This 
stringency may allow only for relatively strong associations to be discovered, while much 
“good signal” obtained by SNPs with modest or small effects goes without attention. This 
is compounded by the fact that many common complex traits are thought to be influenced 
by a large numbers of low-penetrance, small effect variants. Park et al. recently suggested 
that if these large numbers of low-penetrance variants is identified from sufficiently 
powered GWAS, together they could explain 20% or more of the known heritability of 
such traits (20). On the other hand, another concern with GWAS findings is related to the 
“winner’s curse” (21) which becomes evident when identified loci are not being 
replicated in external samples or are not reproduced in subsequent studies. For these 
reasons, the interpretation of GWAS findings is now proposed to become subject to 
different criteria (compared to “traditional” epidemiologic evidence) to assess their 
inferential potential. Based on these proposed “interim guidelines” (22), genome-wide 
evidence should be weighed in terms of amount of evidence, extent of replication and 
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protection from bias and thus classified in a three-level categorization as strong, moderate 
or weak evidence.  
Moreover, it is becoming increasingly evident that the variation detected by 
GWAS is only one dimension of the genetic basis of health and disease (23). For 
instance, the role of copy number polymorphisms (24),  rare alleles (25), epistatic effects 
(26) and that of the non-coding regions (27, 28) in the human genome are thought to be 
parts of the missing piece of the “missing heritability” (25). For example, Dickson and 
colleagues suggested that “synthetic genome-wide associations” can be detected from 
combinations of rare variants (29). In a recent review, Panagiotou and colleagues 
summarized the published evidence of genome-wide association for rare (<5%) variants 
and found that there are still few genome-wide significant rare variants, but suggested 
that a possible confluence of rare and common variants in the same loci is likely to be 
depended on the different ancestry references used (30). Bansal and colleagues, in a 
recent review provided recommendations with regard to analytical approaches that could 
potentially aid in the discovery of “rare variant” effects (31). 
Moreover, it is common ground that biological processes are best represented by 
“cycles” and the action of biological messengers is understood on “pathways”. Therefore, 
it may be overly simplistic to consider independent effects of SNPs when it is recognized 
that usually multi-molecular pathways, feedback loops and regulating mechanisms are 
functioning in tandem. For this reason, any opportunity to jointly evaluate the effect of 
multiple “functionally relevant” SNPs is appealing and is becoming more feasible with 
advances in GWA methods (32, 33). 
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Further, the study of epigenetic phenomena has opened a whole new chapter in 
research of the pathogenesis and therapeutics, by a joint consideration of genotype and 
environmental influences (34) that is not routinely considered in GWAS. Feinberg 
recently suggested that the consideration of epigenomics, the genome-scale study of 
epigenetics in the function of our genomic make-up will likely be equally important to 
our understanding of the relation between function and organ anatomy in humans (35). 
To place this in perspective of studies of CP, it has been shown that bacteria involved in 
periodontal infection are capable of inducing such epigenetic DNA alterations (36).  
 
3. Potential biases  
As explained in detail in the two previous sections, the phenotype characterization 
and limitations inherent to GWAS are two major potential sources of bias for this 
investigation. With regard to the CP phenotype, it is possible that the CDC 
classification is not sensitive or quantitative enough to capture the entire spectrum of 
disease expression. For example, using the CDC trait may be an inappropriate 
phenotype if one considers CP equally likely to develop due to a hyper-inflammatory 
host reaction or an immune-compromised state. Most likely, there are different 
genetic influences for these two types of host-response profile. To address this 
limitation, the consideration of biologically-refined classifications of CP such as the 
BGI may be indicated. 
 Another phenotype-related source of bias is the definition of the “high” 
bacterial colonization traits for our Specific Aim 2. It is known that the semi-
quantitative method of DNA-DNA “checkerboard” hybridization has a lower count 
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detection threshold of 103 to 104. On the other hand, experts agree that CP risk is 
“frankly elevated” at high count levels, in the range of 105 to 106. In our study we 
arbitrarily defined “high colonization cases” those who were in the highest quintile of 
the distribution for each bacterial trait. Using this approach we were able to retain an 
“adequate” proportion of 20% of subjects as cases, representing a “pragmatic” 
approach that allowed an analytically feasible contrast- defining a higher threshold 
would result in fewer “high colonization cases” and perhaps reduced power to detect 
GWA signals. Future studies should, however, explore the feasibility of different 
definitions of the “high colonization” traits. Moreover, although our summation of 
different bacteria into the “red” and “orange” complex groups is based solid 
biological and microbiological ground, it could still represent an over-simplification, 
because different micro-organisms possess different pathogenic and host interaction 
profiles. Therefore, it will be worthwhile for investigators to examine individual 
pathogen colonization profiles using a GWA approach.  
 With regard to the GWAS methodology, in brief, apart from our modest 
sample size for this type of investigation, there are three inherent biases. First, it is 
very likely that many “true association” signals are below the stringent threshold set 
for genome-wide significance or suggestive evidence of association. Second, due the 
low power of the study, it is also likely that the identified associations are 
overestimates of the true effect sizes of these loci. Third, our analysis of only 
common variants restricts our inference to common-only polymorphisms and ignores 
possibly rare (<5%) but large effect size SNPs. To address these biases future studies 
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need to be conducted replicating our findings, investigate for novel ones, and explore 
the role of rare variants. 
Tooth loss due to CP is also another important source of bias. An example would 
be a patient with severe CP that lost all his teeth and in this investigation was 
classified as edentulous and was excluded from the dental ARIC analytical sample; or 
another patient who had his “most severely” affected teeth extracted few weeks 
before the clinical examination, and was subsequently diagnosed with moderate or no 
CP instead of severe CP. An analytical approach quantifying this source of bias 
would include sensitivity analyses that either adjust the genetic models for tooth loss, 
or impute ‘likely CP diagnoses’ based on certain patterns of tooth loss that are found 
among CP patients. 
 
D. Potential impact and public health significance  
1.  Genetic discovery and applications 
The significance of any new discovery in health research is measured by its 
clinical relevance, potential for prevention and public health context (37). The 
unraveling of the genetic component of human traits and diseases has been challenged 
in terms of its potential for immediate public health benefits (38). The contrary can be 
argued, for instance, for pharmaceutical research, were new drugs or vaccines may 
have immediate and dramatic global public health benefits (39). In this respect, the 
central role of epidemiology as the “quarterback” of steering translational research 
into application and public health practice has been increasingly emphasized (40). 
Other authors stress the fact that still not enough attention or efforts are invested in 
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translating novel findings in a manner that can have meaningful impacts in public 
health (41). The findings of this study have the potential to offer insights into the 
pathogenesis of CP, providing possible therapeutic and preventive avenues, but also 
benefit the study of other pathological conditions that have a host-microbiome 
interaction or immunological underpinning. 
Despite the accelerated rates of gene discovery for common complex diseases, 
valid applications of GWAS findings in personalized health care are not yet evident 
(42, 43). Influences by the emerging “personalized medicine” market may subject 
individuals to unnecessary costs or even health risks (44); in this regard, the 
clinicians’ and investigators’ role in providing accurate and evidence-based 
counseling about the potential and the limitations of genetic testing, is critical 
However, regardless of immediate translational potential, discovery of gene variants 
associated with health or disease can lead to the discovery of previously unknown 
biological mechanisms and pathways. Intervening on the genetic makeup is not 
applicable to-date; however, development of drugs that could interact on these 
pathways is an important opportunity treatment and even prevention (vaccine 
development) of disease.  
 
2. Therapeutic avenues for periodontitis 
Despite the great strides in our understanding of the biology of periodontitis 
during the last decades, the therapeutic means available for CP have been long 
unchanged. Efforts in the prevention of CP and periodontal diseases in general have a 
strong behavioral component (45, 46), because meticulous oral hygiene, oral self-care 
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and dental attendance are the cornerstones of oral disease prevention. Periodontal 
therapy however, is needed for individuals who develop the disease, so that the supra- 
and sub-gingival microbial load can be reduced, the inflammatory response 
controlled, and the patient can maintain a periodontal health status via preventive 
efforts and a maintenance-recall protocol. Specifically, the maintenance of a 
microbial colonization profile that is host-compatible has been proposed as a 
“microbial treatment goal” for periodontal therapy (47) 
The use of mechanical means for the microbial load reduction (conventional 
or surgical periodontal therapy based on root scaling and planning) remains 
unchallenged for the treatment of periodontitis (48), while adjunctive antibiotic 
therapy is becoming more frequent in severe or refractory cases of periodontitis (49, 
50). The patterns of colonization by and proliferation of periodontal pathogens has 
been suggested to have a genetic (host) component (51), and this question was indeed 
interrogated in our study. Beyond that, the current stage of knowledge allows 
clinicians and investigators to expect that response to periodontal treatment varies 
greatly between individuals who harbor the same pathogenic microflora (52). The fact 
that non-uniform and often unsustainable results are to be expected by CP patients 
after treatment is a frequent observation (53), which has invited the exploration of 
individual susceptibility or treatment resistance biological markers.  
In medicine, the microbiological component and etiology of disease is well-
established and common sense. In dentistry, in spite of advances in oral microbiology 
and the increasing popularity of antimicrobial applications, the unexplored potential 
is immense (49). This is supported by a substantial variation in quantitative and 
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qualitative aspects of periodontal ecology between patients (54), and recent findings 
that link subgingival bacterial colonization profiles with gingival tissue gene 
expression (55). The incorporation of oral microbiology applications for the 
prevention and therapy of periodontitis, consistent with the “periodontal medicine” 
model, is likely to increase in the future (56-58). 
The introduction of antimicrobials (59-61) or anti-inflammatory drugs (61, 62) 
has showed varying but generally promising results. These reports indicate that 
combinations of conventional and pharmaceutical treatment regimes are likely to 
produce the most predictable treatment outcomes in selected cases. However, it 
would be optimal if individual characteristics of host response could be incorporated 
in diagnosis and therapy to optimize treatment responses. For example, identification 
from the present GWA of susceptibility loci and potential functional genetic variants 
can be used to determine whether adjunctive antimicrobial or anti-inflammatory 
therapy would be indicated for biological subtypes of periodontitis (63).  
Improvements in prevention of periodontitis would have significant and multi-
level implications in the oral health and related quality of life of a substantial 
proportion of the adult population, and may be more important as demographic 
effects increase the life expectancy and mean age worldwide (64). Prevention of CP 
will contribute to the reduction of edentulousness rates (65), which constitutes a 
frequent form of functional and psychosocial impairment. Such advances in 
prevention could indeed stem from a better understanding of the disease pathogenesis, 
progression, and treatment or from the development of new preventive strategies, 
such as the envisioned vaccine against periodontitis (66). Moreover, it will reduce the 
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disease-related somatic and psychological distress and co-morbidities, as well as the 
financial and time loss impact to systems and individuals, due to its treatment or 
sequelae. Additionally, prevention of periodontitis has substantial public health 
implications when its links with systemic health are considered (48). One major and 
direct benefit would be, for instance, improved glycaemic control among patients 
with type 2 diabetes (67).  
 
E. Replication of GWA results and relevance of identified loci 
As noted above, replication of results of genome-wide association studies has 
virtually become a standard requirement for reporting (22, 38). Although successful 
replication of GWA finding provides some level of additional “confidence” that the 
results do not represent spurious associations, non-replication does not always imply 
a “false alarm”. The “winner’s curse” phenomenon, representing novel findings’ 
failure to replicate in subsequent studies, as well as other methodological features of 
GWA studies such as stringent significance thresholds may be responsible for 
overestimation of the true underlying genetic effects (68). For this reason, GWAS are 
considered essentially “discovery attempts” (69, 70) and their results are subject to 
very conservative statistical criteria, as well as replication in independent samples.  
 
1. Replication of prioritized SNPs of chronic periodontitis 
The Health ABC dental cohort 
Replication of the current study’s findings was sought via collaboration with 
investigators of the Health Aging and Body Composition (ABC) study. The Health 
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ABC is a prospective study of well-functioning adults of ages 70-79 at baseline. 
White participants were recruited from a random sample of Medicare beneficiaries in 
the Pittsburgh, Pennsylvania, and Memphis, Tennessee. Eligibility criteria included 
age between 70 and 79, self-reported no difficulty of walking one-quarter mile or 
climbing 10 steps without resting, no difficulty performing basic activities of daily 
living, no reported need of an assistive walking device, and no active treatment for 
cancer (71). As part of the study year 2 and 3 follow-up clinical visits (1998-2000), a 
total of 1,133 white and African American participants were eligible and received 
complete dental and periodontal examinations. About two-thirds of this ancillary 
dental study’s participants were white. Among whites, 21% of men and 14% of 
women were diabetic. With regard to smoking history, proportions of current/former 
smokers among men and women were 5%/61%, and 5%/32%, respectively. 
Replication was based on this subset of approximately 750 Health ABC participants 
(~400 men and ~350 women) that were subsequently genotyped using the Illumina 
Human1M Duo platform.  
 
Replication of the dental ARIC GWA findings 
Replication was sought for our prioritized SNPs based on the genome-wide 
association P<5x10-6 threshold in ‘crude’ or ‘adjusted’ analyses. Fourteen SNPs met 
this threshold and therefore, effect estimates and P-values based derived from the 
Health ABC cohort GWAS were obtained. For these SNPs, the same coded and non-
coded alleles were genotyped in both GWAS (Table A15).  These estimates are 
presented in Tables A16 and A17. A same direction effect and a conventional P<0.05 
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threshold were set as for evidence of replication. Moreover, we took advantage of the 
opportunity to perform a meta-analysis of the reported effect estimates, as an 
additional approach in summarizing the effect of the reported risk loci (72). Meta-
analytical pooled odds ratios and P-values were obtained using the METAL program 
(73), using an inverse-variance weighting method (74). Summary estimates (pooled 
odds ratio) were obtained for SNPs that did not depart substantially from effect 
homogeneity between the two cohorts (defined as homogeneity X2 P<0.2).  
The summary of the replication findings is presented in the Appendix, in Tables 
A16-A18. Noteworthy, only one locus associated with severe CP (7p15, rs2521634) 
met the P<0.05 and same effect direction replication criteria. Additionally, one locus 
associated with moderate CP (19p13.3, rs3826782) neared replication (P=0.06) and 
another (6p21.1, rs7762544) showed a same direction effect with no evidence of 
heterogeneity. Therefore, summary estimates based on inverse-variance weighted 
meta-analysis are presented in Table A18. Pooled odds ratios and associated summary 
P-values for these three loci were: 7p15 (rs2521634)—OR=1.49 (95% CI=1.28-1.73), 
P=3.5x10-7; 19p13.3 (rs3826782)—OR=2.01 (95% CI=1.52-2.65), P=8.2x10-7; 
6p21.1 (rs7762544)—OR=1.40 (95% CI=1.24-1.59), P=7.5x10-8.  
Interestingly, one of these SNPs prioritized for severe CP (rs2521634) provided a 
replication signal also for moderate CP in Health ABC, whereas one moderate CP-
associated SNP in ARIC (rs3826782) provided a replication signal for severe CP in 
Health ABC. It is possible that these risk loci indeed confer risk for both types of CP. 
However, this observation warrants more investigation to clarify whether systematic 
differences between the two study samples may be responsible for this difference (i.e. 
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tooth loss and retention, or periodontal treatment levels that may result to different 
phenotypical expression). An alternative explanation may be that these 
polymorphisms actually confer protection against periodontal pathology, and 
therefore may be associated with “periodontal health” when studying the two CP 
traits.  
 
Relevance of identified and replicated loci 
Presentation and discussion of all prioritized loci for the CP, EAL and “high” 
bacterial colonization traits are presented in the discussion sections of and 
supplemental material of manuscripts 1 and 2 (Sections 4.F, 4.J, 5.F and 5.J). This 
section offers a more detailed presentation of one replicated locus for severe CP, at 
7p15. 
 
The NPY (7p15) locus 
This locus was marked by rs2521634, which was the top SNP in the region with 
P=1.6x10-6 and located 47Kb downstream of NPY. The latter is a gene encoding a 
neuropeptide that is widely expressed in the central nervous system and has been 
suggested to function as an anxiolytic peptide that helps explain inter-individual 
variation in trait anxiety and resiliency to stress (75). Several reports have associated 
a LeuPro substitution in the NPY gene with significantly elevated serum 
triglycerides and lipids among Northern European populations (76, 77). The SNP 
responsible for this missense change (rs16139, predicted as ‘benign’ by PolyPhen-2) 
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was 10Kb upstream of rs2521634 and not in linkage disequilibrium with it (D’=1.00; 
r2=0.01).  
An early immunohistological Swedish study among by Barr-Agholme and 
colleagues observed higher neuropeptide Y levels and sensory hyper-innervation in 
the gingival tissue of Down syndrome (DS) patients, attributing this finding to the 
gingival inflammatory reaction rather that DS itself (78). A 2004 critical review by 
Lundy and Linden (79) emphasized the role of the nervous system in the 
pathophysiology of peripheral inflammation, suggesting a neurogenic inflammatory 
component for periodontitis. These authors suggested that neurogenic inflammation is 
in fact a protective mechanism, with NPY having a pivotal role in the cascade of 
relevant chemical activities.  
A recent case-control study by Lundy and colleagues (80) provided experimental 
evidence consistent with this hypothesis. Elevated NPY levels were found in the 
gingival crevicular fluid of periodontitis compared to healthy sites. Additional 
evidence supports a role of the sympathetic nervous system and NPY in the 
modulation of periodontal inflammation and bone resorption (81, 82). Interestingly, 
inhibition of nerve growth factor (NGF), which is known to up-regulate 
neuropeptides in sensory neurons, via systemic anti-NGF was recently shown to be 
associated with reduced Interleukin 1beta and bone resorption in a rat periodontitis 
model (83). In sum, combined with our GWAS results, there is accumulating 
evidence pointing towards the role of the nervous system and neuropeptide 
messengers (with NPY being an obvious candidate one) across the axis of a 
“neurological inflammatory reflex” in the cascade of events that lead to periodontitis.  
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F. Future research directions 
1. Improvement over candidate-gene approaches 
Candidate-gene studies have been limited in their ability to identify risk loci 
or genes for common complex diseases. In general, candidate-gene approaches have 
had better results when studying “highly penetrant” diseases, where a “disease-gene” 
may exist. Successful candidate-gene studies are typically based on strong prior 
knowledge or mechanistic theory, as is the case of inflammatory mediator gene 
markers and cytokines in the context of inflammatory diseases, such as ulcerative 
colitis (84) and CP (85). In the case of CP in particular, such studies have focused on 
inflammatory mediator molecules and receptors such as the interleukin gene cluster. 
Despite the obvious relevance and replication of this finding across many candidate-
gene studies, it should be expected that multiple genes are implicated in the 
pathogenesis of CP, each conferring likely small to modest excess risk. Although 
previously reported candidate-gene study targets were not marked by strong signals in 
our GWAS we explored several loci that contain such candidate genes, including 
IL1A, IL1RN, IL6, TLR4, MMP2, GLT6D1, FCGR3A, and VDR with visualizations 
that are presented in Figures A30-A33. Moreover, we did identify few loci that were 
contained genes related to previous candidate-gene reports. For example, the 9p24 
locus was identified for “high red” complex bacterial colonization and included IL33. 
Additionally, one locus on chromosome 19 that was identified for severe CP 
contained a tumor necrosis family (TNFSF14) and a complement (C3) gene, which 
are well-documented immune- and periodontitis-related genes (86-90). One of the 
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prioritized loci on chromosome 6 (rs17792917) for the “extent” of attachment loss 
trait has been reported as an eQTL for another TNF-family gene on chromosome 13 
(TNFRSF19), which has been reported as a susceptibility locus for lung cancer (91) 
and vascular dementia (92). Finally, the risk locus on 2p23.3 that emerged for Pg 
“high” colonization is an eQTL for multiple genes including IL17RB on chromosome 
3. We anticipate that future candidate-gene studies will embark in testing and 
potentially replicating our GWA findings. 
 
2. Beyond genome-wide association analyses  
The analytical methods of GWAS data are constantly evolving, and may allow 
a future extension of the present analysis via implementation of novel methodologies. 
For example, despite the initial “agnostic” scan, there is an opportunity to prioritize 
candidate SNPs for analysis in the GWA context, when for instance epistatic effects 
are hypothesized or suspected (32, 93). Other examples of novel but not well-
established approaches include attempts to link prior knowledge (of validated 
polymorphisms) with analytical strategies (94), use of pathway-clustering analysis of 
genetic signals (95), efficient approaches to explore gene-gene and gene-environment 
interactions (96, 97), and the incorporation of expression quantitative trait loci 
(eQTL) with GWAS results (98, 99). 
It is becoming increasingly understood that major advances in our understanding 
of the genetic underpinning of human health and disease can be realized by efficient 
comprehensive, efficient and inexpensive interrogations of genomes, transcriptomes 
and interactomes (100). Next-generation sequencing studies (101-103) have recently 
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emerged and are promising in this respect, with exome sequencing investigations 
providing a high rate of novel findings (104, 105). A particular strength of whole-
exome sequencing studies is that they offer opportunities for both disease gene 
discovery as well as clinical diagnosis, as protein coding genes harbor the vast 
majority of large-effect disease-related mutations (106).  
Finally, several additional explorations of the data presented in this dissertation 
may offer novel insights in the study of CP. The consideration of gene expression 
modulation by proximal (cis) or distal (trans) eQTLs, as noted above (98, 99) can 
provide information that may be functionally relevant. For example, one of the three 
replicated loci, 19p13.3 (marked by rs3826782) has been reported as an eQTL for 
GPR113 (G-protein coupled receptor 113) on chromosome 2p23.3, which has 
functions on the neuropeptide signaling pathway as well as signal transducer activity; 
pathways relevant to the other prioritized locus on 7p15, where neuropeptide Y (NPY) 
is located. Moreover, GPR113 has been found to be particularly expressed intra-
orally, in the taste receptor cells (107).  
Moreover, examining larger sets of prioritized loci in ‘pathway analysis’ networks 
may reveal patterns of association that are otherwise difficult to detect by ‘single-
locus’ explorations. Examples of such exploratory visualizations of functional and 
physical interactions between genes that were identified from our analyses are 
presented in the Appendix Figures A28 and A29. Although these networks arguably 
contain a lot of “noise”, empirical inspection of represented functional pathways and 
physical interactions can be informative. In this network of interactions (figure A28), 
some of these well-represented pathways were collagen, protein phosphatase 2A 
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binding, extracellular matrix, positive regulation of transcription from RNA 
polymerase II promoter, epithelial to mesenchymal transition, platelet activation, Wnt 
receptor signaling pathway, cellular response to growth factor stimulus, regulation of 
fibroblast proliferation and positive regulation of kinase activity.  
 
3. Future studies 
As explained in the previous sections, the present study can be considered as a 
‘fist look’ into the genetic component of chronic periodontitis using a genome-wide 
association approach. Within the limitations of the analyses presented here, this work 
offers new information about candidate loci associated with CP. There is a large 
number of follow-up research and different avenues that can and should be followed 
after the conduct of a GWAS (108, 109). Future studies in this field are needed to 
replicate and validate these associations, discover new ones, elucidate their functional 
role and mechanistic pathways, determine their potential for diagnostic and 
therapeutic applications, and more.  
To be more specific, future GWAS examining the three-level CP 
classification are warranted to replicate the associations with loci that our study 
reported. Although GWAS of bacterial colonization profiles are harder to realize, 
replication of the high periodontal pathogen colonization findings will add to our 
understanding of the contribution of genetic factors to host-microbiome interactions. 
Because GWAS are generally under-powered to detect most small to modest genetic 
effects, future studies of equal size may discover new loci that did not meet the 
suggestive association threshold in our investigation. However, larger GWAS or 
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pooling of existing cohorts may be necessary to enable the detection of small effects 
and GxE or GxG interactions. Factors such as sex, smoking and diabetes should be 
strong candidates as ‘environmental exposures’ for these interaction analyses. We 
emphasize the need and importance of conducting GWAS in populations other than 
whites of European descent, as evidence of the genetic component of CP among 
populations of African, Asian and American descent are lacking. Such studies in 
diverse populations can provide insights about loci that were in fact identified in our 
study population of whites, or discover novel ones. 
Identifying the causal variant(s) in the loci that we report is also an important 
step that future studies should address (110). From our GWAS results it cannot be 
inferred that the SNPs that were identified tagging the prioritized loci are the causal 
variants. It is possible that non-genotyped and non-imputed, perhaps rare (<5%) 
variants are the risk-conferring ones. Fine-mapping represents one strategy that can 
be implemented in future studies seeking to identify the risk variants and causal 
alleles in these or other candidate loci for CP. However, some opportunities to 
interrogate the contribution of rare variants will emerge with the imputation of our 
existing genotype data using the ‘1000 genomes’ haplotypes, a strategy that will offer 
approximately 10 million markers for GWAS, including a substantial proportion of 
rare ones. It is not unrealistic to anticipate that these strategies will eventually be 
superseded by whole genome sequencing, which will become progressively less 
costly and time-consuming in the next decade.  
Subsequent experimental or association studies linking GWAS data with gene 
expression information can also provide information about the functional relevance 
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and candidate mechanistic pathways that the prioritized genes operate on. 
Experimental studies “knocking-out” the new candidate genes in animal models will 
be needed to clarify the role of GWAS discoveries. The use of microarrays to 
interrogate gene expression can also provide tissue-specific insights (111). As more 
data become available with regard to gene expression regulation by quantitative trait 
loci on multiple tissues, future studies may be able to annotate our findings to such 
cis- or trans-acting eQTLs (112). 
Future studies examining traits other than the three-level CDC disease 
taxonomy that we employed may offer additional insights into the genetic component 
of CP. Disease indicators or “proxies” are less valid in the ascertainment of cases, but 
they may be cost-effective and more feasible than gold-standard clinical 
examinations. It may be possible for indicators such as number of remaining teeth, 
radiographically measured alveolar bone loss, and self-reported diagnosis of CP to be 
obtained for population-based samples or existing cohorts with genotype data, thus 
enabling more GWAS of CP. 
Furthermore, genome-wide interrogations of endophenotypes, which represent 
physiologic indicators, biochemical assays, or other “intermediate” traits relevant to 
the disease under study (113, 114) may offer additional opportunities to examine the 
genetic influences for CP. These traits have the benefit of being ‘biologically 
proximal’ to the hypothesized genetic effects, whereas the phenotype expression of 
complex and polygenic diseases is likely to be the result of many genetic and non-
genetic, measured, un-measured and unobservable factors. The bacterial colonization 
profile that we examined as part of our Specific Aim 2 can be considered as an 
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endophenotype of CP. Others may include in vivo quantified inflammatory markers 
such as gingival crevicular fluid Interleukin levels, serum levels of antibodies to 
periodontal pathogens, markers of oxidative stress, and more. 
Extending the concept of the study of intermediate CP phenotypes, it can be 
argued that the identified or the still undiscovered risk loci for CP confer excess risk 
for conditions other than CP. Certain molecular functions and pathways may be 
common in the pathogenesis of a number of diseases. This is indicative of pleiotropy, 
which is the phenomenon of a single gene influencing multiple traits (115). Future 
studies can investigate common risk loci for CP and other, frequently associated 
conditions, such as diabetes and cardiovascular disease. Moreover, simultaneous 
examinations of a wide array of phenotypes for a given genotype, in the context of 
phenome-wide (116, 117) association studies (PheGWAS) are efficient strategies that 
are gaining popularity and may include CP in the future. 
Finally, incorporating the current GWAS findings into epidemiologic and 
clinical investigations will be an important “research translation” step. One can 
envisage how novel candidate genes can be considered in investigations of CP risk or 
treatment response. Genes or promoter regions in the candidate loci that we report, 
such as NPY, could be evaluated as CP risk indicators or prognostic markers CP 
treatment response, alone or in combination with genetic markers that are already 
being tested as such (i.e. the interleukin family gene cluster). The identification of a 
group of genetic markers that have a good combined positive predictive value could 
in the future be used in the design of genetic tests that would inform clinicians and 
patients of their CP risk or their likelihood to respond favorably to various therapeutic 
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options. Such investigations could evaluate for example whether CP patients who are 
carriers of certain genotype of NIN, EMR1, NPY, FBXO38, TBC1D1, CAMTA1 or 
GRID1 have better therapeutic results when treated with conventional-surgical, 
antimicrobial, or anti-inflammatory periodontal treatment, or combinations of these.  
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APPENDIX 
 
 
Table A1. Distribution in the total sample and bivariate associations of periodontal diagnosis (CDC 
classification) and periodontal attachment loss (extent score: percent of sites with ≥3mm attachment loss) with 
brushing and flossing frequency, dental attendance reason and frequency, and education level among the 
Caucasian participants of the Dental ARIC study, for whom clinical and genetic data were matched after 
exclusions (n=4,610) 
  
 
CDC Periodontitis classification  
Attachment loss 
(≥3mm) 
 
Total 
(n, column %) 
 Health-mild 
(n, row %) 
Moderate 
(n, row %) 
Severe 
(n, row %)  
Extent score* 
mean(SD); 
median† 
Total sample 4610 (100)  1864 (40) 1961 (43) 785 (17)  21.1 (21.2); 14  
Brushing 
frequency1,2 
(yesterday)  
 
     
One time or none 1350 (29)  482 (36) 592 (44) 276 (20)  24.0(23.6); 17 
Two or more 3239 (71)  1374 (42) 1361 (42) 504 (16)  19.9(20.1); 13 
Flossed last week1,2        
Did not floss 1464 (32)  506 (35) 641 (44) 317 (22)  26.1(24.4); 18 
Flossed one or more 
times 3124 (68)  1349 (43) 1312 (42) 463 (15)  18.8(19.2); 13 
Dental visit reason1,2        
Regular visits 3809 (83)  1609 (42) 1612 (42) 588 (15)  19.1(19.2); 13 
Only when problem 780 (17)  247 (32) 341(44) 192 (25)  31.3(27.3); 23 
Last dental visit1,3        
<6 months ago 3174 (69)  1312 (41) 1333 (42) 529 (17)  19.8(19.8); 14 
6-24 months 1031 (22)  427 (41) 454 (44) 150 (14)  20.8(21.4); 14 
More than 2 years ago 381 (8)  117 (31) 163 (43) 101 (27)  32.9(28.0); 25 
Education level1,3 
 
 
    
 
Basic (0-11 years) 433 (9)  136 (31) 195 (45) 102 (24)  30.5(27.4); 21 
Intermediate (12-15 
years) 2102 (56) 
 
838 (40) 904 (43) 360 (17)  21.4(21.3); 14 
Advanced (16+ years) 2069 (45)  886 (43) 860 (42) 323 (16)  18.9(19.1); 13 
*third molars were included; †rounded to the closest integer; 1Chi-square test of equivalence between strata of 
periodontitis P<0.05; 2Median test of stratum-specific attachment loss estimates P<0.05; 3Kruskal-Wallis test 
of stratum-specific attachment loss or covariate estimates P<0.05 
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Table A2. Distribution in the total sample and bivariate associations of periodontal diagnosis (CDC 
classification) and periodontal attachment loss (extent score: percent of sites with ≥3mm attachment 
loss) with quintiles of age and BMI among the Caucasian participants of the Dental ARIC study, for 
whom clinical and genetic data were matched after exclusions (n=4,610) 
  
 
CDC Periodontitis classification  
Attachment 
loss (≥3mm) 
 
Total 
(n; median) 
 Health-mild 
(n, row %) 
Moderate 
(n, row %) 
Severe 
(n, row %)  
Extent score* 
mean(SD); 
median† 
Total sample 4610  1864 (40) 1961 (43) 785 (17)  21.1 (21.2); 14  
 
       
Age1,2 (years, 
quintiles; mean)        
Q1 (55.5) 1054; 56  504 (48) 403 (38) 147 (14)  20.0 (18.7); 11  
Q2 (59.5) 1026; 60  445 (43) 425 (41) 156 (15)  18.8 (19.2); 13  
Q3 (63.0) 724; 63  301 (42) 288 (40) 135 (19)  21.6 (21.9); 15  
Q4 (66.5) 890; 66  311 (35) 421 (47) 158 (18)  23.6 (23.0); 16  
Q5 (70.9) 916; 71  303 (33) 424 (46) 189 (21)  25.6 (22.8); 19  
 
       
BMI1,2 (kg/cm2, 
quintiles; mean)        
Q1 (22.1) 922; 22.5  445 (48) 346 (38) 131 (14)  18.9 (20.6); 11  
Q2 (25.3) 922; 25.3  389 (42) 386 (42) 147 (16)  20.3 (20.7); 14 
Q3 (27.5) 919; 27.5  368 (40) 391 (43) 160 (17)  21.5 (21.6); 14  
Q4 (30.1) 923; 30.0  324 (35) 421 (46) 178 (19)  22.9 (22.0); 17  
Q5 (35.6) 918; 34.7  337 (37) 413 (45) 168 (18)  21.9 (21.1); 15  
*third molars were included; †rounded to the closest integer; 1Chi-square test of equivalence 
between strata of periodontitis P<0.05; 2Kruskal-Wallis test of stratum-specific attachment loss or 
covariate estimates P<0.05 
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Table A3. Distribution and bivariate associations of attachment loss (quintile-categorical and three-
level classification of extent score) with periodontal diagnosis (CDC classification) among the 
Caucasian participants of the Dental ARIC study, for whom clinical and genetic data were matched 
after exclusions (n=4,610) 
  
 
CDC Periodontitis classification  
Attachment 
loss (≥3mm) 
Attachment 
loss 
Total 
(n, column %) 
 Health-mild 
(n, row %) 
Moderate 
(n, row %) 
Severe 
(n, row %)  
Extent score* 
mean(SD); 
median† 
Total sample 4610  1864 (40) 1961 (43) 785 (17)  21.1 (21.2); 14 
Quintile-
categorical 
       
Q1 922  892 (97) 29 (3) 1 (0)  2.3 (1.5); 2 
Q2  929  634 (68) 291 (31) 4 (0)  7.6 (1.6); 8 
Q3  918  262 (29) 611 (67) 45 (5)  14.3 (2.3); 14 
Q4  944  61 (6) 622 (70) 221 (23)  25.1 (4.4); 25 
Q5  897  15 (2) 368 (41) 514 (57)  57.3 (19.2); 52 
3-level 
classification 
       
None-mild 
(<10%) 1760 (38)  1480 (84) 276 (16) 4 (0)  4.7 (2.9); 5 
Moderate  
(10-<30%) 1769 (38)  365 (21) 1197 (68) 207 (12)  18.0 (5.5); 17 
Severe  
(≥30%) 1081 (23)  19 (2) 488 (45) 574 (53)  52.9 (20.0); 46 
*third molars were included; †rounded to the closest integer 
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Table A4. Median (interquartile range, IQR)  of sub-gingival microbial counts of eight periodontal pathogens obtained via 
DNA checkerboard immunoblotting among a subset of the Dental ARIC participants (n=1020) 
 P gingivalis T forsythia T denticola P intermedia P nigriscens C rectus F nucleatum A actinom. 
Total sample(n) 1020 1020 1017 1018 1020 1018 1012 1020 
 945 (3061) 1314 (4368) 2665 (9273) 4270 (15432) 3185 (12758) 2524 (19676) 5605 (32326) 2044 (5592) 
Sex         
Females 806 (2716) 1248 (4695) 2788 (9922) 3579 (15930) 3179 (12834) 2260 (10252) 5994 (30347) 1891 (5298) 
Males 1162 (3341) 1435 (4188) 2537 (8968) 5074 (15009) 3191 (12683) 2736 (11230) 5355 (32393) 2257 (5762) 
Smoking status         
Never  987 (2881) 1184 (4777) 2647 (9895) 4164 (18039) 3146 (14186) 2389 (10985) 5502 (39732) 2129 (6476) 
Past- light 1351 (3927) 1558 (4268) 3252 (8968) 5204 (15480) 3514 (13292) 3230 (13005) 7088 (33977) 2138 (5906) 
Past- heavy 725 (2470) 1116 (3732) 1869 (8043) 3200 (11721) 2567 (9438) 1827 (06974) 3811 (23385) 1651 (4309) 
Current- light 2358 (2935) 2671 (5696) 1718 (13022) 5417 (13724) 3216 (13207) 3375 (8652) 6696 (35865) 2491 (5933) 
Current– heavy 1003 (3082) 1318 (6286) 3503 (11592) 6858 (15881) 2726 (13957) 3649 (10491) 6950 (29101) 2250 (4306) 
Diabetic status         
Healthy 897 (2996) 1242 (4079) 2574 (9149) 4118 (14895) 2924 (12601) 2499 (10467) 5433 (28535) 2035 (5539) 
Diabetes mellitus 1305 (3229) 1849 (6770) 2980 (10907) 6031 (17418) 4595 (15681) 2707 (16178) 6853 (42203) 2398 (6474) 
Tooth loss         
0-9 lost teeth 862 (2658) 955 (3280) 2154 (8016) 3466 (13724) 2718 (10288) 1978 (8310) 4621 (26557) 1810 (4818) 
10-18 lost teeth 783 (3195) 1445 (5519) 2249 (10392) 3320 (16363) 3407 (14219) 2679 (12632) 5518 (32747) 1997 (5031) 
19-32 lost teeth 2247 (5848) 3556 (9088) 6192 (19980) 10486 (32331) 6021 (25088) 4947 (25396) 14486 (48825) 4185 (8360) 
No. teeth  
rho (95% CL) 
-0.20 
(-0.16, -0.4) 
-0.14 
(-0.20, -0.08) 
-0.11 
(-0.18, -0.6) 
-0.10 
(-0.16, -0.4) 
-0.08 
(-0.14, -0.02) 
-0.12 
(-0.19, -0.06) 
-0.10 
(-0.16, -0.04) 
-0.13 
(-0.19, -0.07) 
Age  
rho (95% CL) 
0.01 
(-0.05, 0.07) 
0.07 
(0.01, 0.13) 
0.02 
(-0.03, 0.08) 
0.01 
(-0.06, 0.07) 
0.04 
(-0.02, 0.10) 
0.04 
(-0.02,0.10) 
0.03 
(-0.03,0.10) 
0.03 
(-0.03, 0.09) 
BMI  
rho (95% CL) 
0.01 
(-0.05, 0.07) 
0.01 
(-0.06, 0.07) 
0.02 
(-0.04, 0.08) 
0.00 
(-0.07, 0.06) 
0.03 
(-0.03, 0.10) 
0.01 
(-0.05, 0.07) 
0.00 
(-0.06, 0.07) 
0.03 
(-0.03,0.09) 
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Table A5. Median (interquartile range, IQR)  of sub-gingival microbial counts of eight periodontal pathogens obtained via 
DNA checkerboard immunoblotting among a subset of the Dental ARIC participants (n=1020) 
 P gingivalis T forsythia T denticola P intermedia P nigriscens C rectus F nucleatum A actinom. 
Total sample(n) 1020 1020 1017 1018 1020 1018 1012 1020 
 945 (3061) 1314 (4368) 2665 (9273) 4270 (15432) 3185 (12758) 2524 (19676) 5605 (32326) 2044 (5592) 
Brushing frequency 
(yesterday)         
One time or none 996 (3798) 1506 (5244) 3129 (10393) 4948 (17741) 3075 (18176) 2736 (12907) 7447 (40283) 2584 (6912) 
Two or more 904 (2838) 1277 (4109) 2330 (9112) 3977 (14675) 3216 (10557) 2324 (8879) 5048 (26681) 1882 (5004) 
Flossed last week         
Did not floss 1386 (3905) 1734 (6439) 3294 (11529) 6185 (21216) 4208 (18039) 3030 (14578) 7252 (42203) 2779 (6603) 
Flossed 1+ times 780 (2657) 1094 (3588) 2302 (8314) 3582 (13698) 2711 (10246) 2218 (8797) 4830 (26433) 1750 (5004) 
Dental visit reason         
Regular visits 876 (2817) 1143 (3581) 2203 (8226) 3733 (13696) 2827 (10342) 2246 (8377) 4811 (24388) 1876 (4852) 
Only when problem 1409 (5391) 2900 (10448) 4624 (19327) 8204 (32715) 6128 (24793) 4328 (26746) 10653 (73484) 3012 (8944) 
Last dental visit         
<6 months ago 908 (2880) 1164 (3573) 2183 (7841) 3624 (13697) 2637 (10246) 2231 (8310) 5048 (25670) 1822 (4816) 
6-24 months 666 (3086) 1295 (4939) 3355 (11840) 4713 (16502) 4662 (14860) 2618 (13005) 6080 (36723) 2204 (6916) 
2+ years ago 1633 (5947) 3497 (12599) 4875 (21366) 10334 (37253) 6654 (26833) 4112 (28367) 10245 (110673) 4208 (10449) 
Education level         
Basic (0-11 years) 1719 (5961) 2680 (8607) 3616 (16033) 9248 (34555) 4911 (21757) 5424 (27103) 15088 (77493) 3945 (10016) 
Intermediate (12-15 
yrs) 859 (2887) 1535 (4914) 3255 (9823) 3980 (14096) 3385 (12601) 2630 (10467) 6272 (38108) 2267 (5525) 
Advanced (16+ yrs) 910 (2990) 959 (3383) 1973 (8226) 3948 (13950) 2711 (9889) 2048 (8032) 3966 (21940) 1536 (4710) 
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Table A6. Median (interquartile range, IQR) values of sub-gingival microbial counts 
of the “red” and “orange” complex pathogens, and total microbial load obtained via 
DNA checkerboard immunoblotting, in the total sample, stratified by sex, smoking and 
diabetic status and their association with age and BMI among the Caucasian 
participants of the Dental ARIC study, for whom clinical and genetic data were 
matched after exclusions (n=1020) 
 
“Red” complex “Orange” complex Total microbial load 
Total sample 5676 (13629) 22668 (60169) 31640 (76343) 
n 1017 1009 1006 
Sex    
Females 5684 (13150) 22579 (60294) 31594 (73568) 
Males 5676 (14061) 22731 (60252) 32084 (82237) 
Smoking status    
Never  5604 (13100) 23437 (73000) 31186 (96592) 
Ever- light 6848 (12977) 25544 (69412) 35654 (83731) 
Ever- heavy 4591 (10733) 17750 (41055) 26584 (58326) 
Current- light 5540 (16016) 23990 (46456) 42370 (48097) 
Current– heavy 6500 (19215) 22071 (54349) 32580 (61111) 
Diabetic status    
Healthy 5539 (13169) 21728 (56399) 30766 (73756) 
Diabetes mellitus 7246 (20397) 26616 (84427) 34893 (107047) 
Tooth loss1    
0-9 lost teeth 4867 (12089) 18727 (48253) 27334 (63495) 
10-18 lost teeth 5770 (16539) 23813 (71346) 32668 (83626) 
19-32 lost teeth 11044 (25744) 34946 (143873) 49798 (222836) 
Age (rho, 95% CL) 0.05 (-0.01, 0.11) 0.02 (-0.04, 0.08) 0.03 (-0.04, 0.09) 
BMI (rho, 95% CL) 0.01 (-0.05, 0.08) 0.01 (-0.05, 0.06) 0.01 (-0.06, 0.07) 
Number of natural teeth 
(rho, 95% CL) -0.14 (-0.20, -0.08) -0.13(-0.20, -0.07) -0.15 (-0.21, -0.09) 
1Kruskal-Wallis test of stratum-specific bacterial count estimates P<0.05 
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Table A7. Median (interquartile range, IQR) values of sub-gingival microbial counts 
of the “red” and “orange” complex pathogens, and total microbial load obtained via 
DNA checkerboard immunoblotting, in the total sample, stratified by brushing and 
flossing frequency, dental attendance frequency and reason, and education level among 
the Caucasian participants of the Dental ARIC study, for whom clinical and genetic 
data were matched after exclusions (n=1020) 
 
“Red” complex “Orange” complex Total microbial load 
Total sample 5676 (13629) 22668 (60169) 31640 (76343) 
n 1017 1009 1006 
Brushing frequency 
(yesterday)    
One time or none 6352 (17930) 25038 (80044) 33245 (101539) 
Two or more 5518 (12998) 20464 (49853) 28904 (69526) 
Flossed last week1(total only)    
Did not floss 7244 (19794) 25883 (89482) 33900 (127185) 
Flossed one or more times 5444 (12521) 20006 (48350) 28182 (64442) 
Dental visit reason1    
Regular visits 5397 (12535) 20283 (45756) 29129 (61763) 
Only when problem 9289 (30032) 33660 (150830) 49084 (233372) 
Last dental visit2    
<6 months ago 5338 (12387) 20822 (45828) 28888 (62424) 
6-24 months 6251 (18396) 21441 (69189) 31233 (131809) 
More than 2 years ago 9525 (39649) 40110 (176897) 54380 (367130) 
Education level2    
Basic (0-11 years) 8709 (29505) 33695 (158940) 49798 (220499) 
Intermediate (12-15 years) 6356 (13756) 23504 (65055) 32477 (82767) 
Advanced (16+ years) 4935 (12199) 19120 (43498) 27929 (58540) 
1Median test of stratum-specific bacterial count estimates P<0.05; 2Kruskal-Wallis test of 
stratum-specific bacterial count estimates P<0.05 
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Table A8. Sample power calculation for SNP main effect among the ARIC cohort study 
whites. Assumptions are: MAF 0.1-0.5, estimated SNP effects of 1.1-1.6, and outcome 
prevalence 0.2 (severe periodontitis). 
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Table A9 Sample power calculation for SNP main effect among the ARIC cohort study 
whites. Assumptions are: MAF 0.1-0.5, estimated SNP effects of 1.2-1.6, and outcome 
prevalence 0.2 (highest quintile of bacterial colonization phenotypes). 
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Table A10. Sample power calculation for SNP*environment interaction among Caucasians. 
Assumptions are: MAF 0.1-0.5, estimated SNP effect of 1.4, environmental factor prevalence 
0.1 (current heavy smoking), interaction effect 1.2-2.0 and outcome prevalence 0.2 (severe 
periodontitis). 
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Table A11 Sample power calculation for SNP*environment interaction among Caucasians. 
Assumptions are: MAF 0.1-0.5, estimated SNP effect of 1.4, environmental factor prevalence 
0.5 (ever smoker), interaction effect 1.2-2.0 and outcome prevalence 0.2 (severe 
periodontitis). 
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Table A12 Sample power calculation for SNP main effect among African Americans. 
Assumptions are: MAF 0.1-0.5, estimated SNP effects of 1.3-1.7 and outcome prevalence 0.2 
(severe periodontitis). 
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Table A13. Results of SNP interactions (interaction term P<10-5) with sex, diabetes (binary) and smoking status (never, ever, current) in the 
GWA analysis of chronic periodontitis (“extent” of disease trait: proportion of sites exhibiting attachment loss ≥3 mm) among the white Dental 
ARIC participants (n=4610). 
SNP interaction with Sex  SNP interaction with Diabetes Mellitus  SNP interaction with Smoking 
C
hr SNP 
Position  
Build36 
Nearby gene 
(location) 
P 
value  
Ch
r SNP 
Position  
Build36 
Nearby gene 
(location) P value  
Chr
. SNP 
Position  
Build36 
Nearby gene 
(location) P value 
7 rs616939 152391164 ACTR3B (208Kb) 1.4x10
-
6
 
 11 rs7107482 rs7107482 NAV2 (intronic) 1.1x10-7  19 rs8111486 16732705 NWD1 (intronic) 2.0x10-7 
1 rs1551110 105334285 LOC100129138 (913Kb) 
1.5x10-
6
 
 3 rs1405597 rs1405597 C3orf58 (603Kb) 2.4x10
-7
  2 rs1533528 199322315 SATB2 (520Kb) 4.2x10-7 
4 rs10019569 148166054 TTC19 (78Kb) 
2.0x10-
6
 
 10 rs594612 rs594612 NRG3 (intronic) 3.3x10-7  12 rs17676308 51310951 KRT73 (12Kb); KRT2 (14Kb) 1.4x10
-6
 
8 rs12155819 9610089 TNKS (intronic) 
2.3x10-
6
 
 5 rs2160058 rs2160058 ACTBL2 (287Kb) 3.8x10
-7
  7 rs850380 144771261 
TPK1 (607Kb); 
CNTNAP2 
(673Kb) 
2.2x10-6 
4 rs1372486 46864735 GABRB1 (intronic) 
2.5x10-
6
 
 5 rs9327150 rs9327150 PRR16 (intronic) 1.4x10-6  2 rs1505839 139512322 NXPH2 (258Kb) 2.2x10-6 
12 rs4761973 50166536 SLC4A8 2.6x10
-
6
 
 6 rs9461680 rs9461680 HLA-C (3Kb); HCG27 (69Kb) 1.4x10
-6
  12 rs12312201 15003845 ARHGDIB (intronic) 2.9x10
-6
 
1 rs4659467 234987803 ACTN2 (intronic) 3.0x10
-
6
 
 16 rs9302669 rs9302669 MMP2 (56Kb); LPCAT2 (86Kb) 3.4x10
-6
  2 rs17288217 175581131 CHN1 (3Kb); ATF2 (66Kb) 4.5x10
-6
 
13 rs10851261 110767630 
C13orf16 (3Kb); 
ARHGEF7 (12Kb) 
3.3x10-
6
 
 3 rs795346 rs795346 TGFBR2 (5Kb); GADL1 (27Kb) 3.4x10
-6
  18 rs10871635 64716612 CCDC102B (intronic) 4.7x10
-6
 
8 rs2063794 78581773 PEX2 (506Kb) 3.6x10
-
6
 
 2 rs7603311 rs7603311 
STON1-
GTF2A1L 
(38Kb); LHCGR 
(58Kb) 
3.6x10-6  2 rs16861555 14354512 FAM84A (336Kb) 5.8x10
-6
 
12 rs10505960 25165034 CASC1 (intronic) 
4.8x10-
6
 
 15 rs11073534 
rs1107353
4 
LOC91948 
(470Kb) 4.7x10
-6
  3 rs9817711 102371842 IMPG2 (56Kb) 6.5x10-6 
6 rs2326476 4234898 ECI2 (154Kb) 4.8x10
-
6
 
 18 rs948649 rs948649 BOD1P (56Kb) 5.0x10-6  15 rs2413906 46557872 FBN1 (intronic) 7.5x10-6 
16 rs11643337 78900950 
DYNLRB2 
(231Kb) 
5.8x10-
6
 
 3 rs1370045 rs1370045 VGLL3 (25Kb) 5.1x10-6  1 rs9326028 54523213 SSBP3 (intronic) 8.3x10-6 
6 rs1204245 13983271 RNF182 (49Kb) 6.1x10
-
6
 
 9 rs413553 rs413553 PTPRD (intronic) 5.4x10
-6
       
 
21 rs2834319 34278895 ATP5O (69Kb); SLC5A3 (89Kb) 
6.4x10-
6
 
 17 rs12450764 
rs1245076
4 
LOC100499467 
(intronic) 5.6x10
-6
       
 
5 rs7380768 62952975 HTR1A (339Kb) 6.6x10
-
6
 
 6 rs2814124 rs2814124 
MCART3P 
(1Kb); EYS 
(83Kb) 
6.2x10-6       
 
14 rs10140314 21139677 OR10G3 (31Kb) 
7.7x10-
6
 
 9 rs2309932 rs2309932 TMEM2 (195Kb) 6.5x10
-6
       
 
4 rs12641678 174096485 
GALNTL6 
(intronic) 
8.4x10-
6
 
 8 rs17348575 
rs1734857
5 
CSMD1 
(intronic) 7.2x10
-6
       
 
5 rs323565 40884560 CARD6 (intronic) 9.0x10
-
6
 
             
 
9 rs7864512 37939638 SHB (intronic) 9.4x10
-
6
 
             
 
3 rs6767604 176063265 NAALADL2 (intronic) 
9.7x10-
6
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Table A14. Genome-wide association analysis results of the CDC/AAP chronic periodontitis (CP) 
classification traits (severe CP vs. healthy and moderate CP vs. healthy) and extent of attachment loss 
trait (EAL-proportion of sites exhibiting attachment loss ≥3mm), among the white participants of the 
Dental ARIC study (n=4610). Supplemental list of single nucleotide polymorphisms (SNPs) with 
minor allele frequency (MAF-HapMap II CEU) of ≥5% and that emerged below the P<5x10-6 in the 
“sensitivity” analysis that included logistic regression models adjusted for diabetes (binary variable) 
and smoking (never, former, current).  
Chr. SNP 
Position  
Build36 ca1 nca2 
Risk allele 
frequency 
(HapMap 
II- CEU) 
Closest gene(s) 
and position or 
distance 
Risk allele 
frequency 
“cases”/ 
healthy 
P value 
(adjusted) 3 
Odds ratio/beta 
(95% CI4; 
adjusted) 3 
Severe CP         
1p21.1 rs10493998 103500842 C T 0.120 
COL11A1 
(154Kb); RNPC3 
(340Kb) 
0.148/0.109 2.2x10-6 1.68 (1.36, 2.08) 
4q21.3 rs17006135 83836002 C T 0.071 SCD5 (36Kb); SEC31A (123Kb) 0.096/0.059 4.4x10
-6
 1.82 (1.41, 2.35) 
Moderate CP 
 
  
     
12q15 rs11615037 67741708 C G 0.276 CPM (98Kb); CPSF6 (178Kb) 0.281/0.244 4.4x10
-6
 1.33 (1.18, 1.51) 
EAL 
 
 
  
     
4q21.3 rs17006135 83836002 C T 0.071 SCD5 (36Kb); SEC31A (123Kb)  8.2x10
-7
 3.15 (1.90, 4.41) 
14q21.3 rs8006336 48388426 A G 0.651 RPS29 (726Kb); 
PPIL5 (747Kb)  1.4x10
-6
 1.68 (1.00, 2.36) 
1: coded allele 
2: non-coded allele 
3: based on logistic regression models that were adjusted for diabetes (binary) and smoking (never, former, current) 
4: Confidence interval 
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Table A15. Coded and non-coded alleles of prioritized SNPs for severe and moderate 
CP on the Affymetrix 6.0 (ARIC GWAS) and the Illumina Human 1M Duo (ver.3) 
(Health ABC GWAS) platforms. Pending verification by the Health ABC 
collaborating group. 
 Affymetrix 6.0 Illumina Human1M Duo Beadchip 
 
SNP Coded 
allele 
Non-coded 
allele 
Coded 
allele 
Non-coded 
allele 
Different 
strand 
(yes/no) 
rs12883458 C T C T No 
rs2521634 A G A G No 
rs11925054 G T G T No 
rs10493998 C T C T No 
rs17006135 C T C T No 
rs7762544 A G A G No 
rs3826782 A G A G No 
rs12260727 A G A G No 
rs11615037 C G C G No 
 
 
 
 
 
 
 
 
 199 
 
 
Table A16. Genome-wide association replication results [SNPs prioritized based on a 
P<5x10-6 threshold in the dental ARIC (n=4610)] of severe and moderate CP in the Health 
ABC cohort. Reported estimates correspond to the ARIC cohort ‘risk’ allele effect on severe 
and moderate CP and EAL in the Health ABC cohort.  
 Severe CP Moderate CP EAL 
dbSNP P-value OR (95% CI) P-value OR (95% CI) P-value beta (95% CI) 
Severe CP       
rs128834581 0.25 0.65 (0.31, 1.34) 0.71 0.90 (0.51, 1.58) 0.56 -0.05 (-0.21, 0.11) 
rs2521634 0.05 1.65 (1.01, 2.69) 0.03 1.63 (1.06, 2.51) 0.53 0.04 (-0.08, 0.16) 
rs119250541 0.06 0.51 (0.25, 1.04) 0.05 0.53 (0.29, 0.98) 0.27 -0.08 (-0.22, 0.06) 
rs104939982 0.89 1.06 (0.52, 2.15) 0.34 1.31 (0.76, 1.31) 0.24 0.09 (-0.05, 0.23) 
rs170061351,2,3 0.03 0.43 (0.20, 0.90) 0.32 0.73 (0.40, 1.35) 0.39 -0.08 (-0.26, 0.26) 
Moderate CP       
rs7762544 0.34 1.30 (0.76, 2.20) 0.28 1.32 (0.81, 2.16) 0.77 0.02 (-0.10, 0.14) 
rs3826782 0.01 4.18 (1.66, 10.50) 0.06 2.08 (0.99, 4.37) 0.10 0.14 (-0.04, 0.32) 
rs122607271 0.29 1.39 (0.74, 2.60) 0.80 0.93 (0.55, 1.58) 0.11 -0.11 (-0.25, 0.03) 
rs116150371,2 0.37 0.78 (0.46, 1.32) 0.77 0.93 (0.61, 1.44) 0.81 0.02 (-0.10, 0.14) 
1 opposite direction effect; verification of coded SNP in Health ABC GWAS is pending 
2 SNPs that were prioritized based on the P<5x10-6 criterion in exploratory smoking- and diabetes-adjusted 
analysis 
3 rs17006135 marked a shared risk locus for severe CP and EAL in the Dental ARIC GWAS adjusted 
exploratory analysis 
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Table A17. Replication of GWAS results (P-values and effect estimates) of prioritized SNPs 
of the ARIC genome-wide association analysis (crude and exploratory smoking and diabetes-
adjusted analyses) in the Health ABC cohort. Reported effect estimates correspond to the 
‘risk’ allele in the ARIC cohort. 
 ARIC GWAS ARIC GWAS adjusted Health ABC 
dbSNP P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) 
Severe CP       
rs128834581 3.5x10-7 1.89 (1.48, 2.41) 1.1x10-6 1.88 (1.46, 2.43) 0.25 0.65 (0.31, 1.34) 
rs2521634 1.6x10-6 1.47 (1.25, 1.73) 2.6x10-5 1.43 (1.21, 1.69) 0.05 1.65 (1.01, 2.69) 
rs119250541 6.5x10-7 1.69 (1.37, 2.10) 2.6x10-7 1.78 (1.42, 2.23) 0.06 0.51 (0.25, 1.04) 
rs104939982 9.2x10-6 1.59 (1.30, 1.95) 2.2x10-6 1.68 (1.36, 2.08) 0.89 1.06 (0.52, 2.15) 
rs170061351,2,3 1.8x10-5 1.70 (1.34, 2.16) 4.4x10-6 1.82 (1.41, 2.35) 0.03 0.43 (0.20, 0.90) 
Moderate CP       
rs7762544 1.1x10-7 1.41 (1.24, 1.60) 3.8x10-8 1.44 (1.26, 1.63) 0.28 1.32 (0.81, 2.16) 
rs3826782 4.0x10-6 2.00 (1.48, 2.70) 1.4x10-6 2.09 (1.54, 2.84) 0.06 2.08 (0.99, 4.37) 
rs122607271 6.0x10-7 1.54 (1.30, 1.82) 3.0x10-6 1.51 (1.27, 1.79) 0.80 0.93 (0.55, 1.58) 
rs116150371,2 2.6x10-5 1.29 (1.15, 1.46) 4.4x10-6 1.33 (1.18, 1.51) 0.77 0.93 (0.61, 1.44) 
1 opposite direction effect; verification of coded SNP in Health ABC GWAS is pending 
2 SNPs that were prioritized based on the P<5x10-6 criterion in exploratory smoking- and diabetes-adjusted 
analysis 
3 rs17006135 marked a shared risk locus for severe CP and EAL in the Dental ARIC GWAS adjusted 
exploratory analysis 
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Table A18. Meta-analysis of GWAS results (meta-analysis P-values and effect estimates based on inverse variance 
weighting) of prioritized SNPs for severe and moderate CP in the ARIC and the Health ABC studies. Reported effect 
estimates correspond to the ‘risk’ allele in the ARIC cohort. Pooled estimates based on inverse-variance meta-analysis are 
presented for results that did not demonstrate substantial heterogeneity (homogeneity X2 P<0.2 criterion). 
 ARIC GWAS Health ABC Meta-analysis 
     Pooled estimates Heterogeneity assessment2 
dbSNP P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) 
Diff. 
directi
on I2 X2 P<0.2 
Severe CP           
rs12883458 3.5x10-7 1.89 (1.48, 2.41) 0.25 0.65 (0.31, 1.34)   * 86.6 7.5 * 
rs2521634 1.6x10-6 1.47 (1.25, 1.73) 0.05 1.65 (1.01, 2.69) 3.5x10-7 1.49 (1.28, 1.73)  0 0.2  
rs11925054 6.5x10-7 1.69 (1.37, 2.10) 0.06 0.51 (0.25, 1.04)   * 90.1 10.1 * 
rs104939981 9.2x10-6 1.59 (1.30, 1.95) 0.89 1.06 (0.52, 2.15)    48.7 2.0 * 
rs170061351 1.8x10-5 1.70 (1.34, 2.16) 0.03 0.43 (0.20, 0.90)   * 91.6 11.9 * 
Moderate CP           
rs7762544 1.1x10-7 1.41 (1.24, 1.60) 0.28 1.32 (0.81, 2.16) 7.5x10-8 1.40 (1.24, 1.59)  0 0.6  
rs3826782 4.0x10-6 2.00 (1.48, 2.70) 0.06 2.08 (0.99, 4.37) 8.2x10-7 2.01 (1.52, 2.65)  0 0.9  
rs12260727 6.0x10-7 1.54 (1.30, 1.82) 0.80 0.43 (0.20, 0.90)   * 67.7 3.1 * 
rs116150371 2.6x10-5 1.29 (1.15, 1.46) 0.77 0.93 (0.61, 1.44)   * 51.4 2.6 * 
1 SNPs that were prioritized based on the P<5x10-6 criterion in exploratory smoking- and diabetes-adjusted analysis in 
the ARIC cohort 
2 Asterisks (*) correspond to effects of different direction in the ARIC and Health ABC cohorts, and homogeneity X2 P-
values of less than 0.2 
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FIGURES 
 
Figure A1. Power calculation for severe CP among whites for MAF: 0.1-0.5. 
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Figure A2. Power calculation for the “high” bacterial colonization trait among whites 
for MAF: 0.1-0.5. 
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Figure A3. Power calculation for GxE interaction effects for severe CP, assuming 
‘exposure’ prevalence 0.5 and MAF: 0.1-0.5 among the dental ARIC whites. 
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Figure A4. Power calculation for GxE interaction effects for severe CP, assuming 
‘exposure’ prevalence 0.1 and MAF: 0.1-0.5 among the dental ARIC whites. 
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Figure A5. Density plot of average DST among the ARIC cohort study whites zoomed in the 
regions of DST cut-offs for related individuals (first degree DST ≥0.8, second degree 0.745 ≤ 
DST < 0.8). Red dots represent those 380 pairs of first degree and 207 pairs of second degree 
relatives. 
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Figure A6. Density plot of average DST among the ARIC cohort study whites. Red dots 
represent 16 genetic outliers based on average DST values. 
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Figure A.7 Scatter plot matrix of the ten principal components generated with the 
EIGENSTRAT program for the white ARIC cohort study genotyped participants. 
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Figure A.8 Catalogue of published GWA studies (n=951) through June 2011.  
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Figure A.9 Visualization of the 14q21 locus that was marked by rs12883458 (P=3.5x10-7) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort combined with a linkage disequilibrium plot 
generated with Haploview (based on 1000 genomes pilot 1 release haplotype data). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 211 
 
Figure A.10 Visualization of the 7p15 locus that was marked by rs2521634 (P=1.6x10-6) for 
severe chronic periodontitis among the 4610 white participants of the Dental Atherosclerosis 
in Communities Study cohort combined with a linkage disequilibrium plot generated with 
Haploview (based on 1000 genomes pilot 1 release haplotype data). 
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Figure A.11 Visualization of the 3p21 locus that was marked by rs11925054 (P=6.5x10-7) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort combined with a linkage disequilibrium plot 
generated with Haploview (based on 1000 genomes pilot 1 release haplotype data). 
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Figure A.12 Visualization of the 6p21.1 locus that was marked by rs7762544 (P=1.1x10-7) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort combined with a linkage disequilibrium plot 
generated with Haploview (based on 1000 genomes pilot 1 release haplotype data). 
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Figure A.13 Visualization of the 19p13.3 locus that was marked by rs3826782 (P=4.0x10-6) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort combined with a linkage disequilibrium plot 
generated with Haploview (based on 1000 genomes pilot 1 release haplotype data). 
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Figure A.14 Visualization of the 10p15 locus that was marked by rs12260727 (P=6.0x10-7) 
for moderate chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort combined with a linkage disequilibrium plot 
generated with Haploview (based on 1000 genomes pilot 1 release haplotype data). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 216 
 
Figure A.15 Visualization of the 6q15 locus that was marked by rs17792917 (P=1.8x10-6) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort combined with a linkage disequilibrium plot 
generated with Haploview (based on 1000 genomes pilot 1 release haplotype data). 
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Figure A.16 Visualization of the 4q21.3 locus that was marked by rs17006135 (P=4.4x10-6 
after adjustment for smoking and diabetic status) for severe chronic periodontitis among the 
4610 white participants of the Dental Atherosclerosis in Communities Study cohort 
combined with a linkage disequilibrium plot generated with Haploview (based on 1000 
genomes pilot 1 release haplotype data). 
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Figure A.17 Visualization of the 11q22 locus that was marked by rs7120142 (P=3.9x10-6) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort combined with a linkage disequilibrium plot 
generated with Haploview (based on 1000 genomes pilot 1 release haplotype data). 
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Figure A.18 Visualization of the 7q34 locus that was marked by rs10500130 (P=4.6x10-6) 
for severe chronic periodontitis among the 4610 white participants of the Dental 
Atherosclerosis in Communities Study cohort combined with a linkage disequilibrium plot 
generated with Haploview (based on 1000 genomes pilot 1 release haplotype data). 
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Figure A.19 Visualization of the 1q42 locus that was marked by rs11800854 (P=4.0x10-6) 
for “high” Aggregatibacter actinomycetemcomitans colonization among the subset of 1020 
white participants of the Dental Atherosclerosis in Communities Study cohort combined with 
a linkage disequilibrium plot generated with Haploview (based on 1000 genomes pilot 1 
release haplotype data). 
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Figure A.20 Visualization of the 1p22 locus that was marked by rs12032672 (P=9.6x10-7) 
for “high red” complex bacterial colonization among the subset of 1020 white participants of 
the Dental Atherosclerosis in Communities Study cohort combined with a linkage 
disequilibrium plot generated with Haploview (based on 1000 genomes pilot 1 release 
haplotype data). 
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Figure A.21 Visualization of the 5q33 locus that was marked by rs10043775 (P=2.4x10-6) 
for “high red” complex bacterial colonization among the subset of 1020 white participants of 
the Dental Atherosclerosis in Communities Study cohort combined with a linkage 
disequilibrium plot generated with Haploview (based on 1000 genomes pilot 1 release 
haplotype data). 
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Figure A.22 Visualization of the 9p24 locus that was marked by rs16924631 (P=3.2x10-6) 
for “high red” complex bacterial colonization among the subset of 1020 white participants of 
the Dental Atherosclerosis in Communities Study cohort combined with a linkage 
disequilibrium plot generated with Haploview (based on 1000 genomes pilot 1 release 
haplotype data). 
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Figure A.23 Visualization of the 4p14 locus that was marked by rs10010758 (P=3.7x10-6) 
for “high red” complex bacterial colonization among the subset of 1020 white participants of 
the Dental Atherosclerosis in Communities Study cohort combined with a linkage 
disequilibrium plot generated with Haploview (based on 1000 genomes pilot 1 release 
haplotype data). 
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Figure A.24 Visualization of the 1p36.2 locus that was marked by rs1616122 (P=4.9x10-6) 
for “high orange” complex bacterial colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort combined with a 
linkage disequilibrium plot generated with Haploview (based on 1000 genomes pilot 1 
release haplotype data). 
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Figure A.25 Visualization of the 1q42 locus that was marked by rs11800854 (P=4.0x10-6) 
for “high” Aggregatibacter actinomycetemcomitans colonization among the subset of 1020 
white participants of the Dental Atherosclerosis in Communities Study cohort combined with 
a linkage disequilibrium plot generated with Haploview (based on 1000 genomes pilot 1 
release haplotype data). 
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Figure A.26 Visualization of the 9q33.2 locus that was marked by rs10760187 (P=4.5x10-7) 
for “high” Porphyromonas gingivalis colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort combined with a 
linkage disequilibrium plot generated with Haploview (based on 1000 genomes pilot 1 
release haplotype data). 
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Figure A.27 Visualization of the 10p11.21 locus that was marked by rs1360573 (P=1.5x10-6) 
for “high” Porphyromonas gingivalis colonization among the subset of 1020 white 
participants of the Dental Atherosclerosis in Communities Study cohort combined with a 
linkage disequilibrium plot generated with Haploview (based on 1000 genomes pilot 1 
release haplotype data). 
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Figure A.28 Predicted network of associations [physical interactions (grey line), co-
expression (dark blue line), pathway (light blue line), shared protein domain (green line)] 
among genes of prioritized loci for the CP and the “high” bacterial traits in the Dental ARIC 
cohort. Grey lines represent co-expression and blue lines represent physical interactions. 
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Figure A.29 Predicted network of associations [physical interactions (grey line), co-
expression (dark blue line), pathway (light blue line), shared protein domain (green line)], 
generated with the GeneMANIA module) among genes of prioritized loci for the CP and the 
“high” bacterial traits in the Dental ARIC cohort, along with genes that have been previously 
reported to be associated with periodontitis.  
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Figure A.30 Visualization of GWA results for severe CP in the ARIC cohort for loci that 
have been previously associated with periodontitis (IL1A, IL1RN, TLR4, MMP2, GLT6D1, 
GCGR3A). The vertical axis corresponds to each marker’s associated –log10 P-value. The 
overlaid recombination rate plot and the color-coded pairwise linkage disequilibrium values 
with index SNPs were calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure A.31 Visualization of GWA results for moderate CP in the ARIC cohort for loci that 
have been previously associated with periodontitis (IL1A, IL1RN, TLR4, MMP2, GLT6D1, 
GCGR3A). The vertical axis corresponds to each marker’s associated –log10 P-value. The 
overlaid recombination rate plot and the color-coded pairwise linkage disequilibrium values 
with index SNPs were calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure A.32 Visualization of GWA results for the extent of attachment loss trait (proportion 
of sites exhibiting ≥3mm attachment loss) CP in the ARIC cohort for loci that have been 
previously associated with periodontitis (IL1A, IL1RN, TLR4, MMP2, GLT6D1, GCGR3A). 
The vertical axis corresponds to each marker’s associated –log10 P-value. The overlaid 
recombination rate plot and the color-coded pairwise linkage disequilibrium values with 
index SNPs were calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure A.33 Visualization of GWAS results in the IL6 (Interleukin 6) and VDR (vitamin D 
receptor) loci in the ARIC cohort for severe (left column) and moderate CP (right column). 
The vertical axis corresponds to each marker’s associated –log10 P-value. The overlaid 
recombination rate plot and the color-coded pairwise linkage disequilibrium values with 
index SNPs were calculated based on HapMap II – CEU (human genome 18, build 36). 
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Figure A.34 Visualization of the 6p21.1 locus (chr6:41,279,315-41,479,315; flanking 100Kb 
of rs7762544, which was prioritized for moderate CP) using the ENCODE/USCF browser 
and displaying enhancer/promoter associated regions and DNaseI hypersensitivity clusters.  
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Figure A.35 Visualization of the 19p13.3 locus (chr19:6,787,736-6,987,736; flanking 100Kb 
of rs3826782, which was prioritized for moderate CP) using the ENCODE/USCF browser 
and displaying enhancer/promoter associated regions and DNaseI hypersensitivity clusters. 
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Figure A.36 Visualization of the 10p15locus (chr10:10,238,329-10,438,329; flanking 100Kb 
of rs12260727, which was prioritized for moderate CP) using the ENCODE/USCF browser 
and displaying enhancer/promoter associated regions and DNaseI hypersensitivity clusters. 
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Figure A.37 Visualization of the 14q21 locus (chr14:51,179,379-51,379,379; flanking 
100Kb of rs12883458, which was prioritized for severe CP) using the ENCODE/USCF 
browser and displaying enhancer/promoter associated regions and DNaseI hypersensitivity 
clusters. 
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Figure A.38 Visualization of the 7p15 locus (chr7:24,278,040-24,478,040; flanking 100Kb 
of rs2521634, which was prioritized for severe CP) using the ENCODE/USCF browser and 
displaying enhancer/promoter associated regions and DNaseI hypersensitivity clusters. 
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Figure A.39 Visualization of the 3p21 locus (chr3:55,290,886-55,490,886; flanking 100Kb 
of rs11925054, which was prioritized for severe CP) using the ENCODE/USCF browser and 
displaying enhancer/promoter associated regions and DNaseI hypersensitivity clusters. 
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Figure A.40 Visualization of the 6q15 locus (chr6:85,166,965-85,366,965; flanking 100Kb 
of rs17792917, which was prioritized for the “extent” of attachment loss trait) using the 
ENCODE/USCF browser and displaying enhancer/promoter associated regions and DNaseI 
hypersensitivity clusters. 
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Figure A.41 Visualization of the 11q24 locus (chr11:127,557,071-127,757,071; flanking 
100Kb of rs10790919, which was prioritized for the “extent” of attachment loss trait) using 
the ENCODE/USCF browser and displaying enhancer/promoter associated regions and 
DNaseI hypersensitivity clusters. 
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Figure A.42 Visualization of the 11q22  locus (chr11:103,317,781-103,517,781; flanking 
100Kb of rs7120142, which was prioritized for the “extent” of attachment loss trait) using 
the ENCODE/USCF browser and displaying enhancer/promoter associated regions and 
DNaseI hypersensitivity clusters. 
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Figure A.43 Visualization of the 7q34 locus (chr7:138,715,913-138,915,913; flanking 
100Kb of rs10500130, which was prioritized for the “extent” of attachment loss trait) using 
the ENCODE/USCF browser and displaying enhancer/promoter associated regions and 
DNaseI hypersensitivity clusters. 
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